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Abstract
Evi-l shows a temporally and spatially restricted pattern of expression in murine 
embryonic development and is expressed predominantly in the kidney, lung and 
developing oocytes of adult mice. The positions of DNAse 1 hypersensitive sites (DHS) 
within an 18kb region of the 5' Evi-l locus have been examined to identify putative Evi- 
1 gene regulatory regions, in murine kidney and spleen tissues. This analysis identified 
two DHS sites designated DHS I and DHS II. DHS I is located approximately 2kb 
upstream of the transcription initiation sites whereas DHS II maps over exon I.
The transcriptional activity of the Evi-l promoter has been investigated by 
inserting the 5' region of the gene into a luciferase construct and the activity examined 
by transient transfection of cells which express low levels of Evi-l. A substantial 
induction of luciferase activity is observed with a 5kb fragment of the 5' Evi-l locus 
containing exon I, intron I and exon II which includes DHS I and DHS II.
Subsequent deletion mutagenesis has identfied two regions within DHS II, 
located between -338 to -284 and -284 to -254, which upon removal result in a 
substantial reduction of promoter activity. One of these, located between -338 to -284, 
binds several proteins when examined by footprinting and electrophoretic mobility shift 
assays. Interestingly, the most abundant factor, designated EvBPl, has been shown to 
bind a 14bp imperfect palindromic sequence, tttccctggggaaa, which is absolutely 
conserved in the human Evi-l promoter sequence. This sequence contains homology 
with putative binding sites for, AP3, AP2 and C/EBP. However, competition studies in 
EMS A with consensus binding site oligonucleotides failed to identify the components of 
EvBPl. EvBPl might be a novel ubiquitous transcription factor which is required for 
regulation of the Evi-l promoter. Furthermore, EMSA analysis of the second deleted 
region between -284 to -254 has identified a CCAAT binding protein, possibly CPI, 
which may also be important in basal promoter activity.
Functional assays have failed to identify either promoter or enhancer activity for 
DHS I. Since there are no known appropriate high Evi-l expressing cell lines we have 
established Evi-l expressing kidney cultures as a system to examine tissue specific 
expression. This allowed the identification of a 3kb region necessary for higher activity 
in the cultures. This activity might correlate with a DHS site which is part of DHS II 
complex.
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Part 1: Introduction
Chapter 1. Eukaryotic gene transcription
1.1 Transcription control sequences in eukaryotes
Transcription in eukaryotes is dependent on three different RNA polymerases; 
RNA polymerase I which transcribes large ribosomal RNAs (rRNA); RNA polymerase 
13; which transcribes messenger RNA (mRNA) and RNA polymerase III; which 
transcribes transfer RNAs (tRNA) and small nuclear RNAs (snRNA). Although all the 
polymerases are capable of transcribing RNA synthesis from a DNA template they 
require accessory protein factors to initiate transcription from the appropriate start site 
in specific promoters. Since the emphasis of this thesis is on transcriptional regulation 
of a polymerase II gene, which is also responsible for transcribing the majority of genes, 
it will be discussed below. However, many of the principles for RNA polymerase II are 
the same for the other polymerases.
Promoters:TATA box and the basal transcription machinery
Basal transcription is dependent on the regulated assembly of multi-protein 
complexes to ds-acting sites within the promoter regions of genes. The pivotal 
component, and the DNA binding activity, of the transcription machinery was originally 
identified as a general initiation factor for RNA polymerase II (pol II), designated 
TFIID (Matsui et al., 1980). TFIID binds to a conserved ds-acting element containing a 
TATAAAA or related sequence (TATA box) (Sowadogo & Roeder, 1985b; Nakajima 
et al., 1988) which in higher eukaryotes is located about 25-30 nucleotides upstream of 
the transcription start site in the majority of gene promoters transcribed by RNA 
polymerase II (class II promoters) (Breathnach & Chambon, 1981). Interestingly, TFIID 
is itself a multi-protein complex composed of a TATA binding protein (TBP) which is
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responsible for binding to the TATA box and TBP associated factors (TAFs) which are 
important for activator-responsive transcription (reviewed by Hernandez, 1993). 
Although initiation complex formation and subsequent basal transcription by RNA 
polymerase II may be mediated by TBP alone in a reconstituted system, TAFs are 
necessary for response to activators and is probably more reflective of the in vivo 
situation.
In the presence of activators, the initiation complex is formed by the binding of 
TFIID to the TATA box. TBP binding to the TATA box results in the DNA being 
severely bent to accommodate the convex undersurface of the TBP saddle. As a 
consequence binding sites for two other general transcription factors, TF11A and TFIIB, 
are more accessible and therefore bind TFIID to stabilises DNA bending within the 
promoter. This sub-complex is then further stabilised by the recruitment of pol II and 
TFIIF to form a minimal initiation complex. Subsequently, two other general factors, 
TFIIE and TFIIH, bind to form a complete initiation complex (reviewed by Zawel & 
Reinberg, 1993; Buratowski, 1994). Transcription is then initiated in a final ATP- 
dependent step mediated by the helicase activity of TFIIH, which allows conversion of 
the initiation complex to an elongation complex thereby facilitating promoter clearance 
(Goodrich & Tjian, 1994).
Despite no recognisable TATA box sequence the TFIID complex has also been 
shown to be important for the transcription of TATA-less class II promoters (Pugh & 
Tjian, 1990, 1991; Smale et al., 1990). In addition, TFIID is also an important 
component for transcription of RNA polymerase I and III (class I and III respectively) 
(reviewed by Gill, 1992). Interestingly, an initiator (Inr) element, distinct from the 
TATA box, has also been described which directs initiation complex formation from 
TATA-less promoters. The Inr element is also found in TATA containing promoters 
where it may act in isolation or synergistically with the TATA box (Roeder, 1991). A 
number of proteins have been shown to recognise the Inr element including TFII-I (Roy
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et al., 1993), YY1 (Seto et al., 1991) and TAF150 (Verrijzer et al., 1994). The 
mechanism of complex formation by the Inr element is not well understood as for the 
TATA box. However, in vivo studies have suggested that the Inr element is dominant 
over the TATA box in the adenovirus major-late promoter (ad-MLP) which contains 
both elements (Carcamo et al., 1991). It will obviously require further analysis to assess 
if this observation is a general phenomena.
Although TFIID has been shown to be rate limiting in transcription initiation 
presumably other steps in initiation complex assembly may also have a regulatory role 
depending on the local cellular environment, for example, the availability of ATP for 
promoter clearance. Consistent with this, a number of transcriptional regulators bind 
basal transcription factors suggesting that they are targets for activator/repressor 
proteins. It is believed that activators increase the number of initiation complexes, rather 
than their rate of formation (White et al., 1991; 1992; Choy & Green, 1993). Although 
the precise mechanism of rraras-activator mediated transcriptional induction is unknown, 
activators have been shown to directly contact the basal initiation complex presumably 
stabilising complex formation.
As previously mentioned the TAFs are vital for the response of the initiation 
complex to activators. It is therefore significant that an increasing number of TAFs have 
been identified which interact directly with frans-activators (reviewed by Gill & Tijan,
1992). Well studied examples include the lOOkD TAF (TAF110) which interacts with 
the Spl transcription factor (Weinzierl et al., 1993; Hoey et al., 1993) and TAF40 
which binds to the herpes simplex vims trans-activator VP16 (Goodrich et al., 1993). 
In addition, activators may directly interact with the basal transcription factors. For 
example, the activators including the USF (Sowadoga & Roeder, 1985a) and ATF 
(Horikoshi et al., 1988) interact with TFIID, while VP16 may interact with both TFIID 
(Stringer et al., 1990) and TFIIB (Lin & Green, 1991; Lin et al., 1991; Goodrich et a l,
1993). Interestingly, in the absence of a discernible TATA box, upstream activators
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such as Spl have been implicated in directing the TFIID complex to the appropriate 
region of DNA (Dynan, 1986).
Recently inhibitors of initiation complex formation have been identified, Drl and 
Dr2 (Inostrozola et al., 1992; Merino et al., 1993), which bind to TBP and hinder 
access of the basal transcription factors. Interestingly, the TFIIA and GAL4-derived 
activators have been shown to antagonise the action of the Dr2 (found to be 
topoisomerase I) (Merino et al., 1993) by blocking their binding to the TFIID complex.
It is clear that the induction and maintenance of transcription is dependent on 
both the assembly of the basal transcription machinery and co-operation with trans­
activator proteins. Consequently, ds-binding sites for trans-activator proteins are 
consistently present within class II promoters (Guerente & Bermingham-McDonogh, 
1992). A number of conserved trans-activator binding sites have been identified which 
are frequently found in promoter regions (a few are discussed below). In addition, there 
are a diversity of other less common sequences which play important roles in promoter 
regulation which are not mentioned (Faisst & Meyer, 1992).
GC boxes
The GC boxes are GC rich regions of DNA which usually bind the ubiquitous 
transcription factor Spl, although related sites may also be bound by other activators 
including EGR-1 (Christy & Nathans, 1989) and WT1 (Rauscher III et al., 1990). GC 
boxes are found upstream of a number of TATA-containing promoters and act as 
upstream activator sequences to induce transcription. In some genes with TATA-less 
promoters containing multiple GC boxes, Spl binding is crucial for transcription 
initiation (Pugh and Tjian, 1990, 1990). Since TATA-less promoters generally have 
multiple transcription initiation sites this might suggest that the fidelity of this interaction 
may not be as great as for TATA promoters.
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CAAT Boxes
The CAAT box motif is defined by the pentanucleotide sequence CCAAT and is 
commonly found 50-100 nucleotides upstream of the transcriptional initiation site in 
class II promoters. The first CCAAT binding proteins identified were C/EBP (Graves et 
al., 1986) and CTF/NF1 (Jones et al., 1985). The two proteins have different 
properties, C/EBP was found to be heat stabile and would bind a GCAAT mutant 
whereas CTF/NF1 was heat labile and was unable to bind this mutant. C/EBP and 
CTF/NF1 are not related in their DNA binding motifs but may bind the same CCAAT 
binding site in the HSV tk promoter. C/EBP is a member of the basic leucine zipper 
family whereas CTF/NF1 has no structural homology with previously identified 
structural motifs. Subsequent analysis has identified other proteins which bind the 
CCAAT motif, designated CPI and CP2. CPI is a ubiquitous transcription factor and 
is not heat stabile, in contrast to the C/EBP family. Presumably the adjacent sequences 
outside the core site, and the»r profile of expression, contributes to the specificity of 
each of these proteins to particular CCAAT sites.
Octamer
The octamer sequence, defined by ATGCAAAT, was originally identified in the 
immunoglobulin heavy chain (IgH) enhancer and promoter and kappa light chain (IgK) 
promoter (Falkner & Zachau, 1984; Parslow et al., 1984) and was shown to be 
important in lymphoid cell specific expression. The motif was also found in non­
lymphoid restricted promoters, such as the histone H2B promoter (Harvey et al., 1982). 
Two binding activities were originally identified for the octamer motif designated Octl 
and Oct2 (Singh et al., 1986; Staudt et al., 1986). The Octl binding activity was
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observed to be ubiquitous whereas the Oct2 protein was restricted to lymphoid cells 
(Staudt et al., 1986). Separate studies have identified multiple other binding activities 
for the octamer motif suggesting that a range of transcription factors may bind to this 
site {Rosales et al., 1987; Gerster et al., 1987).
1.2 Modularity of promoters
Although the sites described previously have been discussed as separate modules 
the regulation of transcription of class II promoters is more complex being dependent on 
multiple protein/DNA interactions which all contribute to overall activity. This allows 
greater control and flexibility of the promoter in different environments such as during 
development, in cell specificity and in response to hormonal, heat or stress induction.
A number of well characterised promoters including SV40 and HSV tk possess 
activator binding sequences, such as CCAAT and GC boxes, which have intrinsic 
activity in isolation but are collectively essential for maximal activity (Jones et al.,
1985). Interestingly, the binding of multiple activators to a promoter region can lead to 
a synergistic activation, which is characterised by an increase that is greater than the 
activity expected from the sum of the individual binding sites alone. Synergy is 
observed with a number of different transcription factors and probably reflects a 
common theme in eukaryotic gene regulation. The chicken mim-1 gene has been 
shown to be synergistically activated by v-myb and C/EBP transcription factors (Burk et 
al., 1993). Furthermore, synergistic activation of transcription has been observed 
between members of the hormone receptor family. For example, progesterone and 
glucocorticoid may synergistically activate an artificial promoter containing upstream 
GRE and PRE response elements (Tsai et al., 1989).
In addition to synergy, the context of a binding site within a promoter may also 
be important, for example, the mouse major histocompatibility (MHC) class 1 genes are
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responsive to TNFa induction. The promoters contain two binding sites for AP2 and 
KBF1 which are occupied by an AP2-like factor and KBF1 during constitutive levels of 
expression. However, upon induction these factors are displaced by the binding of two 
NF-kB dimers (Israel et al., 1989). This illustrates that the contribution of any given 
binding site to overall activity is dependent on (1) surrounding sites, which may be 
overlapping and (2) the availability, concentration and specificity of different trans­
acting factors. An illustration of altered transcriptional regulatory properties in different 
promoter contexts is given by the GATA-1 transcription factor. The GATA-1 protein 
has been characterised as both a transcriptional activator and a positive regulator of 
erythroid differentiation (Martin et al., 1990; Orkin et al., 1992). By contrast, the 
protein may also act as a developmental repressor in the e-globin gene (Raich et al., 
1995). Transcription factors may therefore act as activators or repressors depending on 
there immediate environment.
1.3 DNA is associated with chromatin
In higher organisms, DNA is generally tightly associated as a nucleoprotein 
complex in chromatin. Chromatin associated DNA is organised into nucleosomes: 
regular repeating structural units consisting of 166bp repeats of DNA wound around a 
histone octamer approximately 1.8 times to form the 'beads-on-a- string' lOnm fibre. 
This basic nucleosomal core is composed of the histones H2, H3, H4, H5 and undergoes 
further condensation, which is mediated by histone HI in the nucleosomal linker to form 
the 30nm fibre. Further condensation then proceeds to form higher order condensed 
structures such as is seen for heterochromatin. However, the molecular framework of 
such structures is not well understood.
Gene transcription in vivo is dependent on the interaction of transcription factor 
proteins with chromatin associated DNA, in contrast to in vitro naked DNA
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transcription from linear templates, which are generally not chromatin associated. In 
this state the DNA is less accessible to transcription factor protein interaction and, as a 
consequence, unable to initiate transcription. In contrast to the bulk of chromatin, 
transcriptionally active regions of DNA acquire a more relaxed, or unwound, structure 
with the chromatin framework.
It has been shown that structural relaxation surrounding transcriptionally active 
genes also correlates with a general increase in the sensitivity to nuclease digestion and 
that small 15-200bp regions exhibit extreme nuclease sensitivity. The most commonly 
used method of mapping nuclease hypersensitive sites (DHS) is DNAse 1 digestion of 
nuclei followed by indirect labelling of the resulting purified double-stranded DNA. 
These DHS sites (Wu et a l , 1979a & b) are generally associated with active promoter 
and enhancer elements (reviewed by Gross and Garrard, 1988). Consequently, mapping 
DNAse 1 sensitivity is a useful method of identifying gaps in the nucleosomal array and 
therefore the location of potentially transcriptionally active genes. However, the 
resolution of the technique, particularly with fragments larger than lkb, is less than 
50bp. A more accurate method for mapping the fine structure of hypersensitivity sites is 
offered by DNAse 1 footprinting. This technique involves running the footprinting 
reactions alongside DNA sequencing tracts of the footprinted region which allows the 
mapping of individual proteins or protein complexes to specific recognition sequences 
(recently reviewed by Plumb and Goodwin, 1991).
1.4 Biology of Hypersensitivity Sites
DHS sites are ubiquitous among eukaryotes, being found in plants, fungi, viral 
and episomal genomes and animals. DHS sites may be conveniently grouped into two 
classes, constitutive or inducible.
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Constitutive DHS sites
These sites are often associated with the promoter regions of low basal 
expressing genes such as housekeeping genes. These DHS sites are also found in 
promoter regions poised for transcriptional activation, such as the mouse 
metallothionein gene (Senear & Palmitter, 1983) and the heat shock genes (Wu, 1980; 
Elgin, 1988). The presence of the constitutive DHS sites are independent of gene 
expression.
Inducible DHS sites
Inducible DHS sites precede gene expression and may persist long after the 
initial stimulus. The nucleosomal displacement associated with induction of a particular 
DHS site is usually concomitant with the activation of a linked gene. Inducible DHS 
sites are classically associated with steroid inducible genes (Jantzen et al., 1987; Kaye et 
a l, 1986) but a variety of other examples exist including, hpopolysaccharide-inducible 
DHS sites in k  immunoglobulin gene enhancer of pre-B-cells (Parslow & Granner,
1983) and light and oxygen tension-inducible DHS sites in plant genes (Paul et al., 
1987; Kaufman et al., 1987).
In addition to inducible DHS sites within a given cell type, DHS sites may also 
be induced in a tissue specific manner. An example of this is the chicken lysozyme gene 
locus. Interestingly this gene locus contains 10 DHS sites, two of which are 
macrophage specific and one is oviduct specific and hormone inducible (Theisen et al.,
1986). The functions of the other sites vary but include constitutive and inducible 
DHS associated sites (Theisen et al., 1986; Steiner et al., 1987; Baniahmad et al.,
1987). This illustrates that DHS sites may be induced in a temporal or spatial manner 
within the same gene locus. In addition to the examples given above, tissue specific
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DHS sites also appear transiently in promoters during differing stages of development as 
in the globin genes (reviewed by Evans et al., 1990).
Presumably the reorganisation in nucleosomal positioning, as assessed by an 
increase in DNA hypersensitivity is necessary, but not sufficient, for transcription 
activation which may also be reliant on limiting transcription factors to achieve optimal 
expression. The functional relevance of DHS sites to transcriptional regulation is 
discussed below. In addition to there putative involvement in transcriptional regulation 
they have been associated with other functions including chromosomal replication, 
recombination and segregation (DePamphilis, 1988 & 1993; Wolffe & Pruss, 1996).
1.5 The inhibitory role of nucleosomes on transcriptional regulation
The 'Pre-emptive'Model
A conceptually simple model for the repressing effect of histones on 
transcription has been proposed which involves the direct blocking of access to ex ­
acting sites within promoter and enhancer regions by histone octamers in resting cells. 
This may be by nucleosomal positioning or a higher-order structure, masking sites which 
would otherwise be exposed to trans-acting transcription factors. Chromatin 
reassembly, or gene activation, would therefore occur during replication when the 
promoter and enhancer regions are partially exposed by the replication fork, and 
allowing direct competition of frans-acting factors and nucleosomes. In this way the 
trans-acting factors must co-operate to create a sufficiently stable complex which 
prevents nucleosome assembly.
The factors vital for stabilising an active transcriptional complex may be 
differentiated from those required for transcription initiation itself. The maintenance of 
nucleosomal free regions is not fully understood, although it has been proposed that
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specific cX-acting structures within DNA aid in this process. For example, AT-rich ex ­
acting scaffold associated regions (SAR) have also been identified as important 
determinants in the maintenance of chromatin structural loops and transcriptionally 
active domains (LaenMlli et al., 1992). These sites may be important in the binding of 
proteins which associate with histone HI and maybe other histone proteins to control 
nucleosome assembly or alternatively may represent sites for topoisomerase enzymes 
which can alter torsion stress of the DNA over large distances, and therefore chromatin 
structure. These mechanisms are not discussed in detail here but are reviewed in 
IM/Mlli et al., 1992.
Alternatively, the folding of DNA during nucleosomal assembly may bring 
together two distant regulatory elements closer together in space (reviewed by van der 
Vliet & Verrijzer, 1993). Such DNA looping(bending) may occur through homo- or 
hetero- dimerisation of widelv spaced trans-actmz factors, such as Spl (Su et al., 1991),
?, progesterone receptor (Theveny et al., 1987) and GATA (Fong & Emerson, 1992). This may 
restrict the formation of repressive histone/DNA contacts and potentiates the 
transcription process, as with the Xenopus vitellogenin B 1 gene promoter, where DNA 
bending allows the interaction of the promoter with oestrogen receptor binding sites 
(Schild et al., 1993).
Support for this model has come from a number of chromatin assembly 
experiments. Pre-initiation complex formation within the adenovirus type-2 major late 
promoter (Ad2-MLP) only occurs before chromatin assembly (Knezetic et al., 1988). 
Furthermore, pre-incubation of Ad2-MLP with TFIID, a component of the pre­
initiation complex, protects the promoter from nucleosomal assembly (Workman & 
Roeder, 1987). Interestingly, if TFIID is added simultaneously with histone proteins in 
the presence of the upstream activator factor (USF) protein a transcriptionally active 
complex is formed (Workman et a l, 1988; Workman et a l, 1990). The mechanism of 
this interaction is unknown but may reflect an increase in overall stability mediated by
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the presence of the USF protein. Similarly experiments have also shown that trans­
acting tissue specific transcription factors bound close to the promoter region of the (3- 
globin gene are able to exclude nucleosomes so long as the nucleosomes were not added 
prior to the transcription factors (Emerson & Felsenfeld., 1984). This suggests that the 
primary role of rraws-activators may be to stabilise the basal transcription machinery, 
resulting in elevated levels of gene expression, which is mediated by the interaction of 
trans-activators with both the transcription machinery and nucleosomes.
Dynamic Model
In the 'dynamic' model trans-acting factors can directly displace/alter 
nucleosomal positioning and consequently is not dependent on DNA replication. An 
example of the 'dynamic' model is illustrated by nucleosomal reorganisation following 
hormone induction of a glucocorticoid-response element (GRE) within the mouse 
mammary tumour virus (MMTV) long terminal repeat (LTR). Prior to induction 
nucleosomes are precisely located along the LTR. Upon induction, the GRE region (-50 
to -250) is bound by its hormone activated receptor, glucocorticoid receptor (GR), 
which displaces a single nucleosome (Richard-Foy & Hager, 1987). This in turn allows 
access of another transcription factor, nuclear factor 1 (NF1) and possibly other factors, 
to this region and subsequent activation of the promoter (Cordingley et al., 1987). This 
response is very rapid with transcriptional activation taking place within a minute of 
exposure to the hormone and the entire process is reversed upon removal of the 
hormone (Zaret & Yamamoto, 1984). In view of this transient nature, presumably 
displacement of the original inducing trans-acting factor (GR) is functionally important 
in controlling reversion of the local chromatin structure. This displacement may be 
mediated by the binding of other higher affinity trans-factors to the promoter, such as 
NF1.
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Similar mechanisms appear to be important in the induction of the 
Saccharomyces cerevisae PH05 gene promoter. The PH05 gene promoter is activated 
in low phosphate conditions and contains functionally important upstream activator 
sequences (UAS) adjacent to the promoter. The nucleosomal positioning over the 
promoter and UAS regions have been determined (Aimer & Horz, 1986). One of the 
UAS sequences contain a DHS site in both inducing and non-inducing conditions. In 
low phosphate conditions the product of the PH04 gene and PH02 gene bind to the 
UAS and displace four nucleosomes exposing the TATA box and a PH04 binding site 
(Aimer et al., 1986; Aimer & Horz., 1986). Overexpression studies revealed that 
displacement of the UAS is dependent on both PH02 and PH04 proteins, since the 
presence of just one protein was insufficient (Fascher et al., 1990).
In contrast to the assumption that all DHS regions are free of nucleosomes, the 
studies with the MMTV LTR also suggest that increased transcription factor binding is 
due to less stringent binding rather than total displacement of the nucleosomal structure. 
This is supported by experiments cross-linking the DHS region induced by GRE/GR 
complex formation in the MMTV LTR and finding it still contains nucleosomal histones 
(Bresnick et al., 1992). However in contradiction to these observation, no histone 
proteins could be cross-linked from the 5' DHS sites of the Drosophila hsp70 genes 
(Karpov et al., 1984) or the 5' DHS site of the chicken p-globin gene (McGhee et al.,
1981). Consequently, there may be more than one mechanism controlling the access of 
transcription factors to DHS regions. In this respect it seems probable that the 
mechanisms of repression mediated by chromatin structure may involve aspects of both 
the pre-emptive and dynamic models, depending on the promoter and the local 
environment.
Genetic analysis carried out in yeast has illustrated the importance of chromatin 
structure as a general repressor of transcription. A single copy of the yeast H4 gene was 
placed under the control of a galactose-inducible promoter and the cells grown on
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glucose media. The subsequent depletion of H4 led to an activation of repressed genes 
including PH05, CYC1 and GAL1 (Han et al., 1988; Han & Grunstein., 1988). The 
induction was independent of upstream activator sequences. However, the level of 
induction was significantly lower then following normal glucose mediated induction of 
the gene. Consequently, the data show that nucleosomes can block transcription from 
inducible promoters, however, full promoter activation requires other factors in addition 
to nucleosomal de-repression. Promoters not affected by nucleosomal loss may 
represent promoter regions constitutively free of nucleosomes, possibly because of the 
presence of activators.
Furthermore genetic analysis, again in yeast, has identified non-histone proteins 
which appear to influence transcription by altering chromatin structure. Mutations in the 
negative regulators SIN1 (a member of the high mobility group (HMG) 1 family) and 
SIN2 (histone H3) were shown to alleviate transcriptional constraints previously 
mediated by mutations in the positive regulating SWI proteins (SWI1, SWI2 and SWI3). 
It has been suggested that the SWI proteins may act to relieve inhibitory effects of 
chromatin structure (Peterson & Hershkowizt, 1992; Hirschhom et al., 1992)). 
Interestingly, a recent study has shown that a SWI/SNF complex may bind DNA and 
introduce positive supercoils, consistent with a role in chromatin structure remodelling 
and transcriptional activation (Quinn et al., 1996). The HMG family are non-histone 
chromosomal associated proteins, which bind to DNA via a HMG-box domain, and 
appear to be important in transcriptional control, although there functions are not well 
understood (reviewed by Landsman and Bustin, 1993).
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1.6 General properties of active chromatin
Active chromatin is characterised by a general depletion of histone HI, 
hypomethylation and histone acetylation. The importance of these three characteristics 
are discussed below;
Histone HI
The linker histone HI can repress transcription by all three RNA polymerases. 
Crosslinking experiments have demonstrated that HI is depleted in active as opposed to 
inactive genes (Nacheva et al., 1989; Bresnick et al., 1992). HI has been implicated in 
the reorganisation of nucleosomal positioning and/or the formation of higher-order 
chromatin structures (Felsenfeld & McGhee, 1986), although the mechanism of action 
is unclear.
Methylation
In vertebrates there is an uneven distribution of the dinucleotide CpG. The bulk 
of DNA is depleted of CpGs with the cytosines within this dinucleotide being methylated 
(Bird, 1987). By contrast, CpG rich stretches of DNA or "CpG islands" are often 
associated with the 5' region of housekeeping and tissue specific genes which are 
generally hypomethylated (Bird, 1986; Gardiner-Garden & Frommer, 1987) although 
this general rule is not true for the genes on the inactivated X-chromosome (Wolf & 
Migeon, 1985).
DNA methylation is generally associated with inactive chromatin, and as a 
consequence has been implicated as a epigenetic element in the repression of gene 
activity. Pre-established and de novo DNA methylation patterns are maintained by the
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DNA methyltransferase (MTase) enzyme. In contrast to in vivo some autosomal genes 
are methylated and consequently inactivated in cell culture including the thymidine 
kinase (Wise & Harris, 1988) and metallothionein genes (Compere & Palmitter, 1981). 
The importance of DNA methylation in transcriptional repression has been questioned 
due to the lack of appreciable methylation in either the Drosophila or Caenorhabditis 
elegans genome. However, homozygous MTase null mice do not survive past mid­
gestation (Li et al., 1992) suggesting an importance of methylation in higher 
eukaryotes.
The mechanism by which DNA methylation results in transcriptional repression 
is poorly understood. It has been shown that some transcription factors are unable to 
bind to methylated DNA, and it has therefore been proposed that direct methylation of 
their appropriate binding sites would be a mechanism of repressing transcription 
(reviewed by Tate & Bird, 1993). However, transcriptional repression mediated through 
methylation, of some promoters do not appear to rely on methylation of particular 
binding sites, an example being the y-globin promoter (Murray & Grosveld, 1987). A 
number of proteins have been identified which specifically bind to methylated DNA, 
including MeCPl, MeCP2, MDBP1, MDBP2, which presumably may compete with 
fra/w-activators and thereby offer another mechanism of transcriptional repression 
(reviewed by Tate & Bird, 1993). The function of these proteins is unclear although 
MeCPl has been shown to repress methylated promoters in vitro (Boyes & Bird, 1991).
Since greater than 80% of methylated CpG residues are packaged into H l- 
containing nucleosomes (Ball et al., 1983^ Methylation of DNA might increase the 
binding affinity of histone HI for this region possibly resulting in reorganised 
nucleosomal positioning and/or the formation of higher-order chromatin structures 
mediated by HI (Felsenfeld & McGhee, 1986). It has been observed that methylated 
plasmid DNA is less sensitive to nucleases than its hypomethylated counterpart if pre­
incubated with histone HI (Higurashi & Cole, 1992). Furthermore, in vitro
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transcription experiments have identified a methylated CpG binding protein, believed to 
be histone HI, responsible for repression of the vitallogenin promoter (Jost et al., 1991).
Acetylation
The core histone proteins (H2, H3, H4 and H5) contain long extended N- 
terminal hydrophilic tails which are not thought to be important in histone core particle 
assembly (Whitlock & Simpson, 1977; Ausio et al., 1989) but rather in histone/protein 
(Johnson et a l, 1990) or histone/DNA (Hill & Thomas, 1990) interactions. The 
positive charges present in the N-terminal tails may be neutralised by the addition of 
acetyl groups to the e-amino group of specific N-terminal lysine residues (hyper- 
acetylation). It has been proposed that histone acetylation weakens N-terminal 
interaction with the negatively charged DNA backbone thereby mediating unfolding of 
chromatin fibers (McGhee & Felsenfeld, 1980) and there is also evidence suggesting 
that higher order chromatin folding is also affected (Annunziato et al., 1988). 
Furthermore, histone hyper-acetylation has been shown to allow greater transcription 
factor access to nucleosomal DNA (Lee et al., 1993). All these studies are consistent 
with acetylation being a positive regulator of transcription.
Hyper-acetylation of H3 and H4 (Cahal et al., 1980; Waterborg & Matthews,
1984) has been associated with induced levels of transcriptional activity (Johnson et al., 
1987; Chan et al., 1988; Hebbes et al., 1988). On the strength of these studies, is has 
been postulated that transcriptionally active genes are located in hyperacetylated 
chromatin regions and that the acetylation sites are likely to be used in non-random 
fashion (Cahal et al., 1980; Waterborg & Matthews, 1984; Chambers & Shaw, 1984; 
Chicoine et al, 1987). Interestingly, deletion of residues 4-28 in H4 results in 
repressing transcription from inducible promoters while deletion of 4-30 in H3 has the
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opposite effect and increases expression (Durrin et al, 1991). This is consistent with 
histone acetylation being important in the control of specific gene expression.
1.7 Enhancers
In addition to cw-binding sequences within the promoter of genes transcription 
factor binding sites may also be found up- or downstream to the promoter region. 
These distal regions are often termed enhancer or silencer (repressor) elements 
depending on their effect on transcription. In a similar manner to DHS sites enhancers 
may be constitutive, tissue specific or inducible in nature. Classically, enhancers are 
characterised by their ability to activate transcription in an orientation independent 
manner, and may be found considerable distances upstream of the transcriptional 
initiation site, as illustrated by the locus control region (LCR) in controlling globin 
expression (reviewed by Evans et al., 1990). In addition, enhancers may also be found 
downstream of genes (O'Prey et al., 1993), within introns (Haung et al., 1993) and 
within coding exons (Tognoni et al., 1985).
There havebeen two proposed mechanisms for how enhancers may function; the 
first more classical model results in increasing the rate of transcription of a linked gene, 
and has been termed the graded model (Lewin, 1990, 1994). This might be achieved by 
the interaction of the enhancer directly with the initiation complex, the intervening 
DNA looping out to allow the interaction. In support of this model the Spl transcription 
factor has been demonstrated to form multimers and stabilise DNA loops (Su et al., 
1991).
The second model, designated the binary model (Walters et al., 1995), 
increases the probability that a promoter will achieve and maintain an active state and 
consequently an observed increase in transcription is due to an increase in the proportion 
of cells expressing as opposed to an increase within cells. The model proposes that
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enhancers act to suppress position effect variegation (PEV) (Walters et al., 1996) which 
is the suppression of genes due to the surrounding heterochromatin and correlates with 
an loss in DNAse 1 hypersensitivity and an increase in methylation (PEV is reviewed by 
Karpen, 1994). DNA looping may also be important in this function to bring active 
genes under the control of heterochromatin regions. Enhancers may also act as origins 
of DNA replication (DePamphilis, 1988), where the activity is mediated by interaction of 
transcription and replication factors (DePamphilis, 1993). Enhancers elements are also 
thought to be important during murine development after the 2 -cell embryo stage 
(reviewed by Majumder & DePamphilis, 1995).
1.8 Positional effects and higher order chromatin structure
Interestingly, enhancers may act over great distances yet function on specific 
promoters, in view of their orientation and position independent manner it might be 
expected that they would act promiscuously on surrounding promoters. Since this is not 
usually observed, except with chromosomal translocations involved in oncogenesis, 
there are presumably mechanisms which usually repress distant enhancers. A possible 
mechanism for this might be the nature of the surrounding chromatin structure. In 
higher eukaryotes, chromatin is organised into discrete active (euchromatin) and inactive 
(heterochromatin) regions which are believed to exist as DNA loops anchored to the 
nuclear scaffold (reviewed by Gasser and Laemmli, 1986). It has been suggested that 
genes brought into heterochromatin regions may be transcriptionally suppressed, by 
PEV (reviewed by Karpen, 1994), although the precise mechanism of this repression is 
unknown.
Analyses of viral gene expression following Moloney leukaemia proviral 
insertions in the mouse identified positional effects in expression mediated by silencer 
and enhancer activities at the site of integration (Jaenish et al., 1981), although the
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silencing effects may also be due to the induction of de novo methylation. By contrast, 
subsequent studies have been used to identify and investigate the sequences important in 
locus control regions (LCRs) which show position independent expression (PIE), a well 
studied example being the human p-globin gene locus (Grosveld et al., 1987; Talbot et 
al., 1989).
The DNA loop regions are believed to be flanked with nuclear targeting 
sequences known as scaffold associated regions (SARs) or matrix associated regions 
(MARs), which were identified as regions of DNA which preferentially associated with 
detergent-extracted nuclear remnants (termed nuclear matrices or scaffolds) (Mirkovitch 
et al., 1984). SARs are believed to protect defined regulatory domains from 
repressive/enhancing effects mediated by neighbouring chromatin and are found in a 
number of gene loci. The human p-globin cluster has been shown to contain eight SARs 
(Jarman & Higgs, 1988) while the chicken lysozyme gene is flanked 5' and 3' by SARs 
which correspond to the DNAsel hypersensitive region (Phi-Van & Stratling, 1988). 
SARs flanking both homologous and heterologous promoters have been shown to 
stimulate transcription by 10-20 fold (Klehr et al., 1991). In addition, the 5' SAR of the 
chicken lysozyme gene has been shown to impose limited PIE in stably transformed cells 
(Stief et al., 1989). SAR regions have been shown to have no effect in transient 
transfecting assays, consequently it is possible that the increase in transcription observed 
in stable transfection is mediated by some association with the chromatin framework. 
Consistent with this is that SAR regions are typically targets for topoisomerase I and II 
enzymes which are associated with controlling DNA torsion stress and chromosome 
condensation (review by Laemmli et al., 1993). Similar SAR like structures, designated 
Scs elements, have also been identified in the Drosophilia hsplO promoter (Udvardy et 
al., 1985) which may confer PIE to integrated constructs (Kellum & Schedl, 1991).
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1.9 Transcription factor families
Transcription factors are modular proteins containing domains for DNA binding, 
dimerisation and transcriptional activation or repression. Transcription factors have 
been characterised into 'families' by similarities in there structural domains. This is a 
convenient way of grouping proteins allowing a framework of transcription factors to be 
built which are related through their DNA recognition motif. This at least helps to 
rationalise what is an immensely complex interplay of multiple transcription factors 
directing the proliferation and differentiation of diverse cell types.
(I) Structural domains important in DNA recognition
Prokaryotic Helix-tum-helix (HTH) proteins
The first helix-tum-helix (HTH) structural motifs described were from the crystal 
stmctures of the bacteriophage X Cro protein (Anderson et al., 1981), X repressor 
protein (McKay & Steitz, 1981) and the Escherimkk coli CAP protein (Pabo & Lewis,
1982). These studies demonstrated a conserved recognition sequence consisting of an 
a-helix followed by a turn and then a second a-helix. Subsequent studies identified a 
large family of HTH DNA recognition motif prokaryotic transcription factors including 
Lac repressor, Trp repressor. A similar structural motif is observed in the bacterial 
Lex A protein except that the turn region is larger than that seen in other HTH proteins.
In contrast to other structural motifs (Zinc-fingers, leucine zipper, etc) the HTH 
motifs are unable to function as an independent domain and require a larger DNA 
binding domain to function. The X repressor-operator has been used extensively to 
characterise the specific contacts of the HTH domain made with the DNA recognition 
sequence. It should also be noted that contacts outside the HTH region are important in
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specificity of DNA recognition (Jordan & Pabo, 1988). The HTH proteins bind as 
dimers with each monomer recognising a half-site.
Homeodomain
The homeodomain was identified as a structural motif present in proteins 
important in Drosophila development and shows similarities with the HTH family 
(McGinnis et a l, 1984; Scott & Weiner, 1984). Subsequently, homeodomains were 
found to be more widespread in eukaryotic gene regulation. The 60 residue 
homeodomain forms a folded structure which may bind DNA independently. The 
crystal structures of the Drosophila engrailed and yeast MAT a2  homeodomain-DNA 
complex have been determined. The engrailed homeodomain contains three oc-helices, 
helix 1 and 2 are packed antiparallel to each other with helix 3 perpendicular to the first 
two helices (Kissinger et al., 1990), a similar structure is also seen for MAT a2 
(Wolberger et a l, 1991). Helix 2 and helix 3 represent the HTH unit, originally 
identified in prokaryotic proteins, although the helices are significantly longer. This 
difference is believed to alter the way the prokaryotic HTH and eukaryotic 
homeodomains line up and contact the DNA. The evolutionary significance of the 
differences in DNA recognition between prokaryotic HTH and eukaryotic homeodomain 
proteins is unclear.
The homeodomain may act as a separate domain, binding DNA in the absence of 
the rest of the protein. However, residues outside the homeodomain are also important 
in DNA recognition. A sub-family of homeodomain proteins which include pit-1 and 
Oct-1, contain a conserved 65-75 residue region, termed the POU-specific domain, 
located on the N-terminal side of the homeodomain (Herr et a l, 1988). The POU 
domain makes DNA contacts adjacent to those made by the homeodomain domain.
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Winged Helix-tum-Helix
This motif is based on the structure of the hepatocyte nuclear factor 
(HNF)3/fork head DNA binding domain, where two loops stick out from either side of 
the HTH motif and make DNA contacts, primarily with the phosphate backbone (Clark 
et a l , 1993). Subsequent studies have identified similar motifs in the heat shock 
transcription factor family, although only one loop is observed (Harrison et al., 1994). 
Similarly, the previously unclassified ETS domain DNA-binding motif has recently been 
shown to contain a winged HTH motif, in the Ets family members Fh-1 (Liang et a l , 
1994) and Ets-1 (Donaldson et al, 1994).
Paired Box motif
The paired box Pax motif was originally identified in three Drosophila 
segmentation genes (Bopp et a l , 1986) but has subsequently been found in human, 
mouse, chicken and zebrafish (reviewed in Deutsch & Gruss, 1991). Sub-groups of the 
Pax motifs have been identified which contain a conserved octapeptide or 
homeodomain motifs outside the paired-box domain. There are an ever increasing 
family of Pax genes (designated Pax 1 to Pax 8  in mouse) which are important in 
development (reviewed in Gruss & Walther, 1992).
Zinc binding domains
Members of the zinc-finger family of transcription factors have been implicated 
in many roles of eukaryotic gene regulation including development, differentiation and 
proliferation signals, basal transcription regulation and oncogenesis. The family was 
originally formed by the identification of a 30 residue zinc-finger motif Cys-X2to4 -Cys-
23
X 12-His-X3.5-His (Cys2-His2) from the Xenopus transcription factor III A (TFIIIA) 
protein (Miller et al., 1985) which binds to the internal promoter of the 5S rRNA genes. 
Subsequent studies have identified other cyteine-rich domains which co-ordinate Zn 
atoms facilitating DNA recognition, which may divided into four structural classes. 
The first class is the TFIIIA like zinc-finger family. The structure of the TFIIIA zinc- 
finger domain has been determined by 2D NMR (Parraga et al., 1988) showing that the 
motif contains an anti-parallel (3-sheet and an a-helix. The two cysteines present within 
the |3-sheet and the two histidines in the a-helix co-ordinate a central zinc ion holding 
the secondary structures together forming a compact globular domain.
The second class of zinc-fingers is the, Cys2-Cys2, structural motif originally 
identified in members of the GAT A family of transcription factors. The proteins have a 
central core of two irregular antiparallel P sheets and a a-helix (Omichinski et al., 
1993) stabilised by four cysteines co-ordinated around a central zinc-ion .
A third class contains six cysteines and two Zn ions per binding element which 
has been termed a, binuclear cluster, identified in the yeast GAL4 protein (Marmorstein 
et al, 1992) and PPR1 (Marmorstein & Harrison, 1994).
The fourth class includes the steroid receptor proteins which act as second 
messengers for transducing hormonal signals including steroid, vitamin D, retinoids and 
thyroid hormones. The proteins have distinct DNA-binding, trans-activation and ligand 
binding domains. The DNA-binding domain possesses eight conserved cysteine residues 
which may co-ordinate with zinc to form a distinct structural motif from the (Cys2- 
His2) zinc-fingers described previously for TFIIIA (Frankel and Pabo., 1988). The 
crystal structure of a glucocorticoid receptor complex suggests that the protein binds as 
a dimer to the recognition sequence (Luisi et al., 1991).
In addition, there are two other relatively recently identified Zn binding motifs 
which have not been demonstrated to bind specifically to DNA. Although the domains 
may be important in protein/protein interactions they are mentioned since the precise
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function of the motifs still remains unclear. The LIM family of proteins are an interesting 
new family of proteins identified which possess novel cysteine rich zinc-binding domains 
(reviewed by Sanchez-Garcia & Rabbitts., 1994). The LIM domain was originally 
identified in the protein products of three genes: the lin-11 (Freyd et al., 1990) and mec- 
3 (Way & Chalfie, 1988) genes from C. elegans and ISL1 gene (Karlsson et al, 1990) 
from rat. Subsequently LIM proteins have been sub-divided into three groups; the first 
group, which include Mec3, Lin-11 and ISL3 possess LIM domains associated with a 
homeodomain (LIM-HD), the second, LIM-PK, contains LIM domains linked to a 
protein kinase domain, and the third possess just LIM domains and have therefore been 
designated LIM-only proteins (reviewed by Sanchez-Garcia & Rabbitts, 1994). LIM 
proteins have been identified in a range of eukaryotic organisms including rat, chicken, 
quail, Xenopus, Drosophila, mouse and human and have been implicated in 
developmental regulation.. Interestingly, LIM proteins have also been associated with 
human leukaemias. The human RBTN1 and RBTN2 LIM domain proteins have been 
implicated in the progression of some childhood human T-cell acute leukaemias 
involving chromosomal translocation within l ip  15 and l ip  13 receptively, which is 
where the human genes are located (Sanchez-Garcia & Rabbitts, 1993). Although the 
LIM domain motifs appears to be important in protein/protein interaction analysis of the 
primary sequence suggests that it might form two folds that are similar to GAT A zinc- 
fingers, consequently it is possible that be important in DNA recognition under the 
appropriate conditions.
The second motif has been designated the ring-finger motif (Freemont, 1993). 
The NMR structure of the ring-finger has been identified (Barlow et al., 1993). 
Interestingly, the breast and ovarian cancer susceptibility gene, BRCA-1 contains a zinc 
ring-finger motif (Miki et al., 1994) although the function of this domain remains 
unclear.
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The members of zinc-finger family of transcription factors are summarised in 
table 1 . 1  below;
Table 1.1: Selected families of zinc-finger domains
Zinc-domain type Approximate consensus sequence Function
Cys2 -His2  (TFIIA) c - x 2 _4 - c -x 1 2 -h -x 3_5-h Nucleic acid
binding
Cys2 -Cys2  (GATA-1) C-X2 -C-X1 7 -C-X2C DNA binding
Cys8 C-X2 -C-X! r C-X2C-X^ 5 C-X5 -C- DNA binding,
(Steroid thyroid receptor) X 1 2 -C-X4-C oligomerisation
Cys6  (GAL4) C-X2 -C-X6 -C-X6 -C-X2 -C-X6-C DNA binding
Cys2 HisCys5 C-X2 -C-X17_i 9 -H-X2 -H-X2 C-X2 -C- Protein/Protein
(LIM domain) X 16-20-C“X 2-3"C interaction,
DNA binding ?
Cys2 HisCys4 C-X2 -C-X9 _2 7 -C-X ] _3 -H-X2 _3 C-X2- Protein/Protein
(Ring-finger) C-X4 _4 8 -C-X2-C interaction ?
DNA binding ?
Adapted from Berg & Shi, 1996
Abbreviations: C; Cys, H; Hys, X; other amino acids.
Leucine zipper and helix-loop-helix
The leucine zipper motif was first identified as a dimerisation motif in the 
CCAAT/enhancer binding protein (C/EBP) (Landschulz et al., 1988). Dimerisation 
forms two parallel a-helices in a coiled-coil arrangement (O'Shea et al., 1991). Leucine 
zippers are characterised by a heptad repeat of leucines over a 30-40 residue segment 
with a positively charged 'basic region', of 30 residues, located at its N-terminus 
important in DNA binding (Landschulz et al., 1988), the structural motif has therefore 
been termed as basic leucine zippers, or bZIP (Shuman et al., 1990). Although the basic 
region is rich in arginine and lysines it also contains other residues which appear to 
influence the specificity of binding to the DNA-recognition sites (Agre et al., 1989).
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Members of the bZip family include the C/EBP family, AP-1 family members, Fos, Jun, 
ATF/CREB family and the yeast factor GCN4 (Harrison, 1991).
A related structural motif to the leucine zipper is the helix-loop-helix motif 
(HLH) which forms a a-helix followed by a loop and then another a-helix. Similarly 
to the bZip proteins the HLH sub-family have a basic region adjacent to the dimerisation 
motif which contacts DNA. Members of this sub-family include the Myc and Max 
proteins (Blackwood and Eisenman., 1991).
High Mobility Group (HMG) proteins
The chromatin associated HMG non-histone proteins are divided into three 
unrelated subclasses HMG 1/2, HMG 14/17 and HMG-I/Y. The HMG 1/2 proteins 
contain a HMG1 box motif important in DNA recognition which have been found in a 
number of proteins. Although the biological functions of the HMG proteins are largely 
unknown it has been suggested that the HMG 1/2 proteins are important in transcription, 
DNA replication and recombination. The properties of the HMG protein are reviewed 
by Landsman & Bustin, 1993 and Lilley, 1992.
Other DNA-binding structural motifs
There are a number of other proteins which bind to DNA in a sequence specific 
manner but do not fit into one of the families mentioned above, these include the myb, 
CTF/NF1, AP2. This suggests that there may be other structural motifs which have yet 
to be identified. Nevertheless, the vast majority of transcription factors identified may be 
grouped into the above families suggesting that evolutionary selection has resulted in a 
limited number of structural DNA-recognition motifs.
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(II) Trans-activation domains
Gene-specific regulation is controlled by a diversity of transcriptional activator 
and repressors which have separable domains for directing the protein to its appropriate 
binding site, by contrast the structures of transcriptional activator and repressor 
domains are poorly understood.
Many DNA binding factors act as transcriptional activators containing domains 
of approximately 30-100 amino acids important in mediating this function. The first 
activation domains to be characterised were from the yeast DNA binding proteins GAL4 
(Ma & Ptsashne, 1987) and GCN4 (Hope & Struhl, 1986). These studies showed the 
regions to be similar in their general negative charge (acidic) and ability to form 
amphipathic a-helical structures. Acidic domains or "acid blobs" have been identified in 
other trans-acting DNA binding proteins including c-Jun (Bohmann et al., 1987), RelA 
(Blair et al., 1994), glucocorticoid hormone receptor (Hollenberg & Evans, 1988) and 
Spl (Courey & Tjian, 1991). Similarly, other structural motifs have been isolated which 
may act as activator domains, these include proline rich domains, CTF/NF1 (Kim & 
Roeder, 1993), Oct-2 (Tanaka et al., 1994a, 1994b) and glutamine-rich domains, Spl 
(Gill et al., 1994) and Oct-2 (Tanaka et al., 1994a, 1994b). Trans-activator proteins 
may possess more than one trans-activation domain which may be 1 ) of the same type, 
the yeast GAL4 protein has two acidic domains or 2) of different structure, Oct-2 has a 
proline and glutamine domain. In some cases activation domains may be masked 
requiring an induction event, such as hormone binding or phosphorylation, to alter the 
conformation of the protein (Tasset et al., 1990).
Consistent with the modular nature of proteins chimeric proteins may be 
constructed containing heterologous DNA binding or trans-activation domains which 
maintain the appropriate function, an example is the fusion of the activation domain of 
VP 16 to the DNA binding domain of GAL4 to create a GAL4-VP16 fusion protein.
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The GAL4 is still able bind to its upstream activation sequence (UAS) binding site and 
activate transcription due to the VPI6  activation domain (Cousens et al., 1989).
7V<ms-activators are believed to mediate their effects by binding to the basal 
transcription machinery, resulting in either an increase in rate of initiation or stabilising 
the pre-initiation complex once formed. Activators may bind directly to basal 
transcription factors including TBP, (Xu et al., 1993) (Emili et al., 1994), TFHB (Choy 
& Green, 1994), TFIIA (Ozer et al., 1994) and TFIIH (Xiao et al, 1994). Despite these 
direct interactions transcriptional activation also requires co-activators (mediators or 
adapters) which include some of the TAFs of the TFIID complex (reviewed by Gill and 
Tjian, 1992).
(Ill) Repression domains
In addition to the negative effects of the chromatin framework transcription 
repression may also be mediated by trans-acting transcription factors. The mechanism 
of repression by trans-acting factors may be active, where the repressors directly 
downregulates transcription. Examples of these type of proteins include WT1 (Madden 
et al., 1991), Drosophila even-skipped (Ham et al., 1992), Kruppel (Licht et al., 1993) 
and the human Kruppel related protein, YY1 (Shi et al., 1991). Although there are 
clear amino acid similarities between the repression domains of active repressors, they 
are generally rich in alanine, glutamine and/or proline and depleted of charged amino 
acids. Since these properties are reminiscent of the modular nature of activation domains 
observed within frans-activator proteins, it is perhaps not surprising that active 
repressors are believed to function by directly contacting the basal transcription 
machinery. For example, the even-skipped repressor prevents TFUD binding to the 
promoter (Austin & Biggin, 1995). Presumably, in addition to the general transcription
29
factors such as TFIID, TFIIB, TFUA etc, the TAFs and other co-activators may be 
targets for active trans-acting repressors.
Alternatively, repression may occur by a passive mechanism, where negative 
regulators either block binding of tams-activator or basal factors or form inactive 
heterodimers. An example of direct competition is the repression of retinoic acid 
induced transcription of the human ostoecalcin gene by activator protein 1 (API) 
through direct competition with the retinoic acid receptor for an overlapping DNA 
binding sites. Altered dimerisation may also result in repression, an example is the 
dimerisation of the bZip proteins, C/EBP and the C/EBP homologous protein (CHOP). 
CHOP has proline substitutions in its basic domain which prevent it binding DNA. As a 
consequence overexpression of CHOP during adipocyte maturation inhibits C/EBP 
activity (Ron & Habener, 1992).
Interestingly, a recent study has shown that the negative regulator adipocyte 
lipid-binding protein 1, ALBP1 contains a domain which contains carboxypeptidase (CP) 
activity, vital for the repression function of the protein (He et al., 1995). The authors 
suggests a novel mechanism of repression exists where the CP activity enzymatically 
cleaves the proteins involved in transcription. Consequently, there appears to exist a 
plethora of positive and negative acting transcription factors which act co-ordinately to 
modulate the level of transcriptional regulation.
1.10 Mechanisms for modulation of transcription factor activity
Dimerisation
Dimerisation or higher complex formation is a common theme between 
transcription factors and gives another level of complexity to transcriptional control. A 
number of transcription factor families have been defined by their characteristic
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dimerisation interfaces. These include helix-loop-helix, (myc, max, MyoD) (Amati & 
Land, 1994), leucine zipper, (C/EBP, Fos, Jun) (Lamb & McKnight, 1991) and Rel 
(NF-kB and dorsal) (Blank et al., 1992). A consequence of heterodimerisation is that 
the protein components may have altered DNA binding and activation properties which, 
depending on the dimerisation partner, may also target the protein complex to a different 
set of promoters.
In addition to dimerisation between families proteins may also form complexes 
with unrelated proteins. For example the c-Myc protein may also bind to the zinc-finger 
protein YY1. However, dimerisation between proteins is not promiscuous since the 
bZip protein c-Fos can form heterodimers with the API family member c-Jun protein 
but not form homodimers or dimers with the C/EBP bZip containing family.
The simplest scenario resulting from different heterodimers is altered DNA 
binding specificity. The nuclear hormone receptors contain a central DNA-binding 
domain which targets the receptor to hormone response elements (reviewed by 
Yamamoto, 1985). The 9-cis retinoic acid X receptor (RXR) may bind a variety of 
other monomers including the all-trans retinoic acid receptor (RAR), the thyroid 
hormone receptor (T3 R), the vitamin D3 receptor (VDR) and fatty acid/peroxisome 
proliferator-activated receptor (PPAR) (Bugge et al., 1992; Leid et al., 1992; 
Issemanm et al., 1993). The resulting heterodimers target different hormone response 
elements (HREs) which may possess altered ligand responses altering their specificity 
for the HRE and tams-activation potential (Forman et al., 1995).
The dimerisation observed between the Max, Myc, and Mad proteins, which are 
members of the basic helix-loop-helix/leucine zipper family, results in different trans- 
activation potentials. Myc trans-activation is dependent on its heterodimerisation to the 
Max protein in order to bind to the recognition site CACGTG (E box) (Blackwood & 
Eisenman, 1991). In addition to binding to Myc, the Max protein can also form
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homodimers or heterodimers with Mad related proteins such as Mxil, which compete 
with Max/Myc heterodimers for the E box sequence (Ayer et al., 1993). The My c/Max 
target gene, human ornithine decarboxylase (ODC) gene, is induced due to the presence 
of an E Box sequence within its promoter (Pena et al., 1993, 1995). Recent data 
indicates that the Myc/Max complex may be inhibited by overexpression of the Mxil 
protein, forming Max/Mxil heterodimers which bind to the E box and prevents Myc 
activation (Wu et al., 1996).
Phosphorylation
Another important mode of control of transcription factor activity is 
phosphorylation. This is underlined by the observation that the majority of transcription 
factor proteins identified exist as phosphoproteins. Phosphorylation of transcription 
factors may affect the protein's, sub-cellular localisation, fraws-activation activity or 
DNA binding activity resulting ultimately in altered promoter regulation.
The control of transcription factor subcellular localisation has the obvious 
consequence of preventing transcription factors from entering the nucleus and thereby 
binding there ds-acting sites. Nuclear proteins are synthesised in the cytoplasm and are 
transported to the nucleus by the presence of a nuclear localisation signal (NLS) 
sequence in the protein. Regulation by direct phosphorylation of the NLS was first 
observed in the SV40 T antigen and is believed to be mediated by a phosphorylation 
site for Caesin kinase II (CKII) within the NLS and a p34cdc2 site adjacent to the NLS 
(Jans et al., 1991). Other nuclear proteins such as mouse c-Myc, c-Abl and human p53 
also contain potential CKII or p34cdc2 phosphorylation sites within the NLS (Jans et 
al., 1991). It has been suggested that both CKII and p34cdc2 might have a general role 
in protein import into the nucleus. Phosphorylation may also aid in the nuclear 
localisation of some members of the Rel family of transcription factor, by a different
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mechanism. In this case NF-kB is held in an inactive complex with IkB, which is 
released by the phosphorylation of the IkB. Both protein kinase A and C (PKA & PKC) 
may phosphorylate IkB in vitro (Shirakawa & Mizel, 1989; Ghosh & Baltimore, 1990).
The control of transcription factor trans- activation mediated by phosphorylation 
has been extensively studied in the cAMP response element binding/activating 
transcription factor protein (CREB/ATF) family. The glutamine-rich activation domain 
of CREB contains a phosphorylation box (P-box) which contains consensus 
phosphorylation sites for a number of kinases (de Groot et al., 1993). Upon induction 
by cAMP CREB is phosphorylated on serine 133 within the P-Box by PKA and as a 
consequence is converted to a potent transcriptional activator (Gonzalez & Montminy, 
1989). Other members of the family may be phosphorylated by different kinases at 
alternative sites (de Groot et al., 1993). In vitro, the repression of CREB following 
stimulation is dependent on dephosphorylation by protein phosphatase- 1 (PP-1) 
(Hagiwara et al., 1992) and CREB may also be dephosphorylated by PP-2A (Nichols et 
a l , 1992).
Phosphorylation may also affect DNA binding, an interesting example is the c- 
Jun protein which shows altered binding activity or rrans-activation function depending 
on the sites phosphorylated. For example, phosphorylation at one set of sites towards 
the C-terminal end close to the basic domain (Ser226, Ser232 and Thr214) decreases 
DNA binding activity (Boyle et al., 1991). Alternatively phosphorylation at other sites 
close to the activation domain, (Ser63 and Ser73) results in an increase in 
transcriptional activity (Binetruy et al., 1991; Pulverer et al, 1991). A single stimulus, 
for example TPA, can induce dephophorylation at inhibitory sites while increasing 
phosphorylation at positive regulating sites (Pulverer et al., 1992).
The examples here are just a fraction of the phosphorylation events that occur in 
transcription regulation. It is likely that phosphorylation plays a central role in 
controlling protein conformation and activity in a number of cellular events, as appears
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to be the case in the signalling pathways, and these events are regulated by kinases and 
the phosphatases.
The points discussed previously have illustrated the immense complexity of 
eukaryotic gene regulation to create a multitude of different regulatory options for 
achieving appropriate tissue specific and developmental gene regulation. Consequently 
some of these aspects of gene regulation are discussed below with regard to tissue 
specific and developmental gene regulation.
1.11 Globin gene expression: a model for tissue specific and developmental gene 
regulation
An intriguing question in eukaryotic gene regulation is how transcriptional 
cascades mediate developmental and tissue specific pathways. A variety of 
developmental pathways (haemopoiesis, liver, kidney) have been used to assess how a 
set of transcription factors specify a particular cell lineage. A particularly good example 
is globin gene expression which has been used as an important paradigm for studying 
tissue specific and developmental transcription regulation. Erythroid cells undergo a 
series of morphological and biosynthetic alterations during erythropoiesis. The human 
p-globin locus contains five genes (e,Gy, Ay, 5 and p) successively expressed as 
erythropoieses progresses during development. The £ gene is transcriptionally active in 
the yolk sac, the two y genes are expressed in the foetal liver followed by expression of 
8  and p in adult bone marrow. The promoters of all five p-globin genes are also 
dependant on distant enhancer elements, termed the P-locus control region (LCR), 11- 
60kb upstream.
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Regulatory elements within the globin promoter
The p-globin promoter contains three conserved positive cis-acting sites a 
TATA box, a CCAAT and a CACCC motif which are necessary for full activity in the 
mouse p-globin gene. The TATA box is important for the binding of the basal 
transcription factor TFIID which recruits other factors of basal transcription machinery 
into the pre-initiation complex, as discussed previously (Chapter 1.1).
The CCAAT box may bind at least five different proteins but evidence suggest 
that the ubiquitous CCAAT protein 1 (CPI) protein binds to the p-globin CCAAT 
element (Chodosh, et al., 1988; de Boer et al., 1988, Gumucio et al., 1988) and 
contributes to increase expression of the gene. Alternatively, a CTF/NFl-like factor, 
probably the CCAAT displacement factor (CDP) first identified in sea urchin (Barberis 
et al., 1987), downregulates the human p-globin gene expression by binding adjacently 
to the CCAAT site and inhibiting binding of CPI (deBoer et al, 1988). Interestingly, 
similar activities have also been observed in the chicken p-globin promoter (Plumb et 
al., 1988) and the CDP factor binds to a duplicated CCAAT element in the y-globin 
promoter preventing CPI binding (Superti-Furga et al., 1988). This suggests that this 
antagonistic relationship may be a common control mechanism in globin gene 
expression.
The CACCC box motif is essential for erythroid development, but may be found 
in non-erythroid promoters (Xiao et al., 1987; Schule et al., 1988). The motif may be 
bound by ubiquitous proteins such as Spl (Barnhart et al., 1988; Jackson et al., 1989) 
or more cell restricted proteins such as, TEF-2 (Xiao et al., 1987), erythroid kruppel 
like factor (EKLF) (Miller & Bieker, 1993) or the newly identified lung erythroid 
kruppel-like factor (LEKF) (Anderson et al., 1995).
The EKLF zinc-finger protein is expressed exclusively in erythroid cells and acts 
as a powerful trans-activator through the CACCC site in transient expression assays
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(Miller & Bieker, 1993; Donze et al., 1995). The EKLF protein is essential for cell- 
specific expression of the P-globin promoter (Bieker & Southwood,1995). Interestingly, 
the EKLF protein binds 8-fold more efficiently to the p-globin promoter relative to the 
y-globin promoter, suggesting that EKLF is important in the transition from human y- to 
p-globin gene switching (Donze et al., 1995). Consistent with this, CACCC box 
mutations which cause p-thalassemias inhibit EKLF binding (Feng et al., 1994). It is 
also interesting to note that the EKLF promoter is regulated by the GATA-1 zinc finger 
protein, another cell-restricted gene which is essential in erythroid development. This 
may, intriguingly suggest that essential erythroid transcription factors may regulate each 
other (Crossley et al., 1994).
The p-globin promoter requires the LCR for tissue specific and developmental 
regulation
Although, some of the p-globin genes may function in a partial tissue- and stage- 
specific manner in the absence of the LCR, (Rutherford & Nienhuis, 1987), the LCR is 
essential for efficient transcription of the P-globin genes. The p-LCR is divided into 
four subdomains which correspond to specific DHS sites in erythroid cells. Surprisingly 
DNAse 1 footprinting analysis only consistently identified three binding motifs within 
the LCR, being GATA, AP-1 and CACC/GGTG (Philipsen et al., 1990; Talbot et al., 
1990; Prunzina et al., 1991; Reddy & Shen., 1991; Straus & Orkin, 1992). The GATA 
and AP-1 motif were shown to bind the cell-restricted GATA-1 and NF-E2 proteins 
respectively, while the CACC/GGTG sequence binds Spl or Spl-like factors (Philipsen 
et al., 1990; Talbot et al., 1990; Kingsley & Winoto, 1992). The model for 
developmental associated switching of the P-globin genes is believed to occur due to 
competition for a shared enhancer. This may reflect differences in the diversity of trans- 
activators/repressors able to interact with the LCR DHS sites or gene promoters. In
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support of this, a stage specific factor, NF-E4, has been suggested to mediate direct 
association of the p-promoter with the enhancer. Mutations within the NF-E4 site, 
which abolish binding, have been shown to result in reciprocal changes between p and e 
gene expression (Foley & Engel, 1992). Interaction of the promoter region with the 
enhancer would presumably be dependent on the DNA looping. It is therefore 
interesting to note that there are a number of Spl sites in the LCR and globin promoters 
since the Spl protein has been shown to stabilise DNA loops (Su et al., 1991). 
Similarly, there is also evidence that the GATA-1 sites within globin promoters and the 
LCR are required for enhancer-dependent transcription (Fong & Emerson, 1992; Gong 
and Dean, 1993). Since the GATA-1, Spl and EKLF proteins may all physically 
interact, protein/protein interaction may be important in stabilising DNA looping 
(Merika & Orkin, 1995).
An alternative model may be that there is a shift in location of the gene relative 
to the LCR, altering its accessibility. Interestingly, the four DHS sites of the LCR 
appear to have different specificities for the gene promoters, with DHS-4 preferring p- 
expression (Fraser et al., 1993). In transgenic mice studies the p-LCR was shown to 
act as dominant control region showing position independent expression (Grosveld et 
al., 1987) and it is possible that the LCR may impart some of its activity by altering the 
surrounding chromatin structure. This form of enhancer control may be similar in 
manner to the PEV effect described previously (chapter 1.7). It is possible that aspects 
of both models may be important in controlling P-globin gene expression.
1.12 Nuclear oncogenes may disrupt transcriptional cascades
Disruption of normal transcription factor cascades during development can lead 
to gross phenotypic alterations, which have been extensively studied in Drosophila 
development (Nusslein-Volhard et al., 1987; Warren & Carrol, 1995). Alternatively,
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aberrant expression patterns results in increased proliferation or altered differentiation 
which in some circumstances progress to oncogenesis. The association of transcription 
factors with cancer progression underlines the importance of transcription factors in 
development. Ironically, therefore, identification of cancer associated nuclear 
oncogenes/tumour supressors has co-ordinately led to the identity of many novel 
transcription factors which are vital for appropriate developmental regulation.
Cancer progression may result from the loss of function of a cellular protein, 
designated a tumour suppressor, or a dominant gain of function, termed a oncogene, 
which represents the most well studied group. Altered expression of proteins may 
induce cancer by abrogating or mimicking growth factors responses (reviewed by Cross 
& Dexter, 1991) or transcription factors (reviewed by Nichols & Nimer, 1992), directly 
affecting endogenous gene expression. However, cancer progression is believed to be a 
multi-step process reliant on the synergy of oncogenes for tumourgenicity (reviewed by 
Adams & Cory, 1992).
Many nuclear oncogenes have been identified in the haemopoietic system where 
chromosomal translocations and inversions commonly activate genes encoding nuclear 
DNA-binding proteins. As a consequence many of the examples given here are derived 
from the haemopoietic system. However, altered expression of transcription factors is 
also important in non-haemopoietic tissues, for example, fusions of paired box (PAX) 
PAX3 and PAX7 genes with the FKHR gene are associated with alveolar 
rhabdomyosarcoma (Shapiro et al., 1993; Davies et al., 1994) or the t(ll;22) 
translocations create a EWS/Fli-1 fusion gene associated with Ewing's sarcoma 
(Delattre et al., 1992). The increased levels of nuclear oncogene products observed in 
tumours may be as a consequence of a variety of mechanisms discussed below.
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Cellular oncogenes are targets for retroviral insertions
Oncogenes are often associated with common sites of retroviral integration 
either at the oncogene locus or at more distant sites resulting in aberrant expression. For 
example, c-Myc (Hayward et al., 1981), c-Myb (Shen-Ong et al., 1986), Fli-1 (Ben- 
David et al., 1991), Spi-1 (Moreau-Gaschelin et al., 1988) and Evi-1 (Morishita et al., 
1988). The mechanisms of oncogene activation may be due to either promoter insertion 
or alternatively activation of the appropriate oncogene promoter by an enhancer, 
presumably the viral LTR.
Translocation resulting in enhancer activation
Chromosomal translocations and inversions may have the consequence of 
bringing a nuclear oncogene under the control of heterologous enhancer or promoter 
elements. Table 1.2 (adapted from Rabbits, 1994) shows a number of examples of non- 
fusion chromosome translocation events resulting in aberrant expression of the 
appropriate gene in haematopoietic tumours. For a more comprehensive review see 
Rabbits 1994 and references therein.
The predominant t(8;14) (q24;q32) translocation in B-cell acute leukaemia, 
rearranges one allele of the c-Myc oncogene into the heavy-chain Ig gene locus which 
brings the c-Myc gene under the control of the strong Ig enhancer (Dalla-Favera et al., 
1983; Taub et al, 1982; Adams et al 1983). Similarly, the t(10; 14) (q24;qll) 
translocation in T-cell acute lymphoma brings the developmentally important HOX11 
gene under the control of the regulatory sequences present in the TCR locus (Dube et 
al., 1991) and the inv (3)(q21;q26) in acute myeloid leukaemia brings the Evi-1 
oncogene under the influence of the enhancer elements of the Ribophorin I gene 
(Suzukama, et al., 1994).
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Table 1.2: Examples of non-fusions from haematopoietic tumours
Type Affected gene Disease Rearranging
gene
Basic-helix-loop-
helix
t(8 ; 14)(q24; q32) c-Myc (8q24) BL, BL-ALL IgH, IgL
t(7; 19)(q35; pl3) LYL1 (19pl3) T-ALL TCR-p
t(l; 14)(p32; q l l ) TALI/SCL (lp32) T-ALL TCR-a
t(7; 9)(q35; q34) TAL2 (9q34) T-ALL TCR-p
LIM Proteins
t ( l l ;  14)(pl5; q l l ) RBTNl/Ttgl ( l lp l5) T-ALL TCR-8
t (l l ;  14)(pl3; q l l ) RBTNl/Ttgl ( l lp l5) T-ALL TCR- 8 /a  /
Homeobox proteins
t(10; 14)(q24; q l l ) H oxll (10q24) T-ALL TCR- a  / p
Zinc-finger proteins
t(3;14)(q27; q32) Laz3/BCL-6 (3q27) NHL/DLCL IgH
inv (3) (q21; q26) Evi-1 (3q26) AML
Others
t( 14; 18)(q32; 21) BCL2 (18q21) FL IgH, IgL
t(14;19)(q32; ql3.1) BCL3 (19ql3.1) B-CLL IgH
t(3;14)(q27; q32) TAN1 (9q34.3) T-ALL TCR-P
Adapted from Rabitts 1994
T-ALL; T-cell acute lymphocytic leukaemia, BL; Burkitt's Lymphoma, FL; Folliculalr 
lymphoma, B-CLL; B-cell Chronic Lymphocytic leukaemia, AML; Acute Myeloid 
Leukaemia, TCR; T-cell receptor locus, Ig; immunoglobulin locus.
Gene amplification
Gene amplifications are common in many types of cancer and are generally 
associated with more advanced tumours (Schwab & Amler, 1990). Analysis of the 
human promyelocytic leukaemia cell line HL-60 showed a 10-fold amplification of the c- 
Myc gene on double minute chromosomes (Dalla-Favera et ah, 1982) and was the first 
gene to be found amplified in human neoplasms. Amplification of another myc family 
member, N-myc, is characteristic in the progression of neuroblastomas (Brodeur et al.,
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1984) while the unrelated c-myb gene has also been found to be amplified, for example, 
in two cell lines from a colon carcinoma (Alitalo et al., 1984). The mechanisms of 
mammalian gene amplification is not discussed here but is reviewed by Stark, 1993.
Chimeric proteins
Chromosomal translocations and inversions may result in the fusion of two 
genes, thereby creating a chimeric protein, with altered function (DNA-binding, trans- 
activation) relative to the wild type proteins. Table 1.3 (adapted from Rabbits, 1994) 
shows a number of examples of transcription factor fusion-proteins resulting from 
chromosome translocation events in haematopoietic tumours. For a more 
comprehensive review see Rabbits 1994 and references therein.
For example, the translocation t(l;19) (q23;pl3), that is associated with about 
a quarter of human pre-B-cell acute lymphoid leukaemias, results in a E2A-PBX1 
chimera. The N-terminal trans-activation domain of the bHLH transcription factor E2A 
gene located on chromosome 19 fuses to the homeobox PBX1 gene on chromosome 1, 
resulting in a number of E2A-PBX1 oncoproteins. Consequently, the PBX1 
transcription factor acquires trans-activator function and still recognises it binding sites 
in lymphoid cells where the gene it not usually expressed, suggesting that the formation 
of chimeric proteins with novel activities may play an important part in the progression 
of cancer (reviewed by Look, 1995; Rabbits 1994).
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Table 1.3: Examples of fusions-proteins from haematopoietic tumours
Type Affected gene Protein domain Disease
t(l;19)(q23; ql3.3) PBX1 (lq23) Homeodomain pre-B-A
E2A (19pl3.3) AD-b-HLH APL
t( 15; 17)(q21; qll-22) PML (15q21) Zinc-finger
RARa (17q21) Zinc-fmger
t(3;21)(q26; q22) AML1 (21q22) DNA binding/runt AML
homolgy
EVI-1 (3q26) Zinc-finger AML
t(8;21)(q22; q22) AML1 (21q22) DNA binding/runt AML
homology
ETO (8q22) Zinc-finger
t(3;21)(q26; q22) AML1 (21q22) DNA binding/runt AML
homology
EAP (3q26) Sn protein
t(3;8)(q26; q22) EVI-1 (3q26) Zinc-finger AML
ETO (8q22) Zinc-finger
t(16;21)(pll; q22) FUS (16p 11) RNA binding Myeloid
ERG (21q22) Ets protein
t(6;9)(p23; q34) DEK (6p23) ? AML
CAN (9q34) Leucine zipper
Adapted from Rabitts 1994
Abbreviations: pre-B-ALL; pre-B-cell acute lymphocytic leukaemia, APL; Acute 
Promyelocytic Leukaemia, AML; Acute Myeloid Leukaemia. AD-b-HLH; Activation 
Domain-basic-Helix-Loop-Helix.
It is clear that nuclear oncogenes are not only important in cancer progression 
but are also vital genes in normal cell proliferation and differentiation, often being 
pivotal genes in developmental and cell cycle regulation. Interestingly, a specific nuclear 
oncogene, Evi-1, encodes a protein of the zinc-fmger family which is an essential 
transcription factor for appropriate murine and human development and is also 
associated in some leukaemias, following ectopic expression. The rest of this chapter 
discusses the properties of the Evi-1 gene.
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1.13 Identification of Evi-1 as a proto-oncogene
Evi-1 was originally identified as a common site of viral integration in the DNA
of AKXD murine myeloid tumours (Mucenski et al., 1988). AKXD recombinant 
Sttmr
inbred mouse'We derived from mating AKR/J and DBA/2J strains which have a high or 
low incidence of lymphoma respectively. These strains have a range of tumour 
incidence and have proved invaluable in identifying common sites of retroviral 
integrations which may represent novel proto-oncogene loci.
A particular strain, AKXD-23, was found to develop myeloid tumours at high 
frequency. The DNA from all the AKXD-23 myeloid tumours examined had a common 
ecotropic retroviral integration in the same locus, termed ecotropic viral integration site 
1 (Evi-1). Subsequent studies identified a putative proto-oncogene, Evi-1, activated by 
provirus in IL-3 dependent myeloid leukaemia cell lines (Morishita et al., 1988).
Evi-1 rearrangements have also been detected in myeloid cell lines and 
leukaemias in NFS/N or NFS/N hybrid mice injected as neonates with wild mouse 
ecotropic MCF MuLV and Cas-Br-E MuLV (Mucenski et al., 1988, Bergeron et al., 
1992). Retroviral insertions within the Evi-1 locus are clustered within non-coding 
exon I or II and are frequently orientated in the same transcriptional direction. The 
mechanism of Evi-1 activation appears to that of promoter insertion since viral derived 
transcripts are detectable.
In a separate study, 23% of all myeloblastic leukaemias induced by infection of 
the friend murine leukaemia vims had proviral integrations in another common site of 
viral integration termed Fim-3 (Bordereaux et al., 1987). In contrast to clustered 
retroviral insertion observed in the Evi-1 locus, insertions in Fim-3 are scattered over 
16kb.
A common retroviral integration site (CB-1) was also found in two IL-3- 
dependent cell lines (DA-3 and DA-34), 90kb upstream of the Evi-1 locus. This
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retroviral integration site is closely linked to the Evi-1 locus is identical to the Fim-3 
locus (Bartholomew et al., 1989). Retroviral insertions within CB-1/Fim3 were shown 
to activate expression of the Evi-1 gene from its normal promoter (Bartholomew & 
Ihle, 1991). Since no RNA expression was detectable from the viral LTR within the 
Fim-3 region it suggests that the mechanism of Evi-1 activation may be that of a distal 
enhancer type. Ectopic expression of Evi-1 may therefore be due to retroviral insertion 
at either the Fim-3 or Evi-1 loci.
1.14 The association of the Evi-1 proto-oncogene in human leukaemias
In humans, ectopic expression of the EVI-1 gene has been correlated with 
progression of some acute myelogenous leukaemias (AML) the closely related 
myelodysplastic syndromes (MDS) and chronic myelocytic leukaemias in blast crisis 
(CML-BC).
AMLs are clonal malignancies characterised by abnormal proliferation and 
differentiation, resulting in the production of blast and other immature granulocytes, 
monocytes, erythroblast, and/or megakaryocytes. As with many leukaemias, 
lymphomas and some sarcomas (Rowley., 1990), AML and MDS are associated with a 
number of recurring chromosomal abnormalities. Included in these are rearrangements 
at 3q26 in about 2% of patients examined. The most frequently observed chromosome 
translocations involving the 3q21q26 group of AMLs are inv(3)(q21q26) and 
t(3;3)(q21;26). The chromosomal breakpoints in 3q26 in these translocations have 
been located between 13-330kb 5' and upto 150kb 3' of the gene (Morishita et al., 
1992, Suzukama et al., 1994). Characterisation of the inv(3)(q21q26) breakpoint 
suggests that ectopic expression of the EVI-1 gene may be a consequence of the gene 
being translocated to within the control of the enhancer elements associated with the 
Ribophorin I gene (Suzukama et al., 1994).
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CML is a clonal disorder of pluripotent haematopoietic stem cells with a 
biphasic clinical course. The initial chronic phase is characterised by leukocytosis with 
maturation followed by acceleration of the disease to a acute blastic crisis (CML-BC) 
phase involving increased cellular proliferation, maturation arrest and karyotype clonal 
evolution. A characteristic of chronic phase CML is presence of the Philadelphia 
chromosome (Ph), t(9;22)(q34;qll) (Rowley, 1973), which results in a BCR-ABL 
chimeric protein with enhanced tyrosine kinase activity (Konopka et al., 1994) 
responsible for its in vivo tumourigenicity (Daley et al., 1990).
The chromosomal abnormalities observed in CML-BC are characteristically 
trisomy or isochromosome. However, the molecular events leading to blastic crises are 
not understood, although p53 is a relatively common target, in about a third of blastic 
crisis patients (Feinstein et al., 1992). Interestingly, a rare reciprocal translocation, 
t(3;21)(q26;q22), event in CML-BC generates a fusion between the AML and EVI-1 
genes which fuses the N-terminal runt homology domain of AML1 to the whole of 
EVI-1 (Mitani et al., 1994). In addition to CML-BC, the t(3;21) translocation is also 
observed in MDS derived leukaemia (Rubin et al., 1990) and the AML 1-EVI-1 fusion 
transcript has also been detected in a MDS patient (Mitani et al., 1994). It has beep 
postulated that t(3;21) translocation plays a critical role in leukaemic progression as 
heamatopoietic stems cells transform to the acute leukaemic phase (Chen et al., 1991).
In addition to the EVI-1 gene, the AML1 gene is also involved in other 
chromosome translocations to generate fusions with other genes, AML1-MTG8 and 
AML1-ETO (Miyoshi et al., 1991; reviewed by Nucifora & Rowley, 1995). An 
increasing number of chimeric fusion transcription factors resulting from reciprocal 
translocations, including DEK-CAN, E2A-PBX1 and PML-RARa, have also been 
identified showing gene fusion is an important mechanism in leukaemogenesis 
(reviewed by Nichols and Nimer, 1992).
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It has also been reported that ectopic expression of the EVI-1 gene in some 
MDSs and other haematological malignancies appears to occur with no gross 
cytological abnormalities of chromosome 3q26 (Russel et al., 1994), suggesting that 
aberrant expression of this gene may result from various mechanisms. Interestingly, 
EVI-1 expression in some AMLs is also accompanied by chromosome 7 deletion 
(Morishita et al., 1992; Fichelson et al., 1992). This would appear be a secondary 
event since, similarly to 3q26 abnormalities, chromosome 7 deletion is often found in 
human leukaemias following treatment with alkylating agents (Le Beau et al., 1986).
Interestingly, leukaemias associated with 3q26 rearrangements involving Evi-1 
often show megakaryopoiesis and elevated platelet counts (Bitter et a l,  1985), 
suggesting that Evi-1 might contribute to the progression of a distinct genetic disease. 
It should also be noted that rearrangements of 3q25 or 3q27 do not involve Evi-1 
(Morishita et al., 1990, Fichelson et al., 1992).
1.15 Structure of the Evi-1 gene
The Evi-1 gene cDNA's were originally isolated from murine IL-3 dependent 
myeloid leukaemia cell lines which ectopically express the gene due to retroviral 
insertion in the Evi-1 locus. This identified a 5.1 kb full length cDNA clone with an 
open reading frame of 3126 nucleotides and a predicted protein of 1042 amino acids 
(Morishita et al., 1988). The Evi-1 protein contains ten Cys2-Hys2 zinc-fmger repeats of 
27-28 amino acids separated into two domains, an N-terminal domain of seven 
(designated ZF1) and a C-terminal domain of three zinc-fingers (designated ZF2) 
respectively. The protein also possesses an acidic rich domain proposed to be important 
in trans-activation function (Ma & Ptashne, 1987) and has been shown to be localised 
to the nucleus (Matsugi et al., 1990) (figure 1.1). The human EVI-1 gene has also been
46
Figure 1.1: Schematic representation 
of the Evi-1 protein
ZF1 ZF2 Acidic
Internal Deletion
m -
Truncation
ZF1 GA ( C /  T ) AAGATAAGATAA
ZF2 GAAGATGAG
isolated as a cDNA clone from the high EVI-1 expressing HEC-1B cell line and shows 
94% homology with the murine gene at the amino acid level.
The Evi-1 protein acts as transcription factor with both zinc-finger domains 
recognising distinct DNA recognition sequences. Bacterially derived fusion proteins 
containing ZF1, ZF2 or the full length Evi-1 were used in binding and amplification 
reactions to establish DNA consensus sequences for ZF1, 
GA(CTT)AAGA(T/C)AAGATAA (Perkins et a l, 1991; Delwel et a l,  1993), ZF2 , 
GAAGATGAG, (Funabiki et a l, 1994) and ZF1/ZF2, GACCAGATAAGATAAN\_28 
CTCATCTTC (Morishita et a l, 1995). The ZF1/ZF2 sequence shows the optimal 
recognition sequence with a normal ZF1 consensus and an inverted ZF2 consensus 
although there is little indication for optimal spacing requirements between the 
consensus sequences (Morishita et a l, 1995). Interestingly the ZF1 recognition 
sequence contains three perfect GATA repeat sequences, recognised by members of the 
GATA zinc-finger family of transcription factors.
In addition to the full length Evi-1 transcript, two alternatively spliced variants 
have also been identified. The first is an internal deletion of 324 amino acids which 
results in the loss of two zinc-finger motifs (6+7) of the first zinc-finger domain 
(Bordereaux et a l, 1990; Morishita et a l, 1990). The zinc-fingers 6 and 7 in the ZF1 
domain have been shown to be important in DNA sequence recognition. Consequently, 
it would be predicted that this splice variant would be unable to bind to the ZF1 DNA 
recognition sequence and exert an effect on the transcription machinery through this 
site. The second is an C-terminal 105 amino acid deletion resulting in a truncated 937 
amino acid protein (Bartholomew, unpublished data).
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1.16 Biological effects of the Evi-1 protein
The biological functions of the Evi-1 gene both in normal cell 
proliferation/differentiation and in cellular transformation are unclear. The structural 
motifs identified in the Evi-1 protein is consistent with the protein being a transcription 
factor. Since transcription factors have been shown to act as transcription activators, 
repressors or both, similar functions have been assessed for the Evi-1 protein.
The EVI-1 protein acts as both a transcriptional repressor and activator
As mentioned in 1.15, the ZF1 recognition sequence is similar to GATA 
suggesting that Evi-1 might target a subset of genes also recognised by GATA factors. 
The EVI-1 protein has been shown to block GATA-1 dependent transcriptional 
activation from expression constructs containing the ZF1 consensus sequence in 
NIH3T3 cells (Kreider et al., 1993) suggesting that EVI-1 acts as a transcriptional 
repressor via a DNA binding competition mechanism. Since GATA-1 and other 
members of the GATA family are expressed in haemopoietic cells it is conceivable that 
repression of some of the GATA target genes may contribute to leukaemogenesis. 
However, no known physiological GATA sites are recognised by Evi-1 (Perkins & 
Kim, 1996).
In a separate study, the AML-EVI1 fusion protein, which contains the AML1 
runt homology domain and the whole of Evi-1, fails to activate a minimal tk luciferase 
reporter construct containing PEBP2 (PEA2) binding sites upstream (Tanaka et al, 
1995). The AML1 protein acts as an trans-activator through the PEBP2 sites (Tanaka 
et al., 1995), which were originally identified in the polyomavirus enhancer (Piettte & 
Yaniv, 1987). There the AML-EVI-1 fusion protein antagonises the wild type AML 
function, probably by a dominant negative mechanism. In addition it also indicates that
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the Evi-1 protein is not a trans-activator protein, at least in this fusion and through this 
site.
In addition, data from our lab has also suggested that the EVI-1 protein can act 
as a active transcriptional repressor, as opposed to the probable passive repression 
mechanisms mentioned above. In these studies we have shown that Evi-1 is able to 
actively repress the function of a strong trans-activator, VP 16, when targeted to the 
DNA either via the GAL4 1-147 DNA binding domain or alternatively through the 
wild-type ZF1 recognition site (Bartholomew et al., manuscript submitted).
In contrast, the EVI-1 protein has been shown to act as a transcriptional 
activator via binding to a consensus sequence GACCAGATAAGATAANi_ 2 8  
CTCATCTTC in both NIH3T3 and HEC-1B cells (Morishita et a l , 1995). This 
sequence contains the consensus binding sequences for both ZF1 and ZF2 and suggests 
the possibility that the combination of these two binding sites may some how alter the 
function of the Evi-1 protein, possibly by some conformational change. Evi-1 has also 
been shown to upregulate both the c-fos and c-jun promoter, although this might be an 
indirect effect. However, interestingly the upregulation of both promoters is dependent 
on the ZF2 DNA binding domain (Tanaka et a l, 1994; Kurokawa et al., 1995).
Therefore, similarly to other transcription factors it seems that the Evi-1 protein 
may be bifunctional. An in vivo target gene, designated 150-B, has recently been 
identified encoding a novel protein, which is suppressed in Evi-1 expressing myeloid 
cells (Matsugi et al., 1995). This and other in vivo target genes will allow a more 
accurate assay for the biological function of the Evi-1 protein and the molecular 
mechanisms involved in transcriptional regulation.
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Evi-1 is oncogenic
The oncogenic nature of the Evi-1 and AML1/EVI-1 fusion proteins, created as 
a result of the (3;21) translocation observed in CML-BC (see chapter 3.4), has been 
assessed using the Rati transformation assay. In these experiments EVI-1 and 
AML/EVI-1 have been shown to transform Rati cells, as measured by their ability to 
allow growth of the cells in soft agar. The introduction of deletion mutants of the 
AML1/EVI1 fusion protein indicated that the EVI-1 ZF2 domain was essential for the 
transforming activity (Kurokawa et al., 1995). In addition, Rati clones were 
established stably expressing the BCR/ABL fusion protein (p210BCR/ABL), a 
characteristic of early chronic CML. These cells formed macroscopic colonies in soft 
agar as described by others (Lugo & Witte., 1989). Interestingly, if p210BCR/ABLRATl 
cells were also transfected with constructs expressing the AML1/EVI-1 fusion an 
enhanced transformation was observed with larger and more numerous colonies formed 
in soft agar (Kurokawa et a l , 1995).
Evi-1 overexpression blocks erythroid and myeloid differentiation and/or proliferation
32Dcl3 is a IL-3-dependent myeloid cell line that differentiates in response to 
G-CSF (Greenberger et al., 1983; Migliaccio et al., 1989). These cells have been used 
to examine the properties of proteins involved in differentiation, including c-Myb (Otten 
et al., 1988) and Evi-1 (Morishita et al, 1992; Khanna-Gupta et al., 1996). The 
introduction of retroviral constructs expressing the full length Evi-1 protein into the 
32Dcl3 cells blocked the ability of the cells to differentiate in response to G-CSF (this 
was not due to a down regulation of the G-CSF receptor). In support of these 
observations the same experiments have also been performed with the AML 1/EVI-1 
fusion protein by a separate group, with the same conclusions (Tanaka et al., 1995).
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However, recent data contradicts some of these previous observations made 
using the 32Dcl3 cells. Firstly 32Dcl3 cells were found to constitutively express high 
levels of Evi-1 protein and secondly the cells were still able to respond to G-CSF 
(Khanna-Gupta et al., 1996). Interestingly, the authors show that further 
overexpression of Evi-1 in 32Dcl3 cells using retroviral Evi-1 expression vectors 
prevents the cells from responding to G-CSF, which is consistent with previous 
observations (Morishita et al., 1992). Consequently, they have proposed that it is the 
level of Evi-1 expression in myeloid cells, rather than ectopic expression, which is the 
most important determinant in contributing to leukaemic progression.
Similarly, experiments have evaluated the response to erythropoietin (EPO) of 
normal mouse bone marrow progenitor cells or 32DEpol cells (a clone of 32Dcl3 cell 
line responsive to EPO) (Migliaccio et al., 1989) following infection with retroviral Evi- 
1 expression vectors (Kreider et al., 1993). The results showed that ectopic Evi-1 
expression was able to block growth of EPO-responsive cells. However, it is not clear 
in these experiments whether the cells were unable to differentiate, proliferate or non- 
viable. In addition, the significance of this result to leukaemogenesis is unclear since the 
AML and CML-BC leukaemias, associated with ectopic EVI-1 expression, are 
generally associated with increased rather than decreased proliferation.
1.17 Evi-1 shows a restricted pattern of expression in adult murine tissue
The involvement of the cellular Evi-1 gene in leukaemic progression led 
workers to evaluate the involvement of the gene in normal cell 
proliferation/differentiation. Initially, the expression of the gene was examined in murine 
tissues and cell lines by Northern blot analysis. This showed that high levels of Evi-1 
expression were confined to kidney and developing oocytes, with lower levels identified 
in lung, uterus and heart, illustrating that the Evi-1 gene has a restricted profile of
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expression in adult murine tissues suggesting that its expression might be important in 
the development of these organs (Morishita et al., 1990; Perkins et al., 1991). Evi-1 
expression in cell lines was found to be restricted to leukaemic myeloid cells containing 
retroviral insertions at either the Evi-1 locus or 90kb upstream in the CB-1 /Fim-3 
locus. No expression was observed in either other myeloid, T-cell and B-cell lymphoma 
cell lines or carcinoma cell lines derived from kidney, lung, ovary, placenta or brain 
(Morishita et al., 1990).
1.18 Evi-1 is essential for murine embryonic development
Evi-1 also shows both temporal and spatial expression during murine embryonic 
development (Perkins et al., 1991). In situ hybridisation experiments on 9.5, 12.5 and 
14.5 day mouse embryos identified high levels of Evi-1 expression in the urinary system 
and the Mullerian ducts, the bronchial epithelium of the lung; the endocardial cushions 
and truncus swellings in the heart; focal areas within the nasal cavities; and the 
developing limbs. The expression patterns of Evi-1 are consistent with the gene being 
important in murine embryonic development.
Recent data from Evi-1 knockout mice has confirmed the importance of Evi-1 
in murine development. Homozygous Evi-1 knock out mice die in utero at day 10.5 
post coitus ip.c.). The mutants have a complex phenotype but the most obvious 
abnormalities include widespread haemorrhaging, the presence of large pericardial sacs, 
and disruption in the development of paraxial mesenchyme which is most obvious in the 
head. The neural ectoderm and the peripheral nervous system fail to develop. 
Furthermore, delayed development was observed in the kidney, heart and limb buds 
(Hoyt et al., manuscript submitted).
Significantly, the Evi-1 in situ hybridisation pattern observed in normal mice 
showed expression in mesoderm and neural crest derived cells, associated with
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development of the peripheral nervous system and in the limb buds, kidney and heart. 
The observed defects are consistent with this expression (Hoyt et al., manuscript 
submitted). However, it should be noted the knockout mice are not null mutants, 
because they still express the internal deletion of 324 amino acids form of the gene. It 
is possible a more severe phenotype might result from knocking out this transcript as 
well.
1.19 Murine kidney development
The high levels of Evi-1 expression in kidney suggest that the gene plays a role 
in development of this organ. The kidney is a heterogeneous organ derived from 
mesenchymal cells which require external stimuli in order to differentiate and mature. 
Metanephric kidney development begins when a caudal outgrowth of the Wolffian duct, 
the ureteric bud, induces undifferentiated mesodermal cells of the metanephric blastema 
to proliferate (figure 1.2 B). Interestingly, mesodermal cell contact with the inducing 
tissue is required for only 24 hours for the cells to commit to advanced stages of 
nephrogenesis (Lehtonen et al., 1983; Ekblom, 1981). This is the 'determination' point 
which implies that the mesodermal cells can be transplanted to another site and still 
differentiate to form renal tubules, so long as the appropriate extrinsic signals are 
supplied. In fact, inductive interaction between ureteric bud epithelium and kidney 
mesenchyme may be reproduced in vitro and has been a useful tool in the study of 
kidney morphogenesis (Grobstein, 1956). However, although the inducing signals are 
well defined the signalling molecules mediating mesenchyme induction are unclear.
Co-ordinately with 'determination', mesodermal cells begin to express 
characteristic epithelial cell adhesion molecules (Grobstein, 1957; Saxen et al., 1983, 
Vestweber et al., 1985; Vainio et al., 1989). The inductive signals of the ureteric 
branches stimulate the cells to aggregate and condense to form a comma-shaped 'renal
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Figure 1.2: Schematic representation 
of the kidney and kidney development
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vesicle' which fuse to the ureter. This gives rise to the S-shaped body which is the first 
evidence of segmentation of the primitive nephron, the functional unit of the kidney 
(figure 1.2 B). The S-shaped body is invaded by primitive blood vessels at one pole 
which eventually becomes the glomerulus while the proximal tube develops from the 
adjoining region. The other pole, which is closer to the ureter, forms the loop of Henle 
and distal tubule (figure 1.2 A + B).
Intriguingly, programmed cell death appears to be widespread in kidney 
development and the bcl-2 protein is highly expressed in mesenchymal condensates, 
being down regulated during maturation of the nephron, suggesting a possible role for 
apoptosis in early kidney development.
The molecular events downstream from the initial inductive signalling events 
between the ureteric bud and the undifferentiated mesenchyme are unclear as are the 
signalling events. Presumably, the early proliferation and differentiation signals of the 
induced mesenchyme must be mediated through the activation of specific sets of 
transcription factors, at least some of which must be directly activated via signalling 
cascades from the cell surface.
A number of transcription factors have been identified which appear to play an 
important role in kidney development. Included in these is the Pax-2 gene which is 
upregulated shortly after ureteric bud induction (Dressier et al., 1992) and its 
suppression by the use of antisense oligonucleotides results in a severe decrease in 
condensing mesenchyme (Rothenpieler & Dressier, 1993). This is consistent with the 
gene being important specifically in the early inductive response, a point which is 
further supported by its downregulation later during tubular differentiation. 
Interestingly, the failure to suppress Pax-2 expression using transgenic mice studies, 
results in immature epithelium reflective of some types of human nephric syndromes 
(Dressier et al., 1993).
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Interestingly, concomitantly with the down regulation of the Pax-2 protein an 
induction is observed of the Wilms' tumour suppressor gene (WT1). Wilms' tumour is 
an embryonal kidney tumour thought to arise through aberrant mesenchymal stem cell 
differentiation following the inactivation of multiple tumour suppressor genes. A 
candidate gene, designated WT1, has been shown to contribute to the development of 
Wilms Tumour (Haber et al., 1990). The homozygous WT1 knock-out mice are 
embryonic lethal because of defective heart development. In these mutants the ureter 
bud fails to grow out of the nephric duct and the mesenchyme is not induced (Kreidberg 
et al., 1993). Interestingly, in-vitro co-cultivation experiments have shown that the 
mesenchyme is unable to respond to wild-type inducer, suggesting a role for WT1 in 
both mesenchyme induction and ureter outgrowth (Kreidberg et al., 1993). The WT1 
zinc-finger protein has been shown to act as a transcriptional repressor (Madden et al., 
1991) by binding to a DNA recognition sequence, cgcccccgc, similar to that of the 
early growth response gene (EGR-1). Interestingly, WT1 may directly repress the Pax- 
2 gene through three sites present in its promoter (Ryan et al., 1995).
Other transcription factors known to be involved in kidney development include 
the liml and Pax-8 proteins which are transiently and spatially induced in the renal 
vesicle and are down regulated as the tubular epithelium matures (Fujii et al., 1994). 
Furthermore, N-myc is activated in the condensing mesenchyme (Magrauer & Ekblom., 
1991). The importance of N-myc in mesenchymal proliferation is further supported 
from gene knockout studies in mice which are embryonic lethal. It was observed that 
the epithelial component of the embryo failed to develop (Stanton et al., 1992).
1.20 The importance of Evi-1 in kidney development
In situ hybridisation has identified Evi-1 expression throughout the 
mesonephric duct and mesonephric tubules in day 9.5 p.c. embryonic kidneys with very
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high expression seen in the tubules of the met anephros at day 14.5 post coitus (p.c.). 
Expression in adult kidney was seen throughout the tubules of the cortex and external 
medulla with the expression highest between the cortical-mudullary junction (Morishita 
et al., 1991). No expression is detected in the glomeruli (Perkins et al., 1991). 
Consequently, Evi-1 appears to induced early in embryonic development and expressed 
primarily in the epithelial ducts and tubules. Evi-1 expression is maintained in the adult 
is to epithelial tubular cells.
The type of tubule cells which show high levels of Evi-1 expression is unknown. 
The kidney is heterogeneous in nature containing many different tubule cells (including 
proximal, distal convoluted tubule, collecting tubule, and the cells of the descending and 
ascending limb) which possess different differentiation states, potentially different 
transcription factor profiles and presumably different functions (figure 1.2).
The time of Evi-1 upregulation relative to the initial inductive signals to the 
mesenchyme is unclear, however, the expression pattern observed at 9.5 days p.c. 
would overlap the transcription factors mentioned previously above. In contrast to the 
Pax genes and WT1 gene little is known about the target genes of the Evi-1 protein in 
kidney cells and its interplay with other transcription factors. In addition, little is known 
about the mechanisms controlling tissue specific expression of the gene throughout 
kidney development.
1.21 Project Aims
The aim of the project was to examine the molecular mechanisms controlling 
tissue specifc expression in kidney cells since the Evi-1 pattern of expression is 
consistent with the Evi-1 gene having an important role in the development of this 
organ. As there were no known high Evi-1 expressing kidney cell lines, we wished to 
screen available kidney cell lines to obtain a high expressing cell line to carry out
56
functional analysis of the Evi-1 promoter. In addition, since the transcription initiation 
sites have been mapped in kidney and ovary (Bartholomew & Ihle, 1991) we wished to 
extend these studies to identify the minimal Evi-1 promoter.
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Part 2: Materials and Methods
Chapter 2: Methods
2.1 Animal Cell Culture
Cell Lines
EACC/ATCC No. Tisse Origin
RAG 89040605 Kidney
G402 90112715 Kidney
ACHN 88100508 Kidney
TCMK-1 90050802 Kidney
293 85120602 Kidney
A704 HTB45 Kidney
YCR Gift from M. Oshimura Kidney
RCC23 Gift from M. Oshimura Kidney
STO CRL 1503 Fibroblast
L929 CCL1 Fibroblast
NIH3T3 1658 Fibroblast
DA-3 Bartholomew et al., 1989 Haemopoietic
FDCP-1 Dexter et al., 1980 Haemopoietic
HEC-1A HTB112 Endometrial
HEC-1B HTB113 Endometrial
Cell Culture conditions
Cell lines were obtained from Beatson Institute stocks. Most cell lines were 
maintained in special liquid medium supplemented with 10% Faetal calf serum and 
2mM glutamine, gassed to 5% CO2  and incubated at 37°C. Cells cultures were 
passaged every 3-4 days to maintain them in a continously growing state. Viable cell 
numbers were evaluated using a haemocytometer. The myeloid DA-3 cell line was 
grown in RMPI-1640 media supplemented with 10% foetal calf serum, glutamine, and 
20 U of purified IL-3 per ml.
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Storage o f animal cells
Animal cells were harvested and resuspended at 10^ cells/ml in faetal calf 
serum and 10% (v/v) DMSO. Cells were transfered to 1ml Nunc cryotubes and 
stored overnight at -70°C. The cells were then transfered to liquid nitrogen for long 
term storage.
2.2 Isolation of kidney cells
Adult and foetal kidney dissections
Adult kidneys were dissected from either tsT or CD1 mice and placed on ice. 
The kidneys were then wash with PBS several times. The capsule surrounding the 
kidney was removed and then washed in PBS again. Embryonic kidneys were taken 
at day 18.5p.c.. Each embryo was dissected and the kidneys placed in ice cold PBS. 
The kidneys were then cut up into small pieces using a sterile scalpel and transfered to 
a 50ml Falcon tube prior to collagenase/trypsin.
Isolation o f kidney cells by collagenase/trypsin treatment
Kidneys (embryonic or adult) were placed into a 50ml Falcon tube containing 
a autoclaved magnetic flea. 7.5ml of collagenase solution (3mg/ml) and 7.5ml of 
trypsin (final concentration of 0.25% made up in PBS) were pipetted into the tube. 
The tube was then placed on a magnetic stirrer in the hot room (37°C) for exactly 8 
minutes. The debris was allowed to settle and the collagense/trypsin solution was 
carefully removed to a universal tube. A further 7.5ml of collagenase and trypsin was
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added and the procedure repeated a further 2 times. To pellet cells the universal 
tubes were spun at 1000rpm/5 minutes/4°C. Cell pellets were washed in 7.5ml PBS 
containing DNAse 1 (0.05mg/ml) and repelleted as above. The final cell pellet is 
resuspended in medium. All fractions are pooled and the cell number evaluated by 
haemocytometer. Cells were seeded out at 1x10^ cells in a t 175 Falcon flask and 
incubated at 33°C.
Kidney cell culture media
Isolated kidney cultures were routinely passaged in SLM media. In addition, 
epithelial selective media was also used as peviously described:
D-Valine (Gilbert & Migeon, 1975)
Serum free medium (Taub et al., 1979)
2.3 Bacterial Culture
Host Strains
E.coli strains XL1 or DH5a were obtained from Beatson Institute stocks. 
Bacterial strains were grown in L-broth at 37°C with good airation.
Competent cells
Competent bacterial cells (DH5a) were obtained from group stocks held by 
Anne-Marie Clarke.
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Transformation o f bacterial cells
Competent cells were thawed slowly on ice and IOOjllI transfered to a pre­
chilled 15ml falcon tube. Plasmid or ligation mix was pipetted into the cells, mixed 
gently by tapping the tube, and incubated on ice for 30 minutes. The cells were heat 
shocked at 42°C for 2 minutes. 900)0,1 of L-broth was then added cells incubated for 
at 37°C for 1 hour in a New Brunswick G25 shaker at 225rpm. 50-200 |il was then 
spread onto 1.5% (w/v) agar L-broth plates containing the appropriate antibiotic. The 
plates were left to air dry and were then inverted and incubated at 37°C overnight.
Glycerol Stocks
E.coli strains containing important plasmids were stored as glycerol stocks. Stationary 
cultures were mixed with an equal volume of glycerol and stored at -20°C.
2.4 Nucleic Acids: DNA Analysis
Preparation o f plasmid DNA
Bacterial colonies were picked using a sterile toothpick and grown overnight 
in 5ml of LB medium, containing the appropriate antibiotic, in an orbital shaker. 
1.5ml of this culture was spun down in a microfuge 13000rpm/2 minutes/RT. The 
cells were resuspended in 100|il of solution I (50mM glucose, 25mM Tris/HCl pH 
8.0, lOmM EDTA) and incubated on ice for 2 minutes. 200|il of solution II (0.2N 
NaOH, 1% SDS) was added the solutions mixed gently and incubated for 5 minutes 
on ice. A 150j l i 1 of solution III (3M Potassium Acetate, 11.5% glacial acetic acid) was 
then added, the tubes vortexed, and placed on ice for a further 5 minutes. After
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incubation the tubes were spun at 13000rpm/5 minutes/4°C. The supernatant was 
removed to a fresh tube and phenol/chloroform extracted. Plasmid DNA was 
precipitated by the addition of 800j l l 1 of cold 100% ethanol and spun 13000rpm/5 
minutes/4°C. The pellet was wash with 70% ethanol, dried in a vacuum dessicater 
for 2 minutes and resuspended in 32|li1 of TE containing lOjig/ml of RNAseA.
Large scale plasmid preparations
lml of overnight culture was inoculated into 250ml of LB medium containing 
the appropriate antibiotics and grown overnight in an orbital shaker at 37°C. The 
culture was spun down at 5000rpm/20 minutes/4°C. The supernatant is discarded, 
the pellet resuspended in ice cold solution I (50mM glucose, 25mM Tris/HCl pH 8.0, 
lOmM EDTA) and incubated for five minutes at room temperature. Add 10ml of 
solution II (0.2N NaOH, 1% SDS) roll tube gently to mix. Incubate on ice for 10 
minutes. Add 7.5ml of ice-cold solution 3 (3M Potassium Acetate, 11.5% glacial 
acetic acid). Incubate on ice for 10 minutes. Spin at 5000rpm/20 minutes/4°C. Filter 
supernatant through several layers of miracloth into a 50ml Falcon tube. Add 0.6 
volumes (12ml) isopropanol at room temperature to precipitate the DNA. Mix and 
incubate at room temperature for 15 minutes. Centrifuge at 5000rpm/30 
minutes/room temperature. Discard the supernatant and resuspend the pellet in 8ml 
of TE (lOOmM Tris/HCl pH8.0, ImM EDTA). Add 8.4g of Caesium Chloride and 
400ul of ethidium bromide solution (lOmg/ml). Centrifuge at 5000rpm/five 
minutes/RT to separate out ethidium bromide/protein complexes. Transfer the clear 
red solution to an appropriate ultracentrifuge tube using a Pasteur pipette. Spin at 
55000rpm overnight at room temperature. Plasmid bands are remove with needle and 
syringe. The ethidium bromide is removed from the DNA solution by butan-l-ol
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extraction's. The solutions are then dialysed against TE, ethanol precipitated with 
l/10th volume 3M sodium acetate pH 4.6. The precipitates are resuspend in TE.
Quantification o f nucleic acids
Nucleic acids were quantified by measuring absorbance (A) at 260nm and 
280nm in a Beckman DU 650 spectrophotometer. 5|il of sample was added to 495jnl 
of distilled water and added to a quartz cuvette blanked against distilled water. An 
A2 6 O value °f 1 was taken to be equivalent to 50jig/ml of plasmid or genomic DNA, 
40jig/ml of RNA and 20jig/ml of oligonucleotide. The A2 6 O/A2 8 O rati° was taken to 
be a sign of purity with samples below 1.75 requiring further purification.
Restriction digests
Restriction digests of plasmid DNA were carried out using the buffered 
solutions sent with the enzymes from the supplier. Typically, plasmid DNA of 
concentration <3ug were digested in a total of 20j l x 1 with 5-10units of enzyme per jig 
of DNA in lx buffer for 1-2 hours at the appropriate temperature (usually 37°C). The 
total volume of the reaction was proportionally increased for larger concentrations of 
DNA. Reactions were terminated by the addition of l/10th volume of agarose gel 
loading buffer (0.25% (w/v) xylene cyanol, 0.25% (w/v) bromophenol blue, 25% 
(v/v) Ficoll in water).
Gel electrophoresis
Typically 1% agarose gels were made to resolve restriction enzyme digested 
DNA. 2g of agarose (low melting point agarose was used for preparative gels) was
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added to lx TAE ( 50x TAE is 2M Tris, 50mM EDTA, 57.1ml/l glacial acetic acid) 
upto a volume of 200ml. The solution was then heated in a microwave and placed on 
a stirring block to cool. When hand hot ethidium bromide was added to 0.5|ig/ml and 
the solution poured into an appropriate gel former. Gels were allowed to set at room 
temperature and transferred to an electrophoresis tank containing lx TAE. Samples, 
containing 1 / 1 0 th volume agarose gel loading buffer (section ) were loaded into 
separate wells and run at 40-120 volts depending on the size of the fragments and the 
time available. The molecular weight standard used was lkb DNA ladder. The DNA 
bands were visualised using a U.V. source and photographed.
Purification o f DNA fragments from agarose gels
DNA fragments were excised from the agarose gels and placed into an 
eppendorf tube. DNA was extracted using a Geneclean kit according to the 
manufacturer's protocol. Prior to further manipulation, the quality and quantity of the 
purified fragment(s) were assessed by electrophoresis of a small aliquot of the DNA 
on the agarose gel.
2.5 Subcloning of DNA
Dephosphorylation of vector DNA
Plasmid vector were digested with the appropriate enzyme (section ). At the 
end of the reaction lul of calf intestinal alkaline phosphatase (CLAP) was added and 
the reaction incubated for a further 30 minutes. For the generation of blunt-ended 
vectors, the reaction was transferred to 56°C for 30 minutes with the addition of a 
further 1ml of CIAP. The vector was then agarose gel purified.
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Generation o f inserts
Inserts were generated by restriction enzyme digestion of either plasmid or 
PCR DNA and were agarose gel purified.
Ligation o f DNA fragments into plasmids
The vector and insert DNA was then included in the following reaction mix, 
2 0 ng of dephosphorylated plasmid 
5 molar excess of DNA insert
2ul of 5x Ligation buffer (0.25M Tris.HCl (pH7.6), 50mM MgCl2 , 5mM
dATP 5mM dithiothreitol, 25% (w/v) polyethylene 
glycol-8000) 
lp l of T4 DNA ligase (lU/|nl)
H2 O upto 1 0 (il 
The reaction mix was incubated at 16°C overnight.
2.6 Polymerase Chain Reaction (PCR)
PCR primers
Oligonucleotide primers were designed such that they were complementary to 
opposite strands and opposite ends of the DNA of interest. In some cases extra non­
specific bases were synthesised at the 5' end to facilitate subsequent cloning into the 
appropriate restriction enzyme site in the plasmid DNA.
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Synthesis o f DNA oligonucleotides
Oligonucleotides were synthesised at the Beatson Institute on an Applied 
Biosystems model 381A DNA synthesiser according to the manufacturers 
instructions. 5'trityl groups were removed by the machine, and the DNA immobilised 
on a column. The DNA was eluted in 29% (v/v) ammonia by passing the solution 
through a column approximately 20 times every 10 minutes for 1.5 hours. This 
solution was sealed in a glass vial an incubated overnight at 55°C. The DNA was 
precipitated by the addition of ammonium acetate to 0.3M and 3 volumes of 100% 
ethanol. The DNA was pelleted at 7000rpm for 15 minutes in a Sorvall SS-34 rotor, 
resupended in 0.2M sodium acetate, and reprecipitated in 3 volumes of ethanol. The 
pellet was then washed in 70% (v/v) ethanol and dissolved in 1ml of distilled water. 
The oligonucleotides were quantified by spectrophometry (section).
Oligonucleotide PCR Primers
5’ and 3’ Functional Constructs
1 ccagatcttttaagtagaaacttaa
198 ccagatctcctgaaagcaattctcc
242 ccagatctctctaacacagactctc
347 cctgtgctcaggacatc
401 cctggagaaatttcccc
431 cggcagaaatctacatg
488 ggacttgggtcttggcg
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553 t t t a c t g a a a g a g g a g c
630 ccagatctctttctggatggccgag
670 ccagatctgaaaccctgcggctggg
R955 ccaagcttgagctcgcagctattcc
Footprinting -474 to -135 construct
SFP ctccaccctatctttcc
SFP3 ttaaagtgacagcagcc
PCR reactions
The appropriate plasmid template of interest was added at a concentration of 
lOOng/reaction together with 20ng of each PCR primer. The reaction also contained 
10ml Taq DNA polymerase buffer, 2pl from 5mM stock solutions of dATP, dTTP, 
dGTP and dCTP, 6 |il of 25mM MgCl2 , 0.5|il of Taq polymerase and distilled water 
to 50j l l 1. The reaction is then overlaid with 50j l l 1 of paraffin oil and incubated in a 
PCR machine (Perkin-Elmer) for 30 cycles 1) 94°C for 1 minute; 2) 50°C for 1 
minute; 3) 72°C for 90 seconds. Reactions were incubated for 15 minutes at 72°C 
after the final cycle, then cooled to 4°C. Each reaction was purified from agarose gel 
(section).
2.7 Sequencing Plasmid DNA
Sequencing of plasmid DNA was performed using the Sequenase Version 2.0 
kit supplied by USB according to the manufacturers instructions. The plasmid DNA 
was denatured as followed, 4jig of plasmid DNA was added to a total volume of 
20|il 0.2M NaOH and the solution incubated at room temperature for 5 minutes. The
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DNA was precipitated by the addition of lOOpl of ethanol and 8 |il of 5M ammonium 
acetate pH 5.2 and the solution incubated on ice for 10 minutes. The DNA is then 
pelleted in a microfuge at 13,000rpm for 5 minutes at 4°C. The pellet is washed in 
70% ethanol, allowed to air dry and resuspended in 7 |il of distilled water.
Sequencing Primers
Footprinting -474 to -135 construct
SFP ctccaccctatctttcc
SFP3 ' ttaaagtgacagcagcc
DHS I region
T3 attaaccctcactaaag
T7 aatacgactcactatag
PJ1 gaggtaggagcatcct
PJ2 gtggtgggttcacctagg
PJ3 gtcgctccgcctccc
PJ4 ggggtctaatgaacat
PJ5 ccgtcccgagataccc
RPJl ggtatttaaccttacg
RPJ2 gggtttggtaaggttc
RPJ3 taaattcacatttgtc
RPJ4 cctaggtgaacccaccac
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2.8 Southern blot analysis
Following DNA separation by electrophoresis the gel was soaked for 15 
minutes in HC1 then washed with distilled water and soaked in alkaline buffer (1.5M 
NaCl, 0.5M NaOH) for 30 minutes. The DNA was transferred to Hybond N+ nylon 
membrane in alkaline buffer for 2 hours using a vacuum blotter. The filter was 
washed in 2xSSC and the DNA fixed using a UV Stratagene 1800 crosslinker.
Random-primed radiolabelling o f DNA probes
DNA probes used in Northern to Southern blotting were prepared as directed 
in the manufacturers instructions. Following labelling unincorporated radionucleotides 
were removed using Sephadex G50 columns. The probes were denatured by boiling 
for 5 minutes immediately prior to addition to the filter.
Hybridisation conditions
All hybridisations were carried out at 42°C in 50% formamide in accordance with the 
manufacturers instructions. Pre-hybridisations were carried out for a minimum of 4 
hours and then replaced with denatured labelled probe at 10^CPM/ml in fresh 
hybridisation solution. The filters were incubated overnight and washed in 
accordance with the manufacturers instructions
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2.9 Nucleic Acids: RNA Analysis
Isolation o f RNA
Total cytoplasmic RNA was prepared using the RNAzol B method 
(Biogenesis Ltd) according to the manufacturers instructions.
Agarose electrophoretic separation o f RNA
To 87ml of DEPC treateed H2 O, lg of agarose and 10ml lOxMOPS (3-(N- 
morpholino)propanesulphonic acid, 50mM sodium acetate, lOmM EDTA pH7.0) was 
added. This was disolved by heating in a microwave, cooled to hand hot and then 
5.1ml formaldehdye solution was added. The gel was then cast and run in lxMOPS 
buffer. Samples of RNA were dissolved in DEPC treated water and 10|il sample 
buffer (which was made up fresh before use: 0.75ml deionised formamide, 0.15 
lOxMOPS, 0.24ml formaldehyde, 0.1ml water, 0.1ml glycerol, 0.08% bromophenol 
blue) was added per 2fil of sample prior to electrophoresis. An RNA ladder (BRL) 
was run to provide markers on each gel.
Northern Transfer o f RNA
Following RNA separation by electrophoresis the gel was soaked in distilled 
water for 10 minutes and then lhour in 20x SSC. The RNA was transferred onto 
Hybond N+ nylon membrane (Amersham International) in 20x SSC using a vacuum 
blotter. The RNA was fixed onto the membrane using a UV Stratagene 1800 
crosslinker.
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2.10 DNAse 1 hypersensitivity analysis of chromatin structure
Isolation o f nuclei from tissue
Frozen tissue samples are ground in the presence of liquid nitrogen and 
homogenised in a dounce homgeniser in A/NT/L (20:30:50) (Solution A: 0.6M 
sucrose, 120mM KC1, 15mM NaCl, 0.3mM spermine, 2mM spermidine, 28mM (3- 
mercaptoethanol, 4mM EDTA, 2mM EGTA, 0.2mM PMSF, 2mM DTT, 0.2% Triton 
X-100, lOmM Tris.HCl pH7.9) (Solution NT: 15mM NaCl, lOmM Tris.HCl pH7.9) 
(Solution L: lOmM NaCl, 0.1% NP-40 (v/v), lOmM Tris.HCl pH7.9). The 
homogenate is filtered through several layers of mira cloth. Nuclei are precipitated by 
centrifugation at lOOOrpm for 10 minutes at 4°c. The nuclei are stained using trypan 
blue and counted for viability using a haemocytometer. The nuclei are resuspended in 
A/NT (50:50) and then pelleted as above. The nuclei are resuspended at 10^/ml in 
storage buffer and stored at -70°c.
Isolation of Nuclei from Cell Lines
1 xlO8  cells are pelleted at lOOOrpm at 4°C. Cells are washed in Hanks 
balanced salt solution and pelleted as above. Cells were resuspended in 17.5ml of ice 
cold nuclear isolation buffer 1 (NEB 1) (60mM KC1, 15mM NaCl, 5mM MgCl2 , 
O.lmM EGTA, 15mM Tris.HCl pH 7.4, 0.5mM DTT, O.lmM PMSF, 0.3M sucrose). 
Cells were disrupted by addition of NEB 2 (60mM KC1, 15mM NaCl, 5mM MgCl2 , 
O.lmM EGTA, 15mM Tris.HCl pH 7.4, 0.5mM DTT, O.lmM PMSF, 0.3M sucrose, 
10% NP-40). Pipette 15ml of NIB3 (60mM KC1, 15mM NaCl, 5mM MgCl2, O.lmM 
EGTA, 15mM Tris.HCl pH 7.4, 0.5mM DTT, O.lmM PMSF, 1.7M sucrose) into a 
36ml Sorvall polypropylene tube. Layer NIB 1/2 lysate onto NEB 3 solution. Spin
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13000rpm for 15 minutes in a pre-chilled centrifuge and rotor at 4°C. Resuspend 
nuclei in 5ml NIB 4 (60mM KC1, 15mM NaCl, 5mM MgCl2 , O.lmM EGTA, 15mM 
Tris.HCl pH 7.4, 0.5mM DTT, O.lmM PMSF, 0.3M sucrose, 5% glycerol). Nuclei 
are either DNase 1 digested immediately or stored at -70°c.
Digestion o f nuclei with DNase 1 enzyme
Immediately prior to digestion the nuclei are thawed (if from -70°C ) and spun 
at 12,000rpm in a microfuge. The nuclei were resuspended in digestion buffer (60mM 
KC1, 15mM NaCl, 5mM MgCl2, O.lmM EGTA, 15mM Tris.HCl pH 7.4, 0.5mM 
DTT, O.lmM PMSF, 0.3M sucrose, 5% glycerol) and split into 500|il aliquots. The 
DNAse 1 enzyme was serially diluted in a range from 20|ig/ml to 0.1 jag/ml. The 
diluted enzyme was then added to the appropriate tube and incubated at 37°C for 3 
minutes. The reaction was stopped by the addition of 50jil of stop buffer (5% SDS, 
lOOmM EDTA). 50j l l 1 of proteinase K was then added and the samples incubated at 
37°C overnight. DNA was isolated by sequential phenol and then chloroform 
extractions and ethanol precipitated.
2.11 Protein Analysis: Isolation of Nuclear extracts
Nuclear protein preparation
All manipulation were carried out at 4°C, and all solutions contained 0.5mM 
PMSF, 0.5mM benzamidine, lOmM sodium butyrate, lOmM p-glycerolphosphate, 
2mM levamisole, 50mM sodium orthovandate pH8.0, and l|ig  (each) of leupeptin, 
aprotinin, bestatin and pepstatin per ml.
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Minipreparation of nuclear extracts
Nuclear extracts were prepared using 1x10^ cells grown in the appropriate 
media. Suspension cells were spun down and washed twice with 1.5ml ice cold PBS, 
adherent cells are scraped of into 1.5ml of ice cold PBS. Cells were spun in a 
microfuge for 10 seconds and resuspended in 400ul of buffer A (lOmM HEPES-KOH 
pH7.9, 1.5mM MgCl2, 10mM KC1,0.5mM DTT, 0.2mM PMSF) by flicking the tube. 
The cells were allowed to swell on ice for 10 minutes, and then vortexed for 10 
seconds. The samples were then span for 10 seconds in a microfuge, resupended in 
lOOjil of buffer B (20mM HEPES-KOH pH7.9, 25% glycerol, 420mM NaCl., 1.5mM 
MgCl2, 0.2mM EDTA, 0.5mM DTT, 0.2mM PMSF) and incubated on ice for 20 
minutes. Cellular debris was removed by spinning the cells at 12000rpm for 2 minutes 
at 4°C. The supernatant was removed, aliquoted and stored at -70°C. The yield was 
typically between 50-75|ig protein /106 cells.
Large scale preparation o f protein nuclear extracts
1 0 1 0  cens were washed in phosphate-buffered saline and then twice in TMS (5mM 
Tris-HCl pH 7.5, 2.5mM MgCl2, 125mM sucrose). Cells were lysed in 200ml of 
TMS plus 0.25% Trion-X-100, and the nuclei were harvested by centrifugation at 
2000rpm for 20 minutes at 4°C. Nuclei were washed three times in 200ml of TMS 
and resuspended in approximately 5ml of TMS (5-10mg of DNA per ml), and 0.1 
volumes of 4M NaCl was added dropwise while stirring. The solution was 
centrifuged at 17,000 rpm for 30 minutes, and the supernatant spun at 35,000 rpm for 
60 minutes. Solid ammonium sulphate was added to 0.35 g/ml and left on ice for 30 
minutes. The precipitate was pelleted at 17,000rpm for 30 minutes and redisolved in 
5ml of E50 buffer (50mM ammonium sulphate, 20mM HEPES pH7.9, 5mM MgCl2,
73
O.lmM EDTA, 0.1% (v/v) glycerol, ImM DTT). The crude protein extract was 
cleared by centrifugation at 35,000rpm for 60 minutes, and aliquots were stored at - 
70°C.
2.12 Protein Analysis: Electrophoretic mobility shift assays
Oligonucleotides
The following oligonucleotides were used in EMSA analysis;
-341 c a c c c t t g t g c t c a g g a c a t c a a a a c c a g a g a g a t t t
-314 a g a g a g a t t t c c c tg g g g a a a c a a a t c c tg c c
uv ag ag a g a5 5 5 c cc5 g g g g aaacaaa5 cc5 g cc
-303 c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
-277 a a a t t t c c c c a t t g g t t g t t t a t c g g c a g a a a t c t a c a t
-237 t t t c t g g g g a t g g t g c a t c t a t a a t c a g t c t g t c c c t a t a g g
-171 t g a c c t c t c c c g c c a g a g g a g g c t g c t g t c a c t t t a a a
-110 c g t c t g g c t t c c g a c c a c t c t g g a g
+ 83 c c g t c c t g c c t g g c a g g c c c c c t a c c t t c g
+ 105 t a c c t t c g c a c a c t t t c c t c c t g c g g g t c t
-294 g a t c a a a c a a a t c c t g c c
-305 g a tc tc c c tg g g g a a a c a
-296 g a t c a g a g a g a t t t c c c t
fb g a t c t t t c c c t g g g g a a a
5= b ro m o d e o x y u r id in e
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Competitor Oligonucleotides
AP2 ccggccccaggct
ZFl ggatccctggacaagataagataaaggcagatct
ZF2 gatccctagctatgtgcctcatcttcgacaggctgtct
C/EBP gatcggatcccaattgggcaatcaggggatcc
NF-1 cttttggattgaagccaatatgaga
SP1 tgggaatcctaactgggcggagttatgctggtggtg
NF-KB agttgaggggactttcccagg
GATA-1 ccgggcaactgataaggattccctg
PU1 gatccataacctctgaaagaggaacttggttaggt
PEA3 gatcctcgagcaggaagttcga
E74 gatctctagctgaataaccggaagtaactcatccta
E Box cccccaccacgtggtgcctga
H4TF-1 tttagatttcccctcccccaccggggcggga
Ea ctacacctataaaccaatcac
Labelling o f double stranded probe
5 jLig of each complimentary oligonucleotides were annealed in TE to give a 
final concentration of 1 0 0 ng/pl. 2 0 0 ng of the annealed oligonucleotide was 
radiolabelled with [y-^P]ATP using T4 polynucleotide kinase according to the 
suppliers instructions. The labelled oligonucleotide was purified after separation by 
PAGE. The appropriate band was visualised by autoradiography, cut out and eluted 
in 1 ml of TE overnight at 37°C.
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Binding reaction
500pg of radiolabelled oligonucleotide probe was incubated with 5(il of 4x 
reaction buffer (lOOmM KC1, lOmM Tris/HCl pH7.6, 5mM MgCl2 ,lmM EDTA, 
ImM DTT, 12.5% glycerol), 6 (xg poly (dl.dC), 5pi nuclear extract (typically 
approximately lOug) and water to 25pl. The reaction was incubated at room 
temperature for 20 minutes. Where appropriate, cold competitor was added prior to 
the addition of labelled oliognucleotide and the reaction pre-incubated for 1 0  minutes 
on ice. Samples were run on a 6 % acrylamide gel in 0.5xTBE running buffer for 2 
hours/120 volts/4°C. The gel was then dried prior to autoradiography.
2.13 DNAse 1 footprinting
The appropriate footprinted region was generated by PCR and subcloned into 
a bluescript KS+ vector. Footprinting probes were prepared by 5' labelling of DNA 
restriction fragments with T4 polynucleotide kinase and [y-^PJATP and isolated 
after secondary restriction (Plumb and Goodwin, 1988). DNAse 1 footprint 
protection assays were performed in a volume of 1 0 0 |il of storage buffer in the 
presence of 6 ug of poly(dl-dC), 2ng of end-labelled restriction fragment, and upto 
80p,l of nuclear protein extract. Following partial DNAse digestion the nucleic acid 
was purified and resolved by denaturing PAGE and autoradiography (Plumb and 
Goodwin, 1988). Marker sequencing reactions were performed on the plasmid DNA 
using the Sequenase version II kit.
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2.14 Western bloting
Isolation and quantification of protein samples
Monolayer cultures were washed twice with PBS. The cells were then lysed 
in RIPA buffer (150mM NaCl, 1% NP-40, 0.5% Deoxycholate, 0.1% SDS, 50mM 
Tris-HCl pH7.6) and scraped off the culture flask to a 1.5ml conical tube. The cells 
were spun at 4000rpm for 10 minutes at 4°C. The lysate is removed to a fresh tube 
and stored at -70°C. Protein concentrations were quantified using a BioRad protein 
assay kit according to the manufactureres instructions.
SDS-PAGE electrophoretic separation
SDS-PAGE gels were cast and protein samples electrophorised in vertical 
polyacrylamide gels as previously described (Sambrook et al, 1989). Samples were 
run with pre-stained size markers.
Westen blotting
Protein samples were tranfered to ECL membrane (Amersham) using a 
Sartorius semi-dry blotter according to the manufacturers instructions.
Immunoprecipitation
Protein samples were pre-cleared with normal rabbit serum before addition of 
the appropriate primary antibody. Protein/antibody complexes were collected by the 
addition of protein A sepharose as described previously (Lane and Harlow, 1988).
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2.15 UV Crosslinking
FpIH oliogonucleotides were synthesized with bromodeoxyuridine substituted 
for thymidine bases, annealed, rediolabelled and used as probes in gel retardation 
reactions as described previously. Protein/DNA coplexes were resolved on a 6 % 
nondenaturing PAGE gel. The relevant band was excised from the gel, illuminated 
with U.V. light (312 nm) for 30 minutes and then soaked in SDS loading buffer (62.5 
mM Tris-HCl, pH6 .8 , 5% SDS, 5% p-mercaptoethanol, 10% glycerol, 2% 
bromophenol blue) for 1 hour. The gel peices containing either U.V. treated or 
untreated cross-linked complexes were placed directly into the wells of a 7.5% SDS- 
polyacrylamide gel and electrophorised. The gel was then dried, autoradiographed 
and typically exposed for several days.
2.16 Transfection into mammalian cell lines
DOTAP
60mm cuture dishes were seeded with 1 x 1 0 ^ cells the day prior to transfection 
so that the cells were approximately 80% confluent. DOTAP reaction were set up as 
described in the maufacturers protocol (Boehringer Mannheim). Typically 5ug of 
reporter plasmid and 5ug of the internal control containing a p-galactosidase gene 
(pHSV p-gal) plamid were used in each reaction. In reactions which were corrected 
for molar ratio, the total amount of DNA was kept constant by the addition of 
pUC19 to the appropiate samples.
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CaPOf
60mm cuture dishes were seeded with 1 x 1 0 ^ cells the day prior to transfection 
so that the cells were approximately 80% confluent. Reaction were set up as 
described in the manufacturers protocol.
2.17 Reporter Gene Assays
Luciferase Assays
60mm cuture dishes were seeded with 1 x 1 0 ^ cells the day prior to transfection 
so that the cells were approximately 80% confluent. Reaction were set up as 
described in the manufacturers protocol (Promega).
$-galactosidase assays
Cell extracts were isolated using the lysis buffer supplied in the luciferase 
assay kit. Typically, 50jil of extract was incubated with 500pl of Solution I (60mM 
Na2 HPC>4 , 40mM NaH2 P0 4 , lOmM KC1, ImM MgCl2 , 50mM p-mercaptoethanol) 
and 100ml of Solution II (60mM Na2 HPC>4 , 40mM NaH2 PC>4 }, 2mg/ml ONPG). 
The reactions were then incubated at 37°C for 10-90 minutes or until the appearance 
of a yellow colouration. The reactions were then stopped by the addition of 250(il of 
1M Na2 CC>3 . The samples were read at an absorbance of 420nm in plastic 2ml 
cuvettes.
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Chapter 3: Materials
3.1 Tissue culture media and supplies
Supplier: Beatson Institute Central Services 
Sterile PE 
Sterile PBS
Sterile glassware and pipettes 
Sterile water 
Sterile CT buffer 
Penicillin (7.5mg/ml)
Streptomycin (lOmg/ml)
Supplier: Gibco Europe Life Technologies Ltd., Paisley, Scotland. 
Special Liquid Medium 
Foetal Calf Serum 
200mM Glutamine 
2.5% (w/v) Trypsin 
Sodium bicarbonate 
Non-essential amino acids (lOOx)
Gentomycin (lOmg/ml)
Supplier: Fisons Scientific Equipment, Loughborough, Leics., England. 
DMSO
Supplier: A/S Nunc, Roskilde, Denmark.
Tissue culture flasks 
Nunc tubes
Supplier: Becton Dickenson Labware, Plymouth, England.
100mm/60mm diameter tissue culture dish 
Supplier: Northumbria Biologicals Ltd., Cramlington, England.
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RPMI-1640
3.2 Bacterial media
Unless otherwise stated bacterial media components were purchased from BDH 
Chemicals Ltd., Poole, Dorset, England.
Supplier: Beatson Institute central services
L-Broth (prepared as according to Sambrook et al., 1989)
Sterile glassware 
Supplier: Difco, Detroit, Michigan, USA.
Agar
Supplier: Sigma Chemical Co., Poole, Dorset, England.
X-gal
Ampicillin
3.3 Plasticware
Supplier: Bibby-Sterilin Ltd., Stone, Staffs, England.
30ml universal tubes 
Bacteriological dishes 
Supplier: Becton Dickenson Labware., Plymouth, England.
Falcon Tubes
3.4 Plasmids
Supplier: Promega., Madison, Wisconsin, USA 
pGL2 luciferase reporter vectors
3.5 Kits
Supplier: Promega., Madison, Wisconsin, USA 
Sequenase version 2.0 kit 
Luciferase Reaction Mix, Lysis Buffer Kit
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Supplier: Boehringer Mannheim UK., Lewes, East Sussex, England. 
Random-primed DNA labelling kit
Supplier: Invitrogen
TA cloning Kit
3.6 Membranes, paper and X-ray film
Supplier: Amersham International pic., Amersham, Bucks, England.
Hybond N+ nylon membrane 
Supplier: Bethesda Research Laboratories, Gibco Ltd., Paisley, Scotland.
Dialysis tubing 
Supplier:
Dialysis tubes
Supplier: Whatman International Ltd., Maidstone, Kent, England.
3MM filter paper 
Supplier: Eastman Kodak Co., Rochester, New York, USA.
X-ray film (X-OMAT AR5)
Supplier: Presentation Technology Ltd., Clydebank, Scotland.
3.7 Nucleotides, polynucleotides, RNA and DNA
Supplier: Amersham International pic., Amersham, Bucks, England. 
Redivue [a-^^P] dCTP 3000 Ci/mmol 
Redivue [y-32p] dATP 5000 Ci/mmol 
Redivue [a -^ S ] dATP 1000 Ci/mmol 
Unlabelled dATP, dGTP, dCTP, dTTP 
Supplier: Parmacia Ltd., Milton Keynes, Bucks, England.
Poly [dl-dC]
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Supplier: Sigma Chemical Co. Ltd., Poole, Dorset, England.
Salmon sperm DNA 
Supplier: Bethesda Research Laboratories, Gibco Ltd., Paisley, Scotland.
RNA ladder 0.24-9.5kb
Bacteriophage 1 DNA markers (Hindlll cut)
3.8 Enzymes
Supplier: Northumbria Biologicals Ltd., Cramlington, Northumberland, England.
Klenow DNA polymerase (lU/|il)
T4 polynucleotide kinase (lOU/pl)
DNA Ligase (IOU/jllI)
Supplier: Lome Laboratories Ltd., Twyford, Reading, Barks, England 
DNAse 1 (Molecular biology grade, RNase and protease free)
Supplier: Boehringer Mannheim UK., Lewes, East Sussex, England.
RNAse A
Calf intestinal alkaline phosphatase (lU/(il)
Supplier: Bethesda Research Laboratories, Gibco Ltd., Paisley, Scotland.]
All enzymes not listed above.
3.9 Chemicals
All chemicals not listed both here and above were obtained (AnalaR grade) from 
BDH Chemicals Ltd., Poole, Dorset, England.
Supplier: Sigma Chemical Co. Ltd., Poole, Dorset, England.
Spermidine
Spermine
Dithiothreitol
Triton-X-100
Diethylpyrocarbonate (DEPC)
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Bromophenol blue 
Xylene cyanol 
MOPS
Supplier: Pharmacia Ltd., Milton Keynes, Bucks, England.
Ficoll 400
Supplier: Rathbum Chemicals Ltd., Walkerbum, Scotland.
Water-saturated phenol 
Supplier: Northumbria Biologicals Ltd., Cramlington, Northumberland, England.
Bovine Serum Albumin (20% w/v)
Supplier: James Burrough Ltd., Witham, Essex, England.
Ethanol
Supplier: Fluka Chemika-Biochemika AG, Buchs, Switzerland.
Formamide
Supplier: Fisons Scientific Equipment, Loughborough, England.
Formaldehyde
Supplier: Cinna/Biotecx Laboratories Inc., Houston, Texas, USA.
RNAzolB
3.9 Water
Distilled water for buffers and general solutions was obtained from Milipore MilliRO 15 
system. Water for protein/enzyme work or recombinant DNA protocols was further 
purified on a Millipore MilliQ system to 18M cm.
84
Part 3: Results
Chapter 4: DNAsel Hypersensitivity Site Analysis of the 
Evi-1 Locus
DNA is generally tightly associated in condensed higher order structures with 
chromatin. In this state the DNA is less accessible to transcription factor protein 
interaction and, as a consequence, unable to initiate transcription. In contrast to the bulk 
of chromatin, transcriptionally active regions of DNA acquire a more relaxed, or 
unwound, structure with the chromatin framework. It has been shown that structural 
relaxation surrounding transcriptionally active genes also correlates with a general 
increase in the sensitivity to nuclease digestion and that small 15-200bp regions exhibit 
extreme DNAsel sensitivity termed DNAsel Hypersensitivity Sites (DHS) (Wu et al., 
1979 a & b). These DHS regions are generally associated with active promoter and 
enhancer elements (reviewed by Gross and Garrard, 1988). Consequently, mapping 
DNAsel sensitivity is a useful method of identifying gaps in the nucleosomal array and 
therefore the location of potentially transcriptionally active genes.
4.1 Chromatin structure of the 5' Evi-1 locus in murine kidney tissue
The Evi-1 gene is expressed in a tissue specific manner, the kidney having one 
of the highest levels of expression (Morishita et al> 1990, Perkins et al, 1991). To 
identify the regions of DNA important in controlling this tissue specific expression DHS 
analysis was performed with nuclei isolated from murine adult kidney. The nuclei were 
digested with DNAsel and subsequently the genomic DNA was isolated, digested with 
appropriate restriction enzymes and examined by Southern blot analysis with the 
appropriate 32-p labelled probe. Two DNA probes were used in all the DHS analysis 
which covered an 18kb region of the 5' Evi-1 locus: either a 2kb EcoRI/BamHI probe 
(probe b) or a 500bp EcoRI/SstI probe (probe a); both originally derived from a X
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bacteriophage clone, designated XCB9 (figure 4.1, adapted from Bartholomew & Ihle, 
1991).
Initially, DHS analysis was performed on a 5kb EcoRI fragment using probe b 
(figure 4.2B). Southern blot analysis with probe b detects a unique 5kb EcoRI fragment 
(figure 4.2 A, lane 1). However, increasing DNAsel digestion reveals the presence of 
two hypersensitivity sites which are clearly visible (figure 4.2A, lanes 7 and 8 ). An 
intense 2.3kb band, designated hypersite I, maps approximately 2kb upstream of the 
major transcription initiation sites while the less intense hypersites, designated hypersite 
II, are located within exon I. The differences in intensity between the hypersites may be 
due to: 1) a diluting effect of DNAsel digestion at hypersite I since this hypersite is 
closer to the probe or: 2) the relative sensitivity of the region to DNAsel which can be 
affected by the proteins binding to the DHS regions.
As mentioned previously DHS sites are generally associated with active 
promoter and enhancer elements. The location of the DHS II hypersites over the 
multiple transcription initiation sites, previously identified in Evi-1 expressing kidney and 
ovary tissues (Bartholomew & Ihle, 1991), is consistent with this association.
In contrast, DHS I was mapped to approximately 2kb upstream of the major 
initiation sites. To confirm this location the filter was striped and reprobed with probe a, 
located at the opposite end of the 5kb EcoRI fragment, (figure 4.3 B). Increasing 
DNAsel digestion reveals a 2.7kb band (in contrast to the 2.3kb band with probe b) 
representing hypersite I (figure 4.3 A, lanes 7 and 8 ). This confirms the location of 
hypersite I as 2.7kb upstream from the 3' EcoRI site and approximately 2kb upstream of 
the major initiation sites (figure 4.3 B). DHS I may represent an enhancer element 
which regulates the transcriptional activity of the putative promoter region.
DHS regions located considerable distances from the promoter may regulate 
transcriptional activity. To identify other hypersites outside of the 5kb EcoRI region we 
extended our analysis both 5' and 3'. The same DNAsel treated kidney genomic DNA
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Figure 4.1 Schematic representation of the probes used for DHS analysis
The diagram shows the Evi-1 locus and the genetically linked fim-3 locus.
DHS analysis of the Evi-1 locus
Two probes, a and b, were used in DHS analysis of the Evi-1 locus both of which were 
isolated from the same XCB9 clone. Probe a is 0.5kb Sstl/EcoRI fragment with probe 
b a 2kb EcoRI/BamHI fragment.
DHS analysis of the Fim-3 locus
A 1.2kb EcoRI/Hindlll fragment, probe c, isolated from a A,CB24 clone, was used in 
DHS analysis of the Fim-3 locus.
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Figure 4.2: DNase 1 hypersite analysis of the 5' Evi-1 Locus in kidney tissue with a
2kb EcoRI/BamHI probe following EcoRI digestion.
A
The DNA was digested with EcoRI restriction enzyme. The 2kb EcoRI/BamHI labelled 
probe shown in figure 1.2, B (Probe b) hybridises to a 5kb EcoRI fragment present at 
the top of all the lanes 1-8. DNAse 1 hypersensitive sites within this 5kb region 
become apparent with increasing DNAse 1 enzyme concentration. A strong hypersite 
(I) and two less intense hypersites (II) are seen in lanes 7 + 8  and are discussed in the 
text.
DNAsel Concentrations
Lane 1: Untreated, Lane 2: 0.312 |Xg/ml, Lane 3: 0.625 fig/ml, Lane 4: 1.25 JLig/ml, 
Lane 5: 2.5 |Lig/ml, Lane 6 : 5 |ig/ml, Lane 7: 10 pg/ml, Lane 8 : 20 pg/ml.
B
Schematic representation of the 5' Evi-1 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Evi-1 locus of 
hypersites I and II are also indicated. Hypersite I maps to approximately 2kb 
upstream of exon I while hypersite II is located within exon I.
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Figure 4.3: Confirmation of the location of DHS I with a 500bp EcoRI/SstI probe
following EcoRI digestion.
A
The DNA was digested with EcoRI restriction enzyme. The EcoRI/SstI labelled probe 
shown in figure 1.3, B (Probe a) hybridises to a 5kb EcoRI fragment present at the top 
of all the lanes 1-8. DNAse 1 hypersensitive sites within this 5kb region become 
apparent with increasing DNAse 1 enzyme concentration. A 2kb frament corresponding 
to hypersite (I) is observed in lanes 7 + 8  and is discussed in the text.
DNAsel Concentrations
Lane 1: Untreated, Lane 2: 0.312 fig/ml, Lane 3: 0.625 |ig/ml, Lane 4: 1.25 Jig/ml, 
Lane 5: 2.5 pg/ml, Lane 6 : 5 |ig/ml, Lane 7: 10 pg/ml, Lane 8 : 20 jig/ml.
B
Schematic representation of the 5' Evi-1 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Evi-1 locus of 
hypersites I and II are also indicated. Hypersite I maps to approximately 2kb 
upstream of exon I while hypersite H is located within exon I.
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isolated previously was digested with BamHI and Southern analysis performed using 
probe b, which hybridises to a unique 7kb fragment (figure 4.4 A, lanel). The DHS 
analysis failed to identify any hypersites further upstream of the EcoRI fragment. 
Consequently, only two DHS regions, DHS I and II, are present in an approximately 
9.3kb of DNA upstream of the major sites of transcription initiation.
Similarly, to identify any DHS sites 3' of the EcoRI fragment DNAsel treated 
kidney genomic DNA isolated previously was digested with Sstl. Southern analysis 
using probe a detects a unique 8.2kb fragment (figure 4.5 A, lanel). Increasing 
DNAsel digestion reveals the presence of a faint hypersite (figure 4.5, lane 6  + 7). This 
hypersite probably maps to the 3' of exon I and overlaps the border with intron I and 
reflecting one of the sites in DHS II previously identified (figure 4.2). However, it is 
conceivable that the hypersite may be located at the other end of the Sstl fragment, 
within intron II.
4.2 Chromatin structure of the 5’ Evi-1 locus in DA-3 and L929 cells
To see if there is a correlation between the pattern of the DHS I and II and the 
level of Evi-1 expression, DHS analysis was performed with nuclei isolated from DA-3 
cells (high Evi-1 expressing cells) and L929 cells (relatively low Evi-1 expressing cells). 
DA-3 cells ectopically express high levels of Evi-1 due a retroviral insertion 90kb 
upstream in the Fim-3 locus (Bartholomew et al., 1989). Since no RNA transcripts were 
identified from the LTR the mechanism of ectopic expression has been suggested to 
occur by a distal enhancer model. Importantly, the induced expression occurs by 
activating the normal Evi-1 promoter (Bartholomew & Ihle, 1991).
To compare the DHS I and II pattern observed in kidney tissue DNAsel treated 
genomic DNA from either DA-3 or L929 cells were digested with EcoRI and the blots 
hybridised with probe b. Again Southern analysis with probe b detects a 5kb EcoRI
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Figure 4.4: DNase 1 hypersite analysis of the 5’ Evi-1 Locus in Kidney with a 2kb
EcoRI/BamHI probe following BamHI digestion.
A
The DNA was digested with BamHI restriction enzyme. The EcoRI/BamHI labelled 
probe shown in figure 1.4, B (Probe b) hybridises to a 7kb BamHI fragment present at 
the top of all the lanes 1-7. There were no DNAse 1 hypersensitive sites seen within this 
7kb region.
DNAse 1 Concentrations
Lane 1: Untreated, Lane 2: 0.625 jig/ml, Lane 3: 1.25 (ig/ml, Lane 4: 2.5 Jig/ml, Lane 
5: 5 pg/ml, Lane 6 : 10 pg/ml, Lane 7: 20 pg/ml.
B
Schematic representation of the 5' Evi-1 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Evi-1 locus of 
the previously identified hypersites I and II are also indicated.
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Figure 4.5: DNase 1 hypersite analysis of the 5’ Evi-1 Locus in Kidney with a
500bp EcoRI/SstI probe following Sstl digestion.
A
The DNA was digested with Sstl restriction enzyme. The EcoRI/SstI labelled probe 
shown in figure 1.5, B (Probe a) hybridises to a 8.2kb Sstl fragment present at the top 
of all the lanes 1-7. There were no DNAse 1 hypersensitive sites seen within this 8.2kb 
region
DNAse 1 Concentrations
Lane 1: Untreated, Lane 2: 0.625 fig/ml, Lane 3: 1.25 pg/ml, Lane 4: 2.5 pg/ml, Lane 
5: 5 pg/ml, Lane 6 : 10 |Xg/ml, Lane 7: 20 jig/ml.
B
Schematic representation of the 5' Evi-1 locus. BamHI (B), EcoRI (E) and Sstl 
(S) restriction enzyme sites are shown. The approximate location within the Evi-1 locus 
of the previously identified hypersites I and II are also indicated.
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fragment (figure 4.6 A & B, lane 1). DHS sites are observed with increasing DNAsel 
concentration (figure 4.6 A & B) which map to the same location as DHS I and II 
previously identified in kidney tissue. The results show that DHS I and II are present in 
both DA-3 and L929 cells. In conclusion, DHS I and II correlate with expression of the 
Evi-1 gene, being present in low and high expressing cells, but not with the level of 
expression.
4.3 Chromatin structure of the 5’ Evi-1 locus in Spleen Tissue and FDCP-1 cells
Our analysis has identified DHS I and II in kidney, DA-3 and L929 cells which 
all express Evi-1. The tissue specific nature of Evi-1 expression might lead us to predict 
the presence of tissue specific hypersites present only in cells that express Evi-1, as is 
the case for other genes such as the p-globin genes (reviewed by Evans et al, 1990). 
To examine if DHS I and II correlates with Evi-1 expression we examined hypersites in 
non-expressing cell lines and tissue from FDCP-1 and spleen respectively.
As previously observed in kidney, DA-3 and L929 cells, EcoRI digestion of 
spleen or FDCP-1 genomic DNA results in a 5kb EcoRI fragment which hybridises to 
probe b (figure 4.7 A & B, lane 1). DHS I is visible in both spleen, (figure 4.7 A, lane
4) and FDCP-1 cells (figure 4.7 B, lane 4) whereas DHS II is not observed to be 
present in either spleen or FDCP-1 cells. The two bands marked N present in figure 4.7 
A, lane 4 are non-specific bands which also appear in the DNAsel untreated lane 1. In 
conclusion, DHS I is a ubiquitous hypersite being present in all the cell lines and tissues 
tested and, by contrast, DHS II is present only in Evi-1 expressing cells.
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Figure 4.6: DNase 1 hypersite analysis of the 5’ Evi-1 Locus in DA-3 and L929 cell
lines with a 2kb EcoRI/BamHI probe following EcoRI digestion.
A
DNA was digested with EcoRI restriction enzyme. The 2kb EcoRI/BamHI labelled 
probe shown in figure 1.6, B (Probe b) hybridises to a 5kb EcoRI fragment present at 
the top of all the lanes 1-4. DNAse 1 hypersensitive sites within this 5kb region 
become apparent with increasing DNAse 1 enzyme concentration. A strong hypersite 
(I) and two less intense hypersites (II) are seen in lanes 7 + 8  and are discussed in the 
text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 5 pg/ml, Lane 3: 10 pg/ml, Lane 4: 20 pg/ml.
B
DNA was digested with EcoRI restriction enzyme. The 2kb EcoRI/BamHI labelled 
probe shown in figure 1.6 , B (Probe b) hybridises to a 5kb EcoRI fragment present at 
the top of all the lanes 1-4. DNAse 1 hypersensitive sites within this 5kb region 
become apparent with increasing DNAse 1 enzyme concentration. A strong hypersite 
(I) and two less intense hypersites (II) are seen in lanes 3 + 4  and are discussed in the 
text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 5 (ig/ml, Lane 3: 10 pg/ml, Lane 4: 20 pg/ml.
C
Schematic representation of the 5' Evi-1 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Evi-1 locus of 
the previously identifed hypersites I and H in kidney cells are also indicated.
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Figure 4.7: DNase 1 hypersite analysis of the 5' Evi-1 Locus in Spleen tissue and
the FDCP-1 cell line with a 2kb EcoRI/BamHI probe following EcoRl digestion.
A
DNA was digested with EcoRI restriction enzyme. The 2kb EcoRI/BamHI labelled 
probe shown in figure 1.7 B (Probe b) hybridises to a 5kb EcoRI fragment present at 
the top of all the lanes 1-4. DNAse 1 hypersensitive sites within this 5kb region 
become apparent with increasing DNAse 1 enzyme concentration. A strong hypersite 
(d was seen in lanes 3 + 4  and is discussed in the text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 5 pg/ml, Lane 3: 10 pg/ml, Lane 4: 20 (ig/ml.
B
DNA was digested with EcoRI restriction enzyme. The 2kb EcoRI/BamHI labelled 
probe shown in figure 1.7, B (Probe b) hybridises to a 5kb EcoRI fragment present at 
the top of all the lanes 1-4. DNAse 1 hypersensitive sites within this 5kb region 
become apparent with increasing DNAse 1 enzyme concentration. A strong hypersite 
(I) was seen in lanes 3 + 4  and is discussed in the text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 5 pg/ml, Lane 3: 10 |Lig/ml, Lane 4: 20 jig/ml.
C
Schematic representation of the 5' Evi-1 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Evi-1 locus of 
the previously identifed hypersites I and II in kidney cells are also indicated.
DINAsel
2 3 4
Spleen
DNAsel
2 3
FDCP-1
N
Evi-1 Locus
B E E
I II
I I
y  v
B E
P ro b e  b
■ 4
> + i
BE
U
lkb
1
>  ATG
4.4 Summary of DHS analysis of the 5' Evi-1 locus
Figure 4.8 shows a schematic representation of the Evi-1 locus and a summary 
of the hypersites found in the different tissues and cell lines examined in this study. An 
approximately 18kb region of the Evi-1 locus has been examined for the DHS sites 
which might be involved in controlling the expression of the Evi-1 gene. DHS analysis in 
Evi-1 expressing and non-expressing cells has identified an ubiquitous hypersite, I, 
located approximately 2kb upstream of the major transcription initiation site. In 
contrast a second region has DHS sites located over exon I which are present only in 
Evi-1 expressing cells.
The location of the ubiquitous DHS I might suggest that this region may act as 
an enhancer element. However, the appearance of DHS enhancer sites are generally 
correlated with increased expression of the gene. Alternatively, it is conceivable that 
DHS I may be important in vivo in maintaining a more relaxed chromatin framework 
around the Evi-1 gene.
The presence of DHS II over exon I presumably reflects that this is the promoter 
region of the gene since transcriptional initiation by RNA polymerase II is generally 
mediated by a TATA box and transcription factors immediately upstream. DHS II may 
also contain regulatory ds-elements important in tissue specific expression of the gene. 
The functional importance of both these regions in transcriptional regulation of the Evi- 
1 promoter are discussed in later chapters.
4.5 Chromatin structure in the Fim-3 Locus
Ectopic expression of the Evi-1 gene in DA-3 cells is due to a retroviral insertion 
in the Fim-3 locus 90kb further upstream (Bordereaux et al, 1987, Bartholomew et al., 
1989). Expression occurs by activating the normal Evi-1 promoter and the mechanism
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Figure 4.8: DHS anlysis of the Evi-1 locus in different cell types
A schematic representation of the Evi-1 locus showing the location of DHS I and II, 
and the 18kb probed region covered using the probes a and b. The presence (+) or 
absence (-) of the DHS I and II in the tissues or cell lines examined is also shown.
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has been postulated to occur by a distal enhancer model. The Fim-3 region was 
examined surrounding the retroviral insertion site to see if there were any DHS sites 
which might contribute to the increase in Evi-1 expression levels. The DHS pattern of 
this region in DA-3 cells was also compared with kidney tissue to evaluate if the Fim-3 
region contributes to normal tissue specific expression of the gene.
Therefore, DNAse 1 treated DA-3 and Kidney genomic DNA were digested with 
EcoRI and examined by Southern blot analysis with the 1.2kb EcoRI/HindlH 32-p 
labelled probe c, from the Fim-3 locus (figure 4.9, B). In DA-3 probe c detects two 
EcoRI fragments of 3.5kb, (normal allele), and 4kb, (rearranged allele containing a 
retroviral insertion) (figure 4.9 A, lane 1). Increasing DNAse 1 digestion identified a 
DHS site, designated DHS III, of 2.2kb which maps to within the retroviral LTR. The 
location of DHS III is confirmed by the observation that the intensity of the 3.5kb 
relative to the 4kb band at lower DNAse 1 digestion is the same (figure 4.9 A, lanes 1 to
5) whereas on appearance of the hypersite the upper 4kb fragment containing the LTR 
becomes less intense than the lower 3.5kb fragment, due to increasing DNAse 1 
digestion within the LTR.
In contrast, Southern analysis of EcoRI digested kidney genomic DNA with 
probe c detects a single 3.5kb EcoRI fragment (figure 4.10, A, lane 1). However, no 
DHS sites were seen with increasing DNAse 1 digestion. In conclusion, no DHS sites 
are located within the 3.5kb fragment of the normal allele in kidney and presumably this 
region of Fim-3 is not important for high levels of tissue specific expression of the Evi-1 
promoter observed in kidney tissue.
4.6 Summary of DHS Analysis in the Fim-3 locus
A summary of the analysis to investigate DHS sites in a 3.5kb EcoRI region of 
the Fim-3 locus in either retroviral LTR containing DA-3 cells or kidney tissue is
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Figure 4.9: DNase 1 hypersite analysis of the Fim-3 Locus in DA-3 cells with a
1.2kb EcoRI/Hindlll probe following EcoRI digestion.
A
DNA was digested with EcoRI restriction enzyme. The 1.2kb EcoRI/Hindlll labelled 
probe shown in figure 1.9, B (Probe a) hybridises to a 3kb and 3.5kb EcoRI fragment 
present at the top of all the lanes 1-8. The doublet is seen as a result of a retroviral 
insertion at one allele and the subsequent presence of a Long Terminal Repeat (LTR). 
DNAse 1 hypersensitive sites within this 5kb region become apparent with increasing 
DNAse 1 enzyme concentration. A hypersite (I) is seen in lanes 7 + 8  and are discussed 
in the text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 0.312 f ig /m l ,  Lane 3: 0.625 (x g /m l, Lane 4: 1.25 | i g / m l ,
Lane 5: 2.5 j i g / m l ,  Lane 6 : 5 j i g / m l ,  Lane 7: 10 J ig /m l ,  Lane 8 : 20 (X g/m l.
B
Schematic representation of the Fim-3 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The approximate location within the Fim-3 locus of 
the identified hypersite (I) is also indicated.
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Figure 4.10: DNase 1 hypersite analysis of the Fim-3 Locus in Kidney with a 1.2kb
EcoRI/Hindlll probe following EcoRI digestion.
A
DNA was digested with EcoRI restriction enzyme. The 1.2kb EcoRI/Hindin labelled 
probe shown in figure 1.10, B (Probe a) hybridises to a 3kb EcoRI fragment present at 
the top of all the lanes 1-8. There were no DNAse 1 hypersites identified in this region 
and this is discussed further in the text.
DNAse Concentrations
Lane 1: Untreated, Lane 2: 0.312 p g / m l ,  Lane 3: 0.625 p g / m l ,  Lane 4: 1.25 J ig /m l,
Lane 5: 2.5 J ig /m l ,  Lane 6 : 5 ( i g /m l ,  Lane 7: 10 | i g / m l ,  Lane 8 : 20 | i g / m l .
B
Schematic representation of the Fim-3 locus. BamHI (B) and EcoRI (E) 
restriction enzyme sites are shown. The location of probe a is also shown.
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illustrated in a schematic representation of the Fim-3 locus (figure 4.11). The induction 
of a DHS site, designated DHS III, within the LTR of the virus in DA-3 cells 
correlates with ectopic expression of the Evi-1 gene from its normal promoter. This is 
consistent with a putative long range enhancer mechanism suggested previously to be a 
possible method for inducing Evi-1 promoter expression in DA-3 cells (Bartholomew & 
Ihle., 1991). However, no DHS sites were identified within this region in kidney 
confirming that DHS III is due to retroviral insertion at this site in DA-3 cells. 
Therefore, the Fim-3 region presumably plays no part in tissue specific expression of 
the Evi-1 promoter in kidney tissue although it is still plausible that there are DHS sites 
present outside the region examined in this study.
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Figure 4.11: DHS anlysis of the Fim-3 locus in different cell types
A schematic representation of the Fim-3 locus showing the location of DHS ID, and the 
3.5kb probed region covered using probe c. The presence (+) or absence (-) of the 
DHS I and II in DA-3 cells or kidney tissue is also shown.
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Chapter 5: Functional analysis of the Evi-1 promoter
Previous studies have shown that the Evi-1 promoter has multiple transcriptional 
initiation sites with two major sites occurring at two adjacent nucleotides in kidney and 
ovary tissue (Bartholomew & Ihle, 1991). However, the functional elements controlling 
Evi-1 promoter activity are unknown. DHS analysis around the promoter region has 
identified two DHS regions I and II (chapter 4.4). DHS II is located over exon I and is 
found exclusively in Evi-1 expressing cell lines and tissues examined (chapter 4.4). In 
contrast, DHS I is found in all cells tested. DHS sites are generally associated with 
active promoter and enhancer elements (reviewed by Gross and Garrard, 1988), and 
therefore the role of these regions in Evi-1 transcriptional regulation was investigated.
5.1 The generation of Evi-1 promoter luciferase reporter constructs
To identify the regions important in controlling Evi-1 promoter activity relatively
large restriction fragments from the Evi-1 locus were inserted upstream of a luciferase
reporter gene. The largest reporter construct examined, designated pGL2E8, is an 8 kb
EcoRI/Smal restriction fragment which extends approximately 4.2kb upstream of the
major sites of transcription initiation and 3.8kb downstream to the end of exon II (figure
5.3). This construct was generated as shown in figure 5.2 and contains both DHS I and
II regions. A second 3' truncated construct, designated pGL2E5, contains a 4.5kb
EcoRI/SstI fragment which extends 4.2kb upstream of exon I and approximately 300bp
downstream to an SstI within exon I. The pGL2E5 construct also has DHS I but may
partially delete the DHS II region (figure 5.3). Two additional constructs, designated
pGL2E2.5 and pGL2E2, possess the same 3' SstI site as pGL2E5 but extend only 
S
1.75kb and 1. lkb respectively, upstream of the major sites of transcription initiation. The 
pGL2E2.5 construct has partial loss of DHS I whereas pGL2E2 deletes the whole
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Figure 5.1: Schematic representation of the steps involved in cloning portions of
the Evi-1 locus upstream of a luciferase reporter.
A 5kb portion of the Evi-1 locus containing exon I and approximately 4kb of 
upstream sequence had previously been cloned into a pKSII+ bluescript vector (Chris 
Bartholomew).
A schematic representation of the Evi-1 locus is shown with exon I, II and III 
represented as shaded boxes.
Reporter Constructs
pGL2E5 construct- an approximately 4.7kb region of the Evi-1 locus was cut out of 
the pKSII+E5 bluescript vector on a SstI restriction fragment (one SstI site is within 
exon I and another further upstream in the vector polylinker). This SstI fragment was 
cloned into a pGL2basic luciferase reporter vector (Promega) which had previously 
been cut with SstI and the ends phosphorylated to prevent re-ligation. The orientation 
of the insert was then evaluated.
pGL2E2.5 construct- an approximately 2.5kb Hindin restriction fragment was cut out 
of the 5kb pGL2 reporter vector (one Hindm site cuts within the previously identified 
DHS I of the Evi-1 locus and the other further downstream in the vector poly linker). 
The Hindlll fragment was cloned into a pGL2basic luciferase reporter vector (Promega) 
which had previously been cut with HindlE and the ends phosphorylated to prevent re­
ligation. The orientation of the insert was then evaluated.
pGL2E2 construct- an approximately 2.kb Bglll restriction fragment was cut out of the 
5kb pGL2 reporter vector (one Bglll site cuts downstream of the previously identified 
DHS I of the Evi-1 locus and the other further 3' within vector poly linker). The Bglll 
fragment was cloned into a pGL2basic luciferase reporter vector (Promega) which had 
previously been cut with Bglll and the ends phosphorylated to prevent re-ligation. The 
orientation of the insert was then evaluated.
Restriction enzyme sites:
S = SstI 
B =BamHI 
E =EcoRI
w
OQ
VI
a
o
a  3
o
$
o *
H A 1 0
W
+
IIS’Siud>!
I«tuS
13
.SP
nJ
*
IIIPUIH
inSa
ioqx
00
-SPOQ03
W
00
iudx
IBUIS
WD
m
3
U
bp
OQ
ii^a
I°MX
IIIPUJH
iii^a
i«qx
00
00
.OQ
PMX
nss
pid*
IBUIS
CO
w  —
Q3 —
W —
CQ
P J
o o
*
CO
( 8
u
w  « 3
^  3
• i  o
^  °
O4 ^
cd
w o
m
H
( M
n J
o
a
7
IIIPUJIL
n £ a
ioqx
00
OQ
W
00
iudx
IBUIS
3
U
IIIPUJH
iifti
ioqx
oo
rv j
H
r o
o
a
CD <D
C/3 CO
c d c dVh V-i
<D 0 )<4—i • ^ <4—(
o
•
o
D HHHH 3 $
J HHT J _ )
IIIPUIJI
ii^a
ioqx
00
nl^a
ioqx
IISS
iud^ i
IBUIS
Figure 5.2: Schematic representation of the steps involved in cloning an 8.0kb
region of the Evi-1 locus, containing both exon I and II, upstream of a luciferase
reporter.
A 5kb portion of the Evi-1 locus containing exon I and approximately 4kb of 
upstream sequence had previously been cloned into a pKSII+E5 bluescript vector (Dr 
Chris Bartholomew).
A schematic representation of the Evi-1 locus is shown with exon I, II and III 
represented as shaded boxes.
Reporter Construct
pGL2E8 construct- A 3kb region of the Evi-1 locus from an SstI site within exon I to 
the end of exon II was generated by PCR as described in Materials and methods. The 3' 
PCR primer (exon II) contained extra nucleotides to incorporate a Smal restriction 
enzyme site. The 3.2kb PCR fragment was cut with Smal enzyme. This produces a 3kb 
fragment which was sub-cloned into a Smal cut pKSII+E5 bluescript vector which 
already contains 5kb of upstream Evi-1 sequence.
The resulting contstruct, designated pKSII+E8 , is a 8.0kb stretch of the Evi-1 
locus which contains exon I, intron I and exon II. Subsequenlty, a 6 kb fragment 
containing exon I, intron I and exon II was excised as a BamHI/Notl restriction 
fragment from pKSII+E8 , ready for cloning into pGL2E5.
However, before this could be accomplished it was necessary to convert a 
HindlH site within the polylinker of the pGL2E5 luciferase reporter vector to a Notl 
restriction site in order to create an appropriate 3' restriction enzyme site for cloning a 
6.0kb fragment. The subsequent vector, designated pGL2E5Not, was then cut with 
BamHI and Notl which removes a 3kb region of Evi-1 sequence, including exon I. 
The 6.0kb BamHI/Notl fragment was then cloned into pGL2E5not to generate an 
luciferase reporter construct containing 8 kb of the 5' Evi-1 locus, designated pGL2E8.
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Figure 5.3: Preliminary reporter constructs containing 8.0kb to 2kb of the Evi-1
locus.
Schematic Representation of the Evi-1 locus and the cloned reporter constructs. 
Exon I and II are labelled and represented as shaded boxes. The approximate location 
of DHS sites I and II are shown with arrows.
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region (figure 5.3). The generation of the pGL2E5, pGL2E2.5 and pGL2E2 reporter 
constructs are described in figure 5.1.
5.3 Activity of the Evi-1 reporter constructs in 293, L929 and HEC-1B cells
To identify the region required for basal transcription of the Evi-1 gene the 
reporter constructs described above were transfected into 293 cells using DOTAP 
(Material & methods). These cells were chosen because they could be transfected 
relatively efficiently and were of kidney origin although they express only low levels of 
Evi-1. The results are shown in figure 5.4, where the promoter activity rs calculated 
relative to the largest 8 kb fragment, pGL2E8, which represents 100% activity. Deletion 
of the 8 kb fragment, removing approximately 3kb of the 3' region to an SstI site at 
+272 within exon I (pGL2E5), does not effect the level of expression from the Evi-1 
promoter. This deletion removes a portion of DHS II suggesting the deleted region is 
not important for basal expression of the Evi-1 promoter in these cells. Subsequent 5' 
deletions to just before exon I (pGL2E2.5 and pGL2E2) also showed no drop in the 
promoter activity. Since these deletions result in the loss of the constitutive DHS I 
region it is assumed that DHS I does not contribute to basal transcription levels in 
these cells.
Similar results were also obtained if the same constructs were examined in L929 
and HEC-1B cells (figure 5.5 & 5.6). L929 cells were chosen since they represent a low 
Evi-1 expressing fibroblastic cell line and HEC-1B cells since they express high-levels of 
Evi-1 protein although the reason for this level is unclear since HEC-1B cells contains 
96 chromosomes and have rearrangements within chromosome 3 (Morishita et al., 
1990). In addition to the conclusions reached in 293 cells the Evi-1 promoter is also 
not responsive to auto-regulation, at least with the constructs used here, since the basal 
expression pattern is the same in high Evi-1 expressing HEC-1B cells.
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Figure 5.4: A histogram showing relative luciferase activity of preliminary Evi-1
promoter constructs in 293 cells.
5(Xg of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20p,g with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 5.5: A histogram showing relative luciferase activity of preliminary Evi-1
promoter constructs in HEC-1B cells.
5|ig of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSILf bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 5.6: A histogram showing relative luciferase activity of preliminary Evi-1
promoter constructs in L929 cells.
5|ig of pGL2basic or equimolar amounts were transfected with 5p,g of pHSV- 
Pgal, which contains a P-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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The results show that DHS I plays no part in modulating basal promoter 
activity. It is plausible that DHS I may be important in inducible expression of the Evi- 
1 gene or alternatively that the region has some intrinsic enhancer function which is 
being masked, either by other factors or by lack of appropriate tissue specific factors. 
Importantly, the results indicate that promoter activity resides around exon I of the gene 
and correlates with the presence of part of the DHS II region.
5.4 Defining the 5' border of the Evi-1 minimal promoter
To more accurately define the location of the Evi-1 promoter, 5' deletions of 
pGL2E2 were created by PCR. The sequence of exon I and immediately upstream have 
previously been published (Bartholomew & Ihle, 1991). The sequence from, -685 to 
+565, relative to the major transcription initiation site was used to design primers for 
the PCR reactions (figure 5.7). The 5' constructs generated by PCR were initially sub­
cloned into a TA cloning vector (Invitrogen. TM) and then subsequently into the 
pGL2basic vector (Promega) used previously to generate the pGL2E vectors (Materials 
and methods). All the 5' deletion constructs contain the same 3' end as pGL2E and are 
summarised in figure 5.8.
5.5 Functional analysis of the PCR generated 5' deletion constructs in 293, L929, 
and HEC-1B cells
The relative luciferase activities of the 5' deletion constructs in 293 cells are 
shown (figure 5.9). The pGL2E2 construct, which represents 100% activity, was used 
to allow direct comparison of the 5' deletion PCR fragments with the preliminary 
constructs. No significant difference in activity is observed with deletions to: -684 
(pGL2-684), -487 (pGL2-487) which removes a putative AP2 site; deletion to -443
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Figure 5.7: PCR primers designed for generating 5' deletion reporter constructs
The 5' sequence of exon I with respect to the major initiation site +1 is shown. 
The 5' PCR primers are underlined with arrows. Putative DNA transcription factor 
binding sites are boxed and labelled appropriately. All constructs have the same 3' 
end at +272.
PCR primers
All constructs used the same 3' reverse primer 
RP ccaagcttgagctcgcagctattcc 
The 5' primers are also shown below;
-684 tttaagtagaaacttaa 
-487 cctgaaagcaattctcc 
-443 ctctaacacagactctc 
-338 cttgtgctcaggacatc 
-284 cctggagaaatttcccc 
-254 cggcagaaatctacatg 
-197 ggacttgggtcttggcg 
-132 atttactgaaagaggag 
-15 catgaaatagaaaccctgcgg
6 8 4  
6 3 4  
5 8 4  
5 3 4  
4 8 4  
4 3 4  
3 8 4  
3 3 4  
2 8 4  
2 3 4  
1 8 4  
1 3 4  
- 8 4  
- 3 4  
+ 1 7
Upstream Evi-1 Basal Promoter -
TTTAAGTAGA AACTTAAATT ATATTTTATT TTAAAATATG CTTAACTGGA
^684 ^
AACTGGAAAT GTGTGTTAGT TTTCA CTTTT GAAGCTGCTG GTCTTGAGAC
TTTTAATGCG AGCCAGTATC TCTTTATCCT AAGAGTTGCC CTGGCCCTCT
 AP2
TCAGAGCTTC CAAACTACCA GCCTGCCTGG GGAGGC
GAAAGCAATT CTCCACCCTA TCTTTCCCAT CCCCCACCC.
: a c c c  t c a c a c c c c t  
c a c c c  . 4 3 7
\  ACTCTAACAC
-443
AGACTCTCTC TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC
TCACACACAC ACACACACAC ACACACACAC ACACACACAC ACACACCCTT
■m - l -338
GTGCTCAGGA CATCAAAACC AGAGAGATTT '
CPI
CCCTGGGGAA ACAAATCCTG
CCTGGAGAAA TTTCCCC ATT G G TT3TTTA T CGGCAGAAAT CTACATGTTT
^284 ^  -254 ^
CTGGGGATGG TGCATCTATA ATCAGTCTGT CCCTATAGGA CTTGGGTCTT
SP1
GGCGACCTTT TTGTGACCTC T|CCCGCC|AGA GGAGGCTGCT GTCACTTTAA
NF-t_____
-197
AAATTTACTG AAAGAGGAGC CCGTCGTCT 3 GCTTCCGACC ACTCTGGAGA
GATA
TA
-132
GCTCCCTT TCTCCCTCGC CCCGGTTTCT TTCTGGATGG CCGAGCAGAT
TATA Box
CCCCTTTAAA GAGACAGTTC ATGAAATAGA AACCCTGCGG CTGGGCGCGG
T-15
AGTGGCTAAA GGGGACGAGC CGGTG + 1
Figure 5.8: The 5' deletion reporter constructs generated by PCR.
5' deletions of the Evi-1 locus with respect to the major site of transcriptional 
initiation were generated by PCR. A schematic representation of exon I is shown with 
the major initiation sites+1 shown. All constructs have the same 3' end at +272.
PCR generated 5 ’ deletions
pGL2-684
pGL2-487
pGL2-443
pGL2-338
pGL2-284
pGL2-254
pGL2-197
pGL2-132
pGL2-15
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Figure 5.9: A histogram showing relative luciferase activity of 5’ deletion Evi-1
promoter constructs in 293 cells.
5jig of pGL2basic or equimolar amounts were transfected with 5jig of pHSV- 
pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20jig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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(pGL2-443) which removes a putative CACCC box and deletion to -338 (pGL2-338) 
which removes a series of CTCT (GAGA) and CACA repeats. Presumably, the putative 
sites indicated in figure 5.7 are not essential for basal transcription. However, removal 
of another 52 base pairs to -284 (pGL2-284), results in an approximately 50% drop in 
activity. This correlates with the loss of a region with sequence homology to AP2, AP3, 
C/EBP and ets binding sites. Deletion of another 30 base pairs to -254 (pGL2-254), 
which removes a putative CPI site, results in a further 20% drop in activity. The 
deletion from -338 to -254 represents the largest drop in functional activity and 
presumably reflects the loss of binding of trans-acting factors which are required for 
Evi-1 basal promoter activity.
Further deletions result in a steady drop in activity down to -15 which removes 
putative, Spl, NF-1, GATA and TATA box sequences, but maintains the initiation sites. 
These observations suggests that other elements within this region are important in basal 
promoter activity. The contribution of any given site in isolation to overall basal activity 
will require site directed mutagenesis of appropriate sites. The -15 construct is still 
approximately 4 to 5 fold higher than the pGL2basic reporter construct (which contains 
just the luciferase gene) and this may reflect the presence of frans-activating proteins 
between +1 and the SstI site at +272.
Similar results were also obtained in L929 and HEC-1B cells (figure 5.10 & 
5.11). suggesting that the 5' border for optimal basal Evi-1 promoter activity is at -338 
A is the same in different cell types. In addition the majority of the basal activity is lost 
with deletion from -338 to -254 in all cell types. Therefore, the upstream activating 
sequences important in basal transcription within this region presumably bind similar 
ubiquitous factors or alternatively there is some redundancy and different proteins have 
the same effects in different cell lines or tissues. In addition, the results also suggest that 
other sequences between -254 and +272 may also contribute to basal activity.
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Figure 5.10: A histogram showing relative luciferase activity of 5' deletion Evi-1
promoter constructs in HEC-1B cells.
5jig of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
Pgal, which contains a (3-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20jig with pKSH+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 5.11: A histogram showing relative luciferase activity of 5’ deletion Evi-1
promoter constructs in L929 cells.
5jig of pGL2basic or equimolar amounts were transfected with 5jig of pHSV- 
|3gal, which contains a (3-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20jig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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5.6 Defining the 3’ border of the Evi-1 promoter
The majority of the constructs generated terminate at a 3' SstI site (+272) within 
exon I. To further define the 3' border of the basal Evi-1 promoter two 3' deletions 
were generated. The first construct, -443 to +163, was made by PCR using primers 
designed from the published sequence (figure 5.12) and results in the loss of two 
putative GATA motifs. The construct was sub-cloned into a TA cloning vector and 
then into a pGL2basic vector to generate pGL2+163 (Material and methods). The 
second 3' deletion construct, -443 to +48 was generated by deleting an Aval restriction 
enzyme fragment (there is an Aval site at +48) from the -443 to +163 fragment located 
in the TA cloning vector, and subsequently cloning this fragment vector into pGL2basic 
to generate pGL2+48. This results in the loss of putative AP2 and PE A3 sites (a 
member of the ets family), in addition to GATA motifs. Both of the 3' deletion 
constructs contain the same 5' end at -443 and are summarised in figure 5.13.
5.7 Functional analysis of the 3' Evi-1 promoter deletion constructs in 293 and 
HEC-1B cells
The relative luciferase activity of the 3' deletion constructs in 293 cells are 
shown in figure 5.14 where they are compared with the optimal pGL2-443 vector The 
pGL2+163 vector shows similar levels of luciferase activity to the pGL2-443 construct. 
This shows that the two putative 3' GATA motif are not involved in basal transcription. 
However, the GATA sequences may be important in mediating signals from more distal 
elements in tissue specific regulation. However, pGL2+48 results in a dramatic 75-80% 
drop in activity. This deletion results in the loss of putative binding sites for AP2 and 
PEA3 although the region is generally GC rich and may therefore also be targets for Spl 
Similar results were also obtained with HEC-1B cells (figure 5.15).
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Figure 5.12: The creation of the 3' deletion reporter constructs.
The 3' sequence of exon I with respect to the major initiation site +1 is shown. 
The 3' +168 PCR primer is underlined with an arrow.
The +48 reproter construct was generated by digesting the -434 PCR product in the TA 
cloning vector with Aval enzyme to remove 104bp, the location of the Aval site within 
exon I is shown.
The vector was then re-ligated and the remaining PCR fragment cloned into in a 
pGL2basic luciferase reporter vector.
Putative DNA transcription factor binding sites are boxed and labelled appropriately. 
All constructs have the same 5' end at -443.
+168 reverse primer tcccactcctctgtcgc
Downstream Evi-1 Basal Promoter
- 8 4  
- 3 4  
+ 1 7  
+ 6 7  
+ 1 1 7  
+ 1 6 7  
+ 2 1 7  
+ 2 6 7  
+ 3 1 7  
+ 3 6 7
TAGCTCCCTT
TATA Box
rrrrTTTAAA
AGTGGCTAAA
GGAGGACCTG 
ets
TCTCCCTCGC CCCGGTTTCT TTCTGGATGG CCGAGCAGAT
+1
GAGACAGTTC ATGAAATAGA AACCCTGCGG CTGGGCGCGG
^  Aval
GGGGACGAGC CGGTGAGGGT CTGGCCCCGA GAAGGCTCTG
AEZ.
GGGGGCCGTC CTGCCT GCA GGCCCCCTAC CTTCGCACAC
H TTCCTqCTG CGGGTCTTGC CCCTGGAGCT GCGACAGAGG AGTGGGAGAA
GATA ^ -GATA
TGATAA GAGCGTTTTAGTAG GTTTCfoGATA AjCTTTCATTA CACATCGGGC
GAGGAAAGAG GGAGGTAGTG AGACCAGAAG GAATAGCTGC 
AGGAAGAGGG GAAAAACCCA AATACACCAA ACCCCGGCTC 
TTAAAACACT GTTGGCGGAC AATAAATCCG AAACGCGTGG 
CAGCTCCCAG GGAACGACAA ACTTATCAGA CACCCATTTG
AAGAGAAAGT
Sstl
GAGCTCATTT
AATTCTGGTC
TCCTGGCGAT
Figure 5.13: The 3’ deletion reporter constructs.
3' deletions of the Evi-1 locus with respect to the major site of transcriptional 
initiation were generated by PCR. A schematic representation of exon I and the major 
initiation sites, +1, are shown. Both constructs have the same 5' end at -434.
PCR generated 31 deletions
+1 +272
pGL2+163
pGL2+48
Figure 5.14: A histogram showing relative luciferase activity of 3’ deletion Evi-1
promoter constructs in 293 cells.
5|Hg of pGL2basic or equimolar amounts were transfected with 5(ig of pHSV- 
Pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20|LLg with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 5.15: A histogram showing relative luciferase activity of 3f deletion Evi-1
promoter constructs in HEC-1B cells.
5pg of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
(3gal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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The results presented here conclude that the minimal basal Evi-1 promoter is 
located between -338 to +168 and that two regions appear to be particularly significant 
in regulating transcriptional activity, a region 5' between -338 to -254 and a region 3' 
between +163 and +48.
5.8 Analysis of the DHS I region
DHS analysis has identified two DHS regions, I and II (chapter 4.4). DHS II, 
present exclusively in Evi-1 expressing cells, represents the promoter region of the gene. 
By contrast, the DHS I region is constitutively present in all cells examined, but does 
not contribute to basal activity of the Evi-1 promoter. As previously mentioned, DHS 
sites are generally associated with active promoter and enhancer elements (reviewed by 
Gross and Garrard, 1988). Therefore the function of the DHS I site was examined.
To characterise the DHS I region an 880bp region containing DHS I was 
sequenced to identify putative ds-acting sequences. Two 440bp restriction fragments 
(BamHI/Hindffl and HindlH/Bglll) each containing part of the DHS I region were 
ligated into an appropriately cut pKSII+bluescript vector and designated pKS-DIBH 
and pKS-DIHB respectively. T3 and T7 primers were used to sequence each end of the 
cloned fragments using the Sequenase version II kit (Materials and methods) (figure 
5.16). The sequence information obtained allowed design of oligonucleotide primers for 
further sequencing (figure 5.16). To confirm the sequence data each of the two 440bp 
fragments were sequenced from both the 5' and 3' end.
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Figure 5.16: Sequence of the 880bp DHS I
The sequence of the 880bp BamHI/Bglll fragment is shown. Pertinent restriction 
enzyme sites are boxed and labelled appropriately. In addition, putative protein 
recognition sequences identified within this region are boxed and labelled.
A schematic representation of the approximate location of DHS I relative to exon I is 
shown.
O  Denotes the approximate location of the DHS I region.
Evi-1 Locus
Bg E x o n  I
lk b
B am H I
GGATCCJTCGCTGTCTTTAGACACATCTCTCAAGGTCTCAGGG
Ets-1PEA 3 PEA3
|AGGAA^Tl(AAGGA^ATTCAGAGGTAGGAbcATCCTcbACTCA
GGCAGTTTCCCAGGTCTGTGTCTGTGAGACTGGAGGCTGCAA
CCAGGCTGTCAGATCCTGGTGGTGGGTTCACCTAGGTCGTTG
AGGCTGCAGGCACTGTACTTTATTTCGGGATACATCGCCACC
_ Xbkl
TAACGGCCTCCAGCCGTACCTGCAAGAATACCATCTAGA GCC 
C T d 5 S ^ ^ iC iC C A G A A O C T _ C T M C T O O O G iQ
AAAACAAAACAAAACA AACAACAACAACAAAAACCTCAAAGG
TTTTTTTTTTTTTTTCCGTGAAATGTGAATTTAGTTAGGACC
TGTCACTGATTTCCCAGGACCTTTGTGTGGCGAGCAAGGTTT
H in d lll CC AAT
CCTGCTTTTCTGAGKAGCTjACTTTTTfcGAATGjCGTCACCCA
CGACGTTCCGGTCCACTTTTTCCAATCGGTCACCCACGAGGT
TCCGGTCCCACCCCACTTCATCCCCGAACCTTACCAAACCCC
G CRE_____________________ PEA 3_____
GffGACTgGTTGGGTCTGGGGGACTAGTTCGACTTCACAGACT
t c g t (g a g t c 4 a g g g g t c t a a t g a a c a t a a a t t a t g t g t t a c g
--------------------------------- ^  NF-E1
t a g t a t t t t g t t t a g a g a g t a g g a c t g t c c t t c t t t t a t c t t ]
GTCGAGT AT CG A GGTCGATAAGGTTAA AT ACC GATT T A ATT T 
TTTTTTTTTTTTTCATTTTCTTTTTCTCGTGAAGTTGTTACC 
CGTTCAACTCCTTCCCGGATTCTAGTTACGTCCCTTCGGGTC
GAT A
TGAGGAGTACTAAGAGTCCGT CCCGAGATACCCTTATAGAGT
PEA 3
: c ^ r
t a c g a a t ^ g c a a t ^ a a t g { t t t c c t ) a a a a a g g g g a c a g a a t g g a  
CRE2 BglH
TGAfrGACGAcKcjrCTAGG
5.9 Creation of DHS I luciferase reporter constructs to assess the transcriptional 
activity of DHS I
Although deletion of DHS I had no impact on basal transcription activity 
(chapter 5, section 5.3) it is plausible that the factors present in the Evi-1 promoter 
repress activation by DHS I. To investigate if DHS I had enhancer activity, an 880bp 
BamHI/Bglll fragment containing the DHS I region was cloned into a luciferase 
reporter gene immediately upstream of either a minimal -32 tk promoter, designated 
pGL2tkBB, or an SV40 promoter, designated pGL2svBB (figure 5.17). In addition, 
the 880bp fragment was sub-cloned as two 440bp BamHI/Hindin and Hindm/Bgin 
fragments into a pKSD+bluescript vector (figure 5.18, A) and subsequently into a 
pGL2promoter vector, designated pGL2svB/H and pGL2svH/Bg (figure 5.17, B), or a 
minimal -32tk vector. The DHS I reporter constructs are summarised in figure 5.18.
5.10 Functional activity of the DHS I region in 293 and HEC-1B cells
DHS I reporter constructs were transfected into 293 cells using DOTAP 
(Materials and methods). The relative luciferase activity of the DHS I containing 
constructs were compared with the parental minimal tk, SV40 promoter and pGL2basic 
constructs (figure 5.19 A & B). All the DHS I constructs in both pGL2tk and pGL2sv 
vectors have the same relative luciferase activities as the parental vectors. 
Consequently, the DHS I region is unable to enhance the activity of a heterologous 
promoter in 293 cells. Similar observations were also seen in HEC-1B cells (figure 5.20 
A & B).
The relative luciferase activity of the -32 tk or SV40 promoters in both 293 and 
HEC-1B cells was not significantly altered, either positively or negatively, by the 
presence of DHS I sequences located immediately upstream. This result is consistent
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Figure 5.17: Schematic representation of the steps involved in cloning the DHS I 
region into a pKSII+ bluescript vector and upstream of a luciferase reporter 
vector.
An 880bp BamHI/Bglll fragment containing the DHS I region was cloned 
directly into a pGL2basic vector at a Bglll site immediately upstream of either a minimal 
tk or SV40 promoter.
A
The 880bp fragment was then sub-cloned as two 440bp BamHI/Hindin and 
Hindin/Bgin fragments into a pKS+bluescript, designated pKS+B/H and pKS+H/Bg 
respectively, and used to sequence the DHS I region.
B
In addition, The 440bp BamHI/HindlH and Hindin/Bgin fragments were clone 
upstream of either a minimal tk or S V40 promoter in a pGL2 luciferase reporter vector.
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Figure 5.18: Summary of DHS I luciferase reporter constructs.
Schematic representation of the DHS I reporter constructs created. All the 
constructs were cloned upstream of an SV40 and minimal -32 tk promoter.
Summary of DHS I constructs
B H
pGL2B/B
pGL2B/H
pGL2H/Bg
pGL2-32 tk 
pGL2 promoter
B g
I  = minimal tk or SV40 promoter 
<m§| = DHS I Region
B = BamHI H = HindIII Bg = Bglll E = EcoRI
Figure 5.19: A histogram showing the promoter activity of the minimal -32 tk and
SV40 promoters in the presence of the DHS I region in 293 cells.
5fig of pGL2basic or equimolar amounts were transfected with 5fig of pHSV- 
pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20jig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 5.20: A histogram showing the promoter activity of the minimal -32 tk and
SV40 promoters in the presence of the DHS I region in HEC-1B cells.
5 | i g  of pGL2basic or equimolar amounts were transfected with 5(Lig of pHSV- 
pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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with the transfection studies performed where the removal of DHS I had no detectable 
effect on the authentic Evi-1 promoter (chapter 5.6). In all the assays performed no 
function for DHS I in controlling transcriptional levels has been identified. As mentioned 
previously, DHS I may be important in inducible or tissue specific expression in the 
appropriate cell type. Alternatively, DHS I may be important in the maintenance of 
nucleosomal positioning within the chromatin framework, which may not be apparent in 
transient assays.
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Chapter 6: In vitro analysis of transcription factor/DNA 
interactions within the minimal Evi-1 promoter
DNAse 1 hypersensitivity site analysis implicated DHS II as being important in 
controlling transcriptional regulation of the Evi-1 promoter since the hypersite was 
found exclusively in Evi-1 expressing cells. In addition, transfection studies have 
identified the minimal promoter located between -338 to +163 (figure 6.1). To 
examine this region in more detail DNA/protein interactions have been investigated 
and their importance in basal transcription assessed.
6.1 DNAsel footprinting of the -474 to -135 region
DNAse 1 footprinting was performed over the -474 to -135 region to 
investigate if there are DNA/protein complexes which correlate with changes in basal 
promoter activity observed in functional studies (Chapter 5.5). Since transfection 
studies had already shown functional activity of the Evi-1 promoter in HEC-1B and 
293 cells, these cells were chosen to isolate nuclear extracts for footprinting analysis. 
A probe for the -474 to -135 region was generated by PCR and sub-cloned into a 
pKSII+ vector. The 339bp EcoRI/HindHl probe was 32p_end labelled at the 3' 
(Hindm) end and footprint reactions performed as described in Materials and 
methods.
Two footprinted regions have been identified with nuclear extracts derived 
from HEC-1B or 293 cells which are labelled Fpin and FpIV (figure 6.2). Two lanes 
are shown for each extract which represents increasing concentrations of DNAse 1. 
Fpin protects a region of approximately 37bp from -321 to -284 while FpIV protects 
approximately 69bp from -277 to -208. To confirm the location of Fpin and FpIV the 
same -474 to -135 region was also ^^P-end labelled from the -474 (5') end and
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Figure 6.1 Sequence of -338 to +163 minimal Evi-1 basal promoter
The major sites of transcriptional initiation (nucleotides CT) are indicated by arrows 
underneath. The sequence is numbered relative the first, C nucleotide, site of 
transcriptional initiation.
The putative TATA box is underlined.
The symbol □ represents the 5' or 3' deletion reporter constructs assayed in transfection 
studies (Chapter 5.5 & 5.7).
-338
i
C C T T
- 3 3 4 G TG CTCA G G A CATCAAAACC AGAGAGATTT CCCTG G G G A A A C A A A TC C TG
- 2 8 4 0C T G G A G A A A T T T C C C C A T T G G T T G T T T A T 03G C A G A A A T C T A C A T G T T T
- 2 3 4 CTGGGGATGG TG C A TC TA TA A TC A G T C T G T C C C T A T A © 3A C T T G G G T C T T
- 1  8 4 G G C G A C C TTT TTG T G A C C T C TCCCG CCA G A G G A G G CTG CT G T C A C T T T A A
- 1  3 4 A 2@ T T T A C T G  AAAGAGGAGC C C G TC G TC TG g c t t c c g X S c A CTC TG G A G A
- 8 4
- 3 4
T A G C T C C C T T
TATA Box
CCCCTTTAAA
T C T C C C T C G C
GAGACAGTT©
C C C G G T T T C T
ATGAAATAGA
T T C T G G A T G G
+ 1
A A CCCTG CG G
C 0 3 G C C C C G A
CCGAGCAGAT
CTGGGCGCGG
+ 1 7 AG TG G CTA A A GGGGACGAGC CGGTGAGGGT G A A G G CTCTG
+ 6 7 GGAGGACCTG GGGGGCCGTC CTG CCTG G CA G G C C C C C TA C C T T C G C A C A C
+ 1 1 7 T T T C C T C C T G C G G G TCTTG C CCCTG G A G CT GCGACAGAGG AGTGGGAI
+163
Figure 6.2: DNAse 1 Footprinting of -343 to -138 of the Evi-1 promoter.
Labelling from 3’, -138 end.
The -343 to -138 region of the Evi-1 promoter was generated by PCR and 
cloned into a bluescript KS+ vector. The PCR primers were constructed so that the 5' 
and 3' ends could be subsequently cut with EcoRI and Hindin restriction enzymes 
respectively. DNA footprinting probes were 32p end-labelled and purified as previously 
described. Labelled probe was incubated in the presence or absence of nuclear extract, 
digested with DNAse 1 enzyme and separated by electrophoresis on a denaturing 
PAGE gel as described by Plumb and Goodwin, 1988. Gels were dried and exposed to 
autoradiograph film.
Labelled probe was incubated either in the absence of nuclear extract, |  , or with 
either nuclear extract from HEC-1B or 293 cells. The nuclear extract used in the 
reaction is shown above the appropriate lane. Approximately 180pg of nuclear extract 
was used in each reaction.
illustrates increasing DNAse 1 concentration.
GATC sequencing tracks are labelled and were performed using the Sequenase version 
n  kit (USB).
Footprinted regions are represented by shaded boxes.
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footprinting reactions performed again as above. The Fpin and FpIV regions are 
shown in figure 6.3.
A summary of the DNAsel protected regions are shown in figure 6.4. 
Computer analysis of this region identified putative binding sites for AP2 and CPI 
transcription factors which correlate with the footprinted region, although other 
putative binding sites were also identified in this region (data not shown).
Other footprints have previously been identified outside this region and are 
labelled within this chapter as Fpl, II and V (Bartholomew, unpublished data). Fpl and 
FpII are further upstream than Fpin and IV identified here. Fpl and FpII are lost in 
the deletions between -487 to -338. However, no change in luciferase activity 
(Chapter 5.5) is observed and therefore is assumed to play no part in maintaining basal 
promoter expression. FpV maps over the transcriptional initiation sites and presumably 
represents the initiation complex.
6.2 Electrophoretic Mobility Shift Assay (EMSA) analysis of protein binding 
activity
In addition to DNAsel footprinting to analyse in vitro protein binding to 
specific DNA sequences another technique commonly used is electrophoretic mobility 
shift assay analysis (EMSA). This technique is advantageous because it, can 
distinguish different DNA/protein complexes binding to the same sequence by virtue 
of their relative mobility, is a simpler and more rapid technique, and requires lower 
concentrations of nuclear extract. As a consequence EMSA was employed to 
examine regions of the minimal promoter for protein binding activity. EMSA analysis 
was undertaken with sequence derived from both FpIE and FpIV to identify the 
proteins binding to these regions.
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Figure 6.3: DNAse 1 Footprinting of -343 to -138 of the Evi-1 promoter.
Labelling from 5', -343 end.
The -343 to -138 region of the Evi-1 promoter was generated by PCR and 
cloned into a bluescript KS+ vector. The PCR primers were constructed so that the 5' 
and 3' ends could be subsequently cut with EcoRI and HindlR restriction enzymes 
respectively. DNA footprinting probes were 32p end-labelled and purified as previously 
described. Labelled probe was incubated in the presence or absence of nuclear extract, 
digested with DNAse 1 enzyme and separated by electrophoresis on a denaturing 
PAGE gel as described by Plumb and Goodwin, 1988. Gels were dried and exposed to 
autoradiograph film.
Labelled probe was incubated either in the absence of nuclear extract, |  , or with 
either nuclear extract from HEC-1B or 293 cells. The nuclear extract used in the 
reaction is shown above the appropriate lane. Approximately 180|ig of nuclear extract 
was used in each reaction.
GATC sequencing tracks are labelled and were performed using the Sequenase version 
H kit (USB).
Footprinted regions are represented by shaded boxes.
• 
•
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Figure 6.4: Summary of DNAse 1 footprinting
A shematic representation of the location of the DNAsel footprints, FpHI and FpIV 
relative to exon 1. FpIII and IV are highlighted in either red or blue respectively. The 
sequence is numbered relative to the first major site of transcriptional initiation, + 1 .
The putative binding sites for either CPI or SP1 are boxed.
-474 to -135 Footprinted Region
I II III IV V
Footprints |  |  1 1  |
+1
Exon 1
- 4 8 4 CTCCACCCTA TCTTTCCCAT CCCCCACCCA ACTCTAACAC
- 4 3 4  AGACTCTCTC TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC
- 3 8 4  TCACACACAC ACACACACAC ACACACACAC ACACACACAC ACACACCCTT
- 3 3 4  GTGCTCAGGA CATCAAAACC AGAGAGATTT CCCTGGGGAA ACAAATCCTG
CPI
- 2 8 4  ©CTGGAGAAA TTT ATT GGTT TTTAT 0&GCAGAAAT CTACATGTTT
- 2 3 4  CTGGGGATGG TGCATCTATA ATCAGTCTGT CCCTAT30GA CTTGGGTCTT
SP1
- 1 8 4  GGCGACCTTT TTGTGACCTC TCCCGCCAGA GGAGGCTGCT GTCACTTTAA
I FpIII 
I FpIV
6.3 Protein interactions with the FpIII region
Figure 6.5 is a schematic representation of the Fpin region highlighting the - 
321 to -284 protected sequence and EMSA probes used in the analysis of this region. 
Figure 6 . 6  shows EMSA analysis using the Fpin probe, which covers most of Fpm  
and a small region 3' down to the start of FpIV. Five complexes are observed in 
EMSA using nuclear extracts from 293 cells. A major specific slow mobility complex 
labelled EvBPl (Evi-1 binding protein 1) was identified which competed with both 
cold Fpm  oligonucleotide as well as cold 5' Fpm  and 3' FpIH oligonucleotides. Faint 
high mobility complexes A and B are not competed with cold 3' FpIH oligonucleotides 
but show slight competition with cold FpIII and 5' Fpin oligonucleotides. Two non­
specific complexes labelled N appeared in all the lanes. It should be noted that the 
relative intensities of some of the minor complexes show some minor variation 
between experiments, the significance of which is unclear.
Functional analysis showed that the first major drop in basal transcriptional 
activity occured between -338 and -284. FpIII covers most of this region, however to 
determine if there are other proteins upstream EMSA analysis was performed between 
-341 to -305. However, this analysis failed to detect any DNA/protein complexes in 
this region (figure 6.7). EMSA analysis with Fpm, was also performed in parallel 
with the same extracts showing the expected EvBPl complex (figure 6.7). EMSA 
analysis of the Fpm  region has, therefore, identified a major EvBPl complex. 
Functional studies show that loss of this binding activity correlates with a significant 
(50%) drop in basal activity.
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Figure 6.5: Schematic representation of the FpIII region
The sequence -321 to -284 represents the FpIH region. The probes used in the 
following EMSA experiments are indicated by shaded boxes.
The arrows show an inverted repeat sequence within the FpIII region.
Footprints I, II and V have previously been identified by (Bartholomew, unpublished 
data).
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Figure 6.6: EMSA showing protein binding to FpIII region.
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to FpIII region was 32p 
end-labelled. Binding reactions were set up using 500pg of labelled oligonucleotide and 
equal amounts of protein nuclear extract (approximately lOpg per reaction). Reactions 
were run on non-denaturing PAGE gels, dried down and exposed to X-ray film 
overnight (Materials and methods).
The labelled oligonucleotide used in all reactions was FpIII. Unlabelled 
competitor oligonucleotides are shown above each lane: |  - indicates no competitor, 
Cold indicates unlabelled FpIII region, 5'- indicates 5' FpIII region, 3'- indicates 3' 
region of FpIII region. All competitors are added at 200 fold excess (lOOng). 293 
nuclear extract was used in all reactions. Unbound labelled FpIII oligonucleotide is 
observed at the bottom of the gel.
Specific complexes are labelled EvBPl, A and B.
Non-specific complexes which are not competed with cold competitor are labelled N. 
Oligonucleotide sequences:
Fpin a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' FpIH a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c
3' FpIH c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
Probe:
Extract:
Competitor:
EvBPl ---->
N —  
N — >  
A — ► 
B — >
Free Probe
Figure 6.7: EMSA showing protein binding from -341 to -305.
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to the Fpin and -341 
region was 32p end-labelled. Binding reactions were set up using 500pg of labelled 
oligonucleotide and equal amounts of protein extract (approximately lOpg per reaction). 
Reactions were run on non-denaturing PAGE gels, dried down and exposed to X-ray 
film overnight (Materials and methods).
The labelled oligonucleotides used were either FpID and -341 as shown above 
the lane. Unlabelled competitor oligonucleotides are shown above each lane: |  -
indicates no competitor, Cold - indicates unlabelled -341 region. All competitors are 
added at 200 fold excess (lOOng). 293 nuclear extract was used in all reactions. 
Unbound labelled -341 and FpID oligonucleotide is observed at the bottom of the gel.
Fpin was added as a positive control for the reactions. The major EvBPl complex is 
clearly retarded with a higher-mobility non-specific complex running below.
Oligonucleotide sequences:
-341 cacccttgtgctcaggacatcaaaaccagagagattt
Fpin agagagatttccctggggaaacaaatcctgcctggagaaatttccccatt
Probe:
Extract:
Competitor:
EvBPl
Free Probe
6.4 Characterisation of FpIII binding activity
To identify the proteins binding to FpIII, particularly the EvBPl complex, a 
competition experiment was performed. This involves incubating excess cold 
candidate consensus binding site oligonucleotides for known transcription factors at 
200 fold excess with labelled Fpin oligonucleotides and nuclear extract. If EvBPl 
contains a component which binds to the consensus binding site oligonucleotide it will 
compete out the EvBPl complex observed with labelled FpIII. Figure 6 . 8  shows the 
results of this analysis using 293 cell extracts. The particular consensus binding site 
oligonucleotide cold competitor used are indicated.
The EvBPl complex is competed with cold FpIII, as shown previously in 
figure 6 .8 . Cold consensus binding site oligonucleotides for E74, PU1, PEA3, SP1, 
NF-1, E box, H4TF-1, NF-kB, ZFI, ZF2, GATA-1 and AP2 all failed to compete for 
the EvBPl complex. However, the C/EBP consensus binding site oligonucleotide 
showed effective competition for EvBPl binding activity, suggesting that a member of 
this family of transcription factors might be a component of the complex. 
Interestingly, this portion of the 5' Fpin region identified a sequence tggggaaac which 
shows some homology to the C/EBP consensus t(t/g)nng(c/t)aa(t/g).
6.5 EvBPl is not a C/EBP homo/hetero dimer
To further investigate the EvBPl complex a C/EBP consensus binding site was 
32p_end labelled and EMSA performed to see if the Fpin cold oligonucleotide could 
compete for C/EBP binding (figure 6.9). The C/EBP ^^P-labelled probe forms two 
complexes when incubated with 293 extract. The slower mobility complex is 
competed with cold C/EBP. The higher mobility complex only partially competes 
suggesting that this complex may be non-specific.
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Figure 6 .8 : EMSA showing competition FpIII oligonucleotide protein binding 
activity
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to FpIII region was 32p 
end-labelled.
Binding reactions were set up using 500pg of labelled oligonucleotide and equal 
amounts of protein nuclear extract (approximately 10pg per reaction). Reactions were 
run on non-denaturing PAGE gels, dried down and exposed to X-ray film overnight 
(Materials and methods).
The labelled oligonucleotide used in all reactions is FpIII. Unlabelled competitor 
oligonucleotides are shown above each lane: |  - indicates no competitor, Cold indicates 
unlabelled FpIII region. All competitors are added at 200 fold excess (lOOng). 293 
nuclear extract was used in all reactions. Unbound labelled FpIII oligonucleotide is 
observed at the bottom of the gel.
Oligonucleotide sequences:
FpIII agagagatttccctggggaaacaaatcctgcctggagaaatttccccatt
5' FpIII agagagatttccctggggaaacaaatcctgcc
3' Fpin cctggggaaacaaatcctgcctggagaaatttccccatt
AP2 ccggccccaggct
ZF1 ggatccctggacaagataagataaaggcagatct
ZF2 gatccctagctatgtgcctcatcttcgacaggctgtct
C/EBP gatcggatcccaattgggcaatcaggggatcc
NF-1 cttttggattgaagccaatatgaga
SPl tgggaatcctaactgggcggagttatgctggtggtg
NF-KB agttgaggggactttcccagg
GATA-1 ccgggcaactgataaggattccctg
PU1 gatccataacctctgaaagaggaacttggttaggt
PEA3 gatcctcgagcaggaagttcga
E74 gatctctagctgaataaccggaagtaactcatccta
E Box cccccaccacgtggtgcctga
H4TF-1 tttagatttcccctcccccaccggggcggga
ZF1 and ZF2 represent the two DNA recognition sequences for zinc-finger domains I 
and H of the EVI-1 protein.
Pr
ob
e: 
Fp
II
I
ZdV
P [ o
d d 3 7 0  
P \o j
I - v i v o
ZdZ
I I Z
? j  1 - I I P H  
x o g  3
1 - 3 N
I d S  
£ V 3 d  
I f i d  
PL3.
•  •  
Uo
0 > 
a
£o
U
a
u
W
&
CO
t d
Fr
ee 
Pr
ob
e
Figure 6.9: EMSA showing competition of a labelled C/EBP consensus
oligonucleotide with the FpIII region.
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to an C/EBP consensus 
binding site was 32p end-labelled. Binding reactions were set up using 500pg of 
labelled oligonucleotide and equal amounts of protein nuclear extract (approximately 
lOpg per reaction). Reactions were run on non-denaturing PAGE gels, dried down and 
exposed to X-ray film overnight (Materials and methods).
The labelled oligonucleotide used in all reactions was C/EBP. Unlabelled 
competitor oligonucleotides are shown above each lane: indicates no competitor,
Cold indicates unlabelled C/EBP region, 5'- indicates 5' Fpin region, 3'- indicates 3' 
region of Fpm  region. All competitors are added at 200 fold excess (lOOng). Unbound 
labelled C/EBP oligonucleotide is observed at the bottom of the gel.
A specific, C/EBP related complex, and a non-specific (N) complex are labelled 
appropriately.
Oligonucleotide sequences:
C/EBP g a tc g g a t c c c a a t tg g g c a a tc a g g g g a tc
FpID a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c
3' Fpm  c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
Probe: C/EBP
Extract: 293
■O H o - eu
—  k .  b
Competitor: | (j u* irt
C/EBP > <■* M
N — >
The C/EBP complex was examined by competition with either cold FpIII, 5' 
FpIII or 3' FpIII. Interestingly, only the 3' FpIII region was able to compete for the 
C/EBP binding complex. The 3' Fpin region disrupts a potential inverted repeat 
sequence which binds the EvBPl complex (chapter 6.7). An explanation for the 
observed difference in specificity for the C/EBP complex may therefore be that the 
DNA forms a secondary structure which usually masks any affinity of C/EBP for this 
region. Alternatively, it might be that C/EBP competes for EvBPl because of 
similarity of sequence, although the affinity is low for the C/EBP site. This may also 
explain the observation that the 3' FpIE competes for the EvBPl complex with 
decreased affinity relative to cold Fpin or 5' Fpin (figure 6.6) and the 3' Fpin 32p_ 
end-labelled probe also has substantial decreased ability to form the EvBPl complex, 
figure 6.10. Both the identity and function of complex C in figure 6.10 is unknown.
A characteristic of C/EBP family members is that they are heat stab le. To 
further prove that the EvBPl complex is not a C/EBP family homo- or heterodimer a 
heat stability experiment was performed to see if the EvBPl complex is still present 
following heat treatment, figure 6.11. Non-treated 293 extracts form either EvBPl or 
C/EBP complexes in the presence of the appropriate labelled probe which are also 
competed with cold competitor. If the labelled probes are incubated with extracts heat 
treated at 50°C for 5 minutes then only the C/EBP complex is formed. This suggests 
that the EvBPl complex is not heat stable and consequently is not a C/EBP complex. 
However, the experiment cannot rule out the possibility that C/EBP is a component of 
the EvBPl complex and that the dimerisation partner is heat sensitive.
6.6 The EvBPl complex is ubiquitous
EMSA analysis was performed with 32p end-labelled FpID and different cell 
extracts, to evaluate if the EvBPl complex components are ubiquitously expressed, as
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Figure 6.10: EMSA showing binding to labelled 3' FpIII region
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to Fpm  region was 32p 
end-labelled. Binding reactions were set up using 500pg of labelled oligonucleotide and 
equal amounts of protein nuclear extract (approximately lOpg per reaction). Reactions 
were run on non-denaturing PAGE gels, dried down and exposed to X-ray film 
overnight (Materials and methods).
The labelled oligonucleotide used in all reactions is 3' Fpffi. Unlabelled 
competitor oligonucleotides are shown above each lane: |  - indicates no competitor, 
Cold indicates unlabelled 3' Fpm  region. All competitors are added at 200 fold excess 
(lOOng). 293 nuclear extract was used in all reactions. Unbound labelled Fpm 
oligonucleotide is observed at the bottom of the gel.
Specific complexes are labelled A, B, C, and D are discussed in the text.
Oligonucleotide sequences:
FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' Fpm a g a g a g a t t t c c c tg g g g a a a c a a a t c c tg c c
3' Fpm c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t  
C/EBP g a t c g g a t c c c a a t t g g g c a a t c a g g g g a tc
Probe: 3' FpIII
293Extract: -------------
" 8  * • _  m© a
Competitor: l sj —
A > 
B  >
C  >  
1) >
Free Probe
Figure 6.11: EMSA showing the heat stability of the EvBPl and C/EBP protein 
complexes.
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to a C/EBP consensus 
binding site and the FpIII region were 32p end-labelled. Two aliquots of 293 nuclear 
extracts were heated at 50°Cc for five minutes or 90°C for 15 minutes, prior to setting 
up the binding reactions. Binding reactions were set up using 500pg of labelled 
oligonucleotide and equal amounts of the appropriate protein nuclear extract 
(approximately lOpg per reaction). Reactions were run on non-denaturing PAGE gels, 
dried down and exposed to X-ray film overnight (Materials and methods).
The labelled oligonucleotide used was either FpID or C/EBP and is shown above 
the lanes. Unlabelled competitor oligonucleotides are shown above each lane: |  - 
indicates no competitor, Cold indicates unlabelled C/EBP region. All competitors are 
added at 200 fold excess (lOOng). Unbound labelled C/EBP oligonucleotide is observed 
at the bottom of the gel.
Oligonucleotide sequences:
C/EBP g a t c g g a t c c c a a t t g g g c a a t c a g g g g a tc c
FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' Fpm a g a g a g a t t t c c c tg g g g a a a c a a a t c c tg c c
3' Fpm c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
Probe: FpIII C/EBP
Extract: 293
Competitor: - +
No 50 90 No 50 90
Heat 5m ins 15 mins Heat 5 mins 15 mins
■ + -  +  -  + -  + ■ + ■ +
would be predicted if the protein complex was important in basal promoter activity. 
Figure 6.12 shows the presence of the EvBPl complex in a variety of cell types 
including human kidney; 293 and A704 cells, murine fibroblasts; L929 cells, bovine 
palate keratinocytes, PalK cells, human endometrial carcinoma cells; HEC-1B and 
murine myeloid; DA-3 cells. In addition, murine kidney cultures (isolated from 
transgenic mice harbouring a temperature sensitive T-antigen, Chapter 7) also contain 
the EvBPl complex (figure 6.13).
6.7 EvBPl complex binds a 14bp inverted repeat sequence
To identify the DNA recognition sequence for the EvBPl protein, 14bp 
stretches of the 5' FpIII region were synthesised and tested in EMSA to evaluate their 
ability to compete for the EvBPl complex. The results of this competition are shown 
in figure 6.14. The -314 and -296 oligonucleotides did not compete for EvBPl 
whereas -305 and IR (inverted repeat region) oligonucleotides competed for the 
EvBPl complex with the same efficiency as cold FpID oligonucleotide. Partial 
competition is also observed with the 3' FpHI region.
The inverted repeat region, tttccctggggaaa, is also able to bind the EvBPl 
complex if it is 32p-end labelled (data not shown). This 14bp sequence contains a 
putative ets core, ggaa, a rel half site, gggaaa, homology to an inverted AP2 site, and 
tggggaaac shows some homology to the C/EBP consensus t(t/g)nng(c/t)aa(t/g). 
However, as already described consensus NF-kB, PE A3, E74, PU1, and AP2 binding 
site oligonucleotides failed to compete for the EvBPl complex, figure 6 .8 . This 
analysis has eliminated a number of candidate factors and therefore the component(s) 
of the EvBPl complex are unknown.
Consistent with the importance of the 14bp EvBPl binding sequence in basal 
promoter expression, it is also interesting to note that the inverted repeat region is
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Figure 6.12: EMSA showing EvBPl binding to the FpIII region with nuclear 
extracts from differing cell lines.
Nuclear extracts were prepared from 293, L929, HEC-1B, PalK, A704 and DA- 
3 cells as described in Materials and Methods. A double stranded oligonucleotide 
corresponding to FpIII region was 32p end-labelled. Binding reactions were set up 
using 500pg of labelled oligonucleotide and equal amounts of protein nuclear extract 
(approximately 10pg per reaction). Reactions were run on non-denaturing PAGE gels, 
dried down and exposed to X-ray film overnight (Materials and methods).
The labelled oligonucleotide used in all reactions is FpIII. Unlabelled competitor 
oligonucleotides are shown above each lane: |  - indicates no competitor, Cold
indicates unlabelled FpIII region. All competitors are added at 200 fold excess (lOOng). 
The appropriate nuclear extract used in each reaction is indicated above the lane. 
Unbound labelled Fpm  oligonucleotide is observed at the bottom of the gel.
Oligonucleotide sequences:
FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' Fpm  a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c
3' Fpm c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
Cell Lines:
293 Human kidney epithelial cell line
A704 Human renal cell carcinoma cell line
HEC-1B Human endometrial carcinoma cell line
PalK Bovine epithelial keratinocytes
DA-3 Murine myeloid cell line
L929 Murine fibroblasts
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Figure 6.13: EMSA showing binding of EvBPl in kidney extracts
Nuclear extracts were prepared from 293, primary adult kidney (PAK), primary 
embryonic kidney (PEK), adult kidney cultures (AK), embryonic kidney cultures (EK) 
cells as described in Materials and Methods.
PAK and PEK were kidney cultures harvested after four days in culture and 
were unpassaged. AK and EK were kidney cultures harvested after two weeks in 
culture and after several passages. All kidney cultures were from transgenic mice 
harbouring a temperature sensitive T antigen, previously described in Chapter 2.
A double stranded oligonucleotide corresponding to FpIII region was 32p encj_ 
labelled. Binding reactions were set up using 500pg of labelled oligonucleotide and 
equal amounts of the appropriate protein nuclear extract (approximately lOjug per 
reaction). Reactions were run on non-denaturing PAGE gels, dried down and exposed 
to X-ray film overnight (Materials and methods).
The labelled oligonucleotide used in all reactions is FpIII. Unlabelled competitor 
oligonucleotides are shown above each lane: |  - indicates no competitor, Cold indicates 
unlabelled FpIII region. All competitors are added at 200 fold excess (lOOng). The 
nuclear extract used in each reaction is shown above each lane. Unbound labelled FpIII 
oligonucleotide is observed at the bottom of the gel.
Oligonucleotide sequences:
FpIII a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
5' Fpm a g a g a g a t t t c c c t g g g g a a a c a a a t c c t g c c
3' FpIII c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
Probe:
Extract:
Competitor:
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Figure 6.14: EMSA showing competition of EvBPl with small 14bp stretches of 
the 5' FpIII region
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to the FpIII region was 32p 
end-labelled. Binding reactions were set up using 500pg of labelled oligonucleotide and 
equal amounts of protein nuclear extract (approximately lOjig per reaction). Reactions 
were run on non-denaturing PAGE gels, dried down and exposed to X-ray film 
overnight (Materials and methods).
The labelled oligonucleotide used in all reactions was FpIII as shown. Unlabelled 
competitor oligonucleotides are shown above each lane. | -  indicates no competitor, 
Cold - indicates unlabelled FpIII region. All competitors are added at 200 fold excess 
(lOOng). 293 nuclear extract was used in all reactions Unbound labelled Fpin 
oligonucleotide is observed at the bottom of the gel.
Oligonucleotide sequences:
FpHI agagagatttccctggggaaacaaatcctgcctggagaaatttccccatt
3' FpHI c c t g g g g a a a c a a a t c c t g c c t g g a g a a a t t t c c c c a t t
-2 9 6  g a t c a a a c a a a t c c t g c c
-3  05 g a t c t c c c tg g g g a a a c a
-3 1 4  g a t c a g a g a g a t t t c c c t
IR gatctttccctggggaaa
Probe:
Extract:
Fp III
293
■0 t  »Ti c
: z  c  *■ n  MCompetitor: w 1 1 1
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absolutely conserved in the human sequence (a gift from J.N. Ihle, unpublished data) 
(figure 6.15).
6.8 U.V. Cross-linking of the EvBPl Complex
To identify the components of EvBPl the retarded complex was U.V. cross- 
linked (Material and methods). The Fpin region oligonucleotide was re-synthesised 
replacing the adenine bases with BrdU, the oligonucleotide ^^P-end-labelled and 
EMSA performed confirming that the oligonucleotide is still able to bind EvBPl (data 
not shown). This analysis reveals a U.V. light dependent specific band of 
approximately 97 kDa in size (figure 6.16). A very faint band is also observed with an 
approximate size of 200 kD which probably reflects a dimer of the lower band. The 
probability of cross-linking the dimerised form is much reduced and hence its fainter 
intensity. A protein/oligonucleotide complex of approximately 97kD in size is too 
large to be C/EBP (42 kD), AP2 (50 kD), AP3 (48/57 kD) or ets (54/68 kD) 
transcription factors and is further evidence that these factors are unlikely to be part of 
the EvBPl complex.
6.9 Binding activity of the FpIV region
The second substantial drop in promoter activity corresponds with FpIV. 
Figure 6.17 is a schematic representation of the FpIV region showing the -277 to -208 
protected region and two EMSA probes used in this analysis. Figure 6.18 shows 
EMSA analysis using the -277 probe, which covers most of FpIV. Six complexes, A to 
F, are observed in EMSA using nuclear extracts from 293 cells. All six complexes 
competed with cold -277 probe. Data base analysis of the sequence in this region 
identified a putative CPI (CCAAT box protein 1) site which is boxed (figure 6.17),
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Figure 6.15: Comparison of human and murine sequence over the FpIII and 
FpIV region
Murine DNA sequence is shown on top of the human.
The DNAse 1 footprints identified, FpIII and FpIV, are highlighted in either red or blue 
respectively.
The sequence is numbered relative to the first major site of transcriptional initiation, +1. 
The symbol I represents conserved nucleotides between murine and human.
A putative CCAAT box within this region is also highlighted in green.
Comparison of Murine and Human 
Sequence
-343 CACACC- --CTTGTGC- -TCAGGACATCAAAACCAGAGAGA Murine 
CACACCACACTTGTGCTTTCAAGACATCGAAACGGAGGCTA Human
-307 TTTCCCTGGGGAAACAAATCCTGCCTGGAGAAATTTCCCCA 
TTTCCCTGGGGAAAGAAATCCTGCCTGGCGAGATCTCCCCA
-266 TTGGTTGTTTATCGGCAGAAATCTACATGTTT-CTGGGGAT 
TTGGTTGTTTACCCGGAGAAATCTACATGTTTAAGGGGGAT
-226 GGTGCATCTATAATCAGTCTGTCCCTATAGGACTTGGGTCT 
GGTGCATCCATAATCAGTCTGTCCCTATAGGACTT-GGTCT
-192 TGGGTCTTGGCGACCTTTTTGTGACCTCTCCCGCCAGAGGA 
T-GGTCTTGGCGACCTTTTTGTGACCTCTCCCGCCAGAGGA
-151 GGCTGCTGTCA-CTTTAAAAATTTACTGAAAGAGGAGCCCG
I I I I I II I I I I lllllllllllll lllllllllll
GGCTGCTGTCAGCTTTAAAAATTTA--AAAAGAGGAGCC--
| FpIII I EvBPl
| FpIV | CCAAT Box
Figure 6.16: U.V. crosslinking of EvBPl
Gel slices containing DNA/protein complexes either treated or untreated with U.V. 
light. The gel pieces were placed directly into the wells of a 7.5% SDS-polyacrylamide 
gel and electrophorised. The gel was then dried, autoradiographed and typically 
exposed for several days.
An approximately 97kD protein is observed specifically in the U.V. treated lane. A 
fainter approximately 200kD band is also observed at the top of the gel probably 
representing the dimerised form of the protein.
The 200, 97.4 and 69 kD bands from ^C-labelled molecular weight rainbow markers are 
also shown.
U.V. Crosslinking of EvBPl
+ U.V. -U.V.
MW kD
200
9 7 . 4
6 9 . 0
Figure 6.17: Schematic representation of the FpIV region
The sequence -277 to -206 represents the FpIV region. The probes used in the 
following EMSA experiments are indicated by shaded boxes.
Footprints I, II and V have previously been identified by (Bartholomew, unpublished 
data).
EMSA Probes
-277 aaatttccccattggttgtttatcggcagaaatctacat
-237 tttctggggatggtgcatctataatcagtctgtccctatagg
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the CCAAT site is in the reverse orientation. Again competition experiments were 
carried out with candidate oligonucleotides to identify the proteins, the particular 
consensus binding site oligonucleotide cold competitor used being shown above the 
appropriate lane (figure 6.18). No competition was observed with consensus binding 
site oligonucleotides from E74, PEA3 or SP1. However, oligonucleotides NF-1, 
C/EBP and E a  all compete for complex A and C, with NF-1 also competing complex 
B and E. All three consensus binding site oligonucleotides may bind CCAAT binding 
proteins. The CPI protein shows varied specificity for different CCAAT boxes 
suggesting that the region immediately surrounding the CCAAT box is also important 
in CPI specificity. The E a  oligonucleotide has been shown to bind the CPI protein. 
This correlation is consistent with the presence of a putative CPI site within this 
region but further work is required to show that it is definitely able to bind. 
Interestingly, deletion between -284 to -254 transfection studies which removes this 
putative CPI site results in a significant drop in basal promoter activity in 293 cells 
(Chapter 5.3). The identity and function of complexes B, D, E, and F are unknown.
Figure 6.19 shows EMSA analysis using the -237 probe, which covers most of 
the remainder of FpIV (figure 6.17). Three complexes, A, B and C, are observed in 
EMSA using nuclear extract from 293 cells. All three complexes are competed with 
cold -237 probe. No competition is observed with consensus binding site 
oligonucleotides from E74, PEA3, NF-1 or NF-kB, SP1, C/EBP and E a  only partially 
compete for complexes A, B and C. There is no obvious known transcription factor 
binding sites within this region except for a putative TATA box. Since the promoter 
has multiple initiation sites it is plausible that this TATA box might also be used for 
TFIID binding and subsequent pre-initiation complex formation.
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Figure 6.18: EMSA showing protein binding to -277 to -239 region
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to the -277 region was 
32p end-labelled. Binding reactions were set up using 500pg of labelled 
oligonucleotide and equal amounts of protein extract (approximately 1 0 pg per reaction). 
Reactions were run on non-denaturing PAGE gels, dried down and exposed to X-ray 
film overnight (Materials and methods).
The labelled oligonucleotides used were Fpin and -277 as shown. Unlabelled 
competitor oligonucleotides are shown above each lane: |  - indicates no competitor, 
Cold - indicates unlabelled -277 region. All competitors are added at 200 fold excess 
(lOOng). 293 nuclear extract was used in all reactions. Unbound labelled -277 
oligonucleotide is observed at the bottom of the gel.
Specific complexes are labelled A, B, C, D, E and F are discussed in the text.
Oligonucleotide sequences:
-277 aaatttccccattggttgtttatcggcagaaatctacat
C/EBP gatcggatcccaattgggcaatcaggggatcc
NF-1 cttttggattgaagccaatatgaga
SPl tgggaatcctaactgggcggagttatgctggtggtg
GATA-1 ccgggcaactgataaggattccctg
PUl gatccataacctctgaaagaggaacttggttaggt
PEA3 gatcctcgagcaggaagttcga
E74 gatctctagctgaataaccggaagtaactcatccta
H4TF-1 tttagatttcccctcccccaccggggcggga
Ea gtgtgaaacattttttctgattgtttaaaagttgagtgct
Probe: 277
Extract:_____________ ___________
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Figure 6.19: EMSA showing protein binding to -237 to -196.
Nuclear extracts were prepared from 293 cells as described in Materials and 
Methods. A double stranded oligonucleotide corresponding to the -237 region was 
32p end-labelled. Binding reactions were set up using 500pg of labelled oligonucleotide 
and equal amounts of protein nuclear extract (approximately 1 0 |ig per reaction). 
Reactions were run on non-denaturing PAGE gels, dried down and exposed to X-ray 
film overnight (Materials and methods).
The labelled oligonucleotides used were Fpin and -237 as shown. Unlabelled 
competitor oligonucleotides are shown above each lane: |  - indicates no competitor, 
Cold - indicates unlabelled -237 region. All competitors are added at 200 fold excess 
(lOOng). 293 nuclear extract was used in all reactions. Unbound labelled -237 
oligonucleotide is observed at the bottom of the gel.
Specific compexes labelled A, B and C are discussed in the text.
Oligonucleotide sequences:
-237 tttctggggatggtgcatctataatcagtctgtccctatagg
C/EBP gatcggatcccaattgggcaatcaggggatcc
NF-1 cttttggattgaagccaatatgaga
SP1 tgggaatcctaactgggcggagttatgctggtggtg
NF-KB agttgaggggactttcccagg
PEA3 gatcctcgagcaggaagttcga
E74 gatctctagctgaataaccggaagtaactcatccta
Ea gtgtgaaacattttttctgattgtttaaaagttgagtgct
Probe:
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6.10 Conclusions
The results have identified two footprinted regions, Fpin and FpIV, 5' of the 
major sites of transcriptional initiation. Sequential deletion of these footprinted 
regions results in a substantial drop in relative promoter activity suggesting that the 
proteins binding to these regions are important for basal promoter activity. EMSA 
analysis of FpIE has identified binding activity over a 14bp inverted repeat sequence, 
designated EvBPl. Interestingly, this recognition sequence is absolutely conserved in 
the human sequence. The components of the EvBPl complex are still unknown but 
U.V. crosslinking has identified a monomeric protein/oligonucleotide complex of 
approximately 97kD.
EMSA analysis of the FpIV region identified multiple protein binding activities 
some of which are competed with C/EBP, E a  and NF-1. Interestingly, a putative CPI 
binding site (CCAAT) is present in this region and the loss of this CCAAT site also 
correlates with a significant drop in basal promoter activity.
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Chapter 7: Tissue Specific Expression of the Evi-1 Gene
7.1 Evi-1 expression in murine tissues
Previous work has shown that the Evi-1 gene is expressed in a tissue specific 
manner (Chapter 1.17). To study tissue specificity of the Evi-1 promoter we required a 
suitable cell line expressing high levels of the endogenous gene. The pattern of Evi-1 
expression was examined in murine tissues by Northern blot analysis of different adult 
tissues from CD1 mice using an 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe 
(figure 7.1). The full length 5kb transcript and alternatively spliced 4.5kb transcript 
(Bordereaux et a l, 1990; Morishita et al., 1990) are indicated with arrows. Highest 
levels of expression were observed in adult lung, ovaries and kidney with high levels 
also detected in embryonic kidney (17.5 and 15.5 days p.c.) as seen by others (Morishita 
et al., 1990; Perkins et a l, 1991). Therefore we examined murine kidney derived cell 
lines to identify cells suitable for studying the high level tissue specific expression of the 
murine Evi-1 gene.
7.2 Evi-1 expression in kidney cell lines
In view of the high Evi-1 expression levels seen in adult kidney we assessed the 
levels of Evi-1 expression in kidney cell fines. The abundance of Evi-1 mRNA in a panel 
of kidney cell lines was monitored by Northern blot analysis using a 2kb SstI fragment 
Evi-1 cDNA probe (figure 7.2).
High levels of expression were observed in DA-3 cells (which ectopically 
express the gene due to a retroviral insertion) kidney tissue and HEC-1B. The human 
endometrial carcinoma cell fine HEC-1B expresses high levels of Evi-1 as compared 
with parental HEC-1A cells (figure 7.2 B). However, the reason for the expression is
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Figure 7.1: Northern blot showing Evi-1 expression in different murine tissues.
Northern blot analysis using a 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe.
The appropriate tissue from which RNA was isolated is given above each lane. The 
RNA from embryonic kidneys were isolated at 15.5 and 17.5 days post coitus.
5kb and 4.5kb Evi-1 transcripts are labelled with arrows.
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Figure 7.2: Northern blot showing Evi-1 expression in different kidney and other
cell lines.
Northern blot analysis using a 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe.
The appropriate tissue or cell line from which RNA was isolated is given above 
each lane.
The cell lines used are listed below:
Kidney:
RAG
G402
ACHN
TCMK-1
293
A704
YCR
RCC23
Fibroblast:
STO
L929
NIH3T3
Haemopoietic:
DA-3
FDCP-1
Endometrial:
HEC-1A
HEC-1B
RNA loading was controlled by stripping the blots and re-probing with a cDNA 
p-actin 32P-labelled probe.
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unclear, but HEC-1B cells contains 96 chromosomes and have rearrangements within 
chromosome 3 (Morishita et al., 1990). Unfortunately, all the kidney cell lines examined 
(RAG, G402, ACHN, TCMK-1, 293, A704, YCR and RCC23) showed no or relatively 
low levels of Evi-1 expression similar to that observed in the fibroblastic cell lines 
(L929, STO and NIH3T3). Although expression levels in STO cells appear higher no 
consistent difference is observed between the fibroblastic cell lines. The relatively low 
levels of Evi-1 expression in all the kidney cell lines examined suggests that none of the 
cell lines are appropriate for investigating Evi-1 promoter activity.
7.3 Isolation of kidney cultures from transgenic mice harbouring a temperature 
sensitive Simian virus 40 large T-antigen gene.
The absence of a suitable high expressing cell line meant we had no cell line with 
optimal activity of the Evi-1 promoter. Although no Evi-1 expression is observed in 
kidney cell lines, expression is retained in 5 day primary kidney cultures established from 
18.5/7.C. foetal kidneys (Bartholomew & Clarke., 1994). However, the cultures are 
difficult to maintain and although adult kidney cultures may survive for several weeks at 
confluence if the medium is routinely changed the cells do not passage and attempts to 
do so results in massive cell death and tiny cell colonies which fail to continue to 
proliferate (data not shown). To circumvent this problem a new approach was 
undertaken in an attempt to generate Evi-1 expressing primary cell cultures which would 
be more suitable for examining the Evi-1 promoter activity.
In previous studies primary immortalised cell lines have been established by co­
transfecting the cultures with immortalising viral proteins such as the SV40 T-antigen 
and a antibiotic resistance marker. A number of studies have suggested that 
immortalisation of various cell types with the SV40 large T-antigen can maintain cell 
type specific functions (Paul et al., 1988., Williams et al., 1988.). A temperature
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sensitive mutant of the large T-antigen from the SV40 virus, designated tsA58, has also 
been used successfully to isolate stable cell lines which are temperature sensitive for 
expression of tsA58 T-antigen (Jat, P.S. & Sharp, P.A., 1989, Robinson et al, 1994, 
Piedagnel, et al, 1994). The mutant is stable at the permissive temperature of 33°C but 
becomes unstable and is degraded at the non-permissive temperature of 39°C.
Interestingly, a transgenic mouse harbouring the tsA58 SV40 large T-antigen 
(tsT) gene under the control of an interferon-inducible Class I antigen promoter has 
been developed. Recently the H-2KbtsA58 transgenic mouse has been proposed to be a 
new tool in rapid generation of novel cell lines (Noble et al, 1995). Conditionally 
immortal cell lines have been successfully established from these transgenic mice which 
maintain some cell-type specific responses. (Yanai et al., 1991a, Yanai et al., 1991b, Jat 
et al., 1991).
In an attempt to establish our own kidney cell lines and to maintain primary 
cultures which express the Evi-1 gene for extended periods of time the H-2KbtsA58 
mouse was used to establish kidney cultures from both adult and foetal kidneys (day 
18.5p.c.) (Taub et al., 1979). Adult and foetal kidneys were dissected, incubated with 
collagenase/trypsin and put into culture, (see Materials and methods). Adult and foetal 
kidney cultures were initially established in either a general media, SLM, or epithelial 
selective, serum free or D-valine, media (Material and methods), which has been used 
successfully by other workers to establish primary cultures (Chung et al., 1982). The 
cultures were observed to grow best in SLM media which was therefore routinely used 
in all the experiments (data not shown). Fibroblastic cells made up a component of the 
kidney cultures but never proved a problem with overgrowing the culture, which is 
similar to observations by other workers when establishing primary kidney cultures 
(Ebert et al., 1990).
A range of Interferon-y concentrations to induce SV40 T-antigen expression 
comparable to those used by others in similar studies (Jat et al., 1991) was also added
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to the culture media with both adult and foetal kidney cultures. However, the interferon- 
y  inducible promoter constitutively expressed the tsA58 T-antigen in our kidney 
cultures, negating the necessity for interferon y  supplementation.
Interestingly, both adult and foetal kidney cultures were observed to be 
particularly sensitive to trypsin treatment on the first couple of passages. However, 
collagenase treatment alone was found to be less harsh on the cells and therefore the 
protocol was modified accordingly for the first few passages.
Figure 7.3 shows the morphology of the isolated adult kidney cultures at 33°C 
at sub-confluence or 33°C and 39°C at either confluence or 7 days post-confluence. 
Adult kidney cultures at 33°C grow as typical epithelial islands at sub-confluence (figure
7.3 A), forming a monolayer of cobblestone appearance when confluent (figure 7.3 B), 
similar to observations by others (Ebert et al., 1990). Even after 7 days post-confluence 
at 33°C the morphology of the cells remained unchanged. Upon switching the confluent 
cultures to the non-permissive temperature (39°C) the cells were still similar in 
appearance. However, after 7 days post-confluence at 39°C the cells were generally 
larger and elongated representing a more spindle appearance, the cells were also more 
difficult to focus. Similar observations were made with foetal kidneys (figure 7.4 A, B 
and C).
Interestingly both adult and foetal kidney cultures grown at 33°C appeared to 
survive for several weeks at confluence, so long as the medium was changed, which is 
similar to our observations with adult kidneys from 'normal' mice. However, unlike the 
normal primary kidney the tsT cells also survived being passaged. Adult and foetal 
kidney cultures grown for longer than seven days at 39°C were found to die out slowly. 
Interestingly, if cells grown for seven days at 39°C and then split and put back at 33°C 
or 39°C the cells at 33°C recovered, while the cells at 39°C died out, showing that the 
cells require the SV40 T-antigen to survive.
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Figure 7.3: Morphology of adult kidney cultures at 33°C and 39°C.
A
Pasaged kidney cells were grown at 33°C and used to seed two T^5 flasks. The 
flasks were returned to 33°C until the cultures were just sub-confluent and the cells 
were photograph. At this point one of the two flasks were switched to 39°C.
B
The flasks were then incubated at the permissive or non-permissive temperature 
until confluent, at which point they were photographed.
C
The flasks were then incubated a further seven days and photographed again.
Adult Kidney
3 3 ° C 3 9 ° C
B
Figure 7.4: Morphology of embryonic kidney cultures at 33°C and 39°C.
A
Pasaged embryonic kidney cells were grown at 33°C and used to seed two T^5 
flasks. The flasks were returned to 33°C until the cultures were just sub-confluent and 
the cells were photograph. At this point one of the two flasks were switched to 39°C.
B
The flasks were then incubated at the permissive or non-permissive temperature 
until confluent, at which point they were photographed.
C
The flasks were then incubated a further seven days and photographed again.
Embryonic Kidney
33°C 39*t
B
C
It has been observed by others that some conditionally immortal hepatocyte and 
kidney tubule cell lines are growth arrested at the non-permissive temperature of 39°C 
and undergo apoptosis. The authors suggest that an accumulation of p53 which binds to 
T-antigen at 33°C is released at 39°C resulting in apoptosis (Yanai & Obinata, 1994). 
We find that kidney cultures grown at 33°C which are then split and switched to 39°C 
grow to reach confluence, will survive for about a week and then begin to die out. 
However, the mechanism of cell death in these cultures has not been examined.
7.4 Heat Stability of the tsT at 33°C and 39°C
To confirm that tsT has the expected properties in our culture system the levels 
of protein were assessed in both foetal and kidney cultures. Adult or foetal kidney 
cultures were grown to semi-confluence and then incubated at either 33°C or 39°C for 
seven days. Protein extracts were prepared with RIP A buffer (Materials and methods) 
and equal protein concentrations used in immunoprecipitation reactions with an SV40 
T-antigen monoclonal antibody (Sigma). Following SDS-PAGE electrophoresis the 
proteins were examined by Western blot analysis using the same SV40 T-antigen 
monoclonal antibody.
The results of this analysis are shown in figure 7.5. The 97.5kD tsT protein is 
clearly visible in embryonic kidney incubated at 33°C but not at 39°C (figure 7.5 A). 
Similar results are also observed with adult kidney cultures (figure 7.5 B). These results 
conclude that tsT is abundant in cells grown at the permissive temperature (33°C) but is 
degraded at the non-permissive temperature (39°C). This supports the observation that 
continual survival of tsT adult and foetal kidney cultures is due to the expression of the 
97.5kD tsT-antigen present in these cells.
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Figure 7.5: Heat stability of the 97.5kD T antigen in conditionally immortalised 
embryonic and adult kidney cultures.
Kidney cultures isolated from transgenic mice harbouring a temperature sensitve 
T antigen (Jat et al, 1989) were grown to just below confluence and then incubated at 
either 33°C or 39°C for seven days. Protein extracts were made using RIPA buffer and 
equal protein concentrations used in immuneprecipitation reactions. Sepharose 
A/Antibody/protein complexes were boiled and electrophorised on an SDS-PAGE gel 
(Material and methods). The proteins were then blotted onto ECL nitrocelluose 
membrane and the levels of T antigen determined by ECL detection according to the 
manufacturers protocol.
A
Expression of 97.5kD T antigen in embryonic cultures at either the permissive 
temperature of 33°C or non-permissive temperature of 39°C.
B
Expression of 97.5 kD T antigen in adult kidney cultures at either the permissive 
temperature of 33°C or non-permissive temperature of 39°C.
A
Embryonic Kidney
33 39
T antigen
B
Adult Kidney
33 39
T antigen
7.5 Evi-1 expression in adult and day 18.5p.c. foetal kidney cultures
To evaluate the Evi-1 expression levels in the isolated tsT adult kidney cultures a 
Northern blot was performed using an 2kb SstI fragment Evi-1 cDNA 32p-labelled 
probe (figure 7.6). Established kidney cultures were incubated at 33°C, the culture was 
split and then allowed to reach sub-confluence or confluence for 3 or 7 days, at both 
33°C and 39°C, before RNA was isolated.
Relatively high levels of the full length 5kb Evi-1 transcript were observed in 
'normal' adult kidney, tsT kidney and tsT primary adult kidney cultures (a less intense 
4.5kb transcript is typically seen in the cultures on longer exposure but in the following 
experiments only the full length 5kb transcript is shown). Passaged kidney cultures 
incubated at 33°C showed relatively low levels of expression, Evi-1 transcripts being 
detectable on longer exposure. The same expression pattern was also seen with 
passaged cultures incubated at 39°C. Similar observations were made with day 18.5p.c. 
foetal kidney cultures (figure 7.7).
The results show that Evi-1 expression is high when cells are first put into 
culture but is dramatically down regulated over a period of time. Therefore, we wished 
to establish when the down regulation occured. RNA was isolated from tsT primary 
kidney cultures, after one, two, three or four passages. To assess the abundance of the 
full length 5kb Evi-1 transcript at each split, Northern blot analysis was performed 
using a 2kb SstI fragment cDNA ^^P-labelled probe (figure 2.8). The moderate level 
of full length Evi-1 expression observed in primary kidney is maintained until the fourth 
passage at which point the level drops to undetectable. As indicated by the 7S loading 
control Passage 3 RNA was significantly underloaded, a faint Evi-1 band could be seen 
on the original autoradiograph within this lane suggesting that there may be some Evi-1 
expression still present at this passage. In conclusion, the primary kidney cultures
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Figure 7.6: Northern blot showing Evi-1 expression in adult kidney cultures
isolated from transgenic mice.
Northern blot analysis using a 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe.
The appropriate tissue or kidney culture from which RNA was isolated is given above 
each lane and is explained below,
Adult kidney- Kidney RNA was isolated from adult kidneys.
All the kidneys and cultures below were isolated from transgenic mice harbouring a 
temperature sensitive T antigen.
'Tf adult kidney- RNA was isolated from adult kidneys
Primary Kidney-kidney cultures established and RNA isolated at confluence
The following procedure was carried out at both 33°C and 39°C.
Sub-confluence-kidney cultures established over several passages were grown to just 
below confluence and then harvested for RNA.
3 days-kidney cultures established over several passages were grown to confluence, left 
for three days, and then harvested for RNA.
7 days-kidney cultures established over several passages were grown to confluence, left 
for seven days, and then harvested for RNA.
RNA loading was controlled by stripping the blots and re-probing with a 7S
32p-labelled probe.
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Figure 7.7: Northern blot showing Evi-1 expression in embryonic kidney cultures 
isolated from transgenic mice.
Northern blot analysis using a 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe.
The appropriate tissue or kidney culture from which RNA was isolated is given above 
each lane and is explained below,
All the kidneys and cultures below were isolated from transgenic mice harbouring a 
temperature sensitive T antigen.
'T ' adult kidney-RNA was isolated from embryonic kidneys taken at 18.5 days post­
coitus.
Primary Kidney-kidney cultures established and RNA isolated at confluence
The following procedure was carried out at both 33°C and 39°C.
Sub-confluence-kidney cultures established over several passages were grown to just 
below confluence and then harvested for RNA.
3 days-kidney cultures established over several passages were grown to confluence, left 
for three days, and then harvested for RNA.
7 days-kidney cultures established over several passages were grown to confluence, left 
for seven days, and then harvested for RNA.
RNA loading was controlled by stripping the blots and re-probing with a 7S
32p-labelled probe.
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express moderate levels of Evi-1 which is dramatically down regulated in established 
kidney cultures.
The results show that Evi-1 expression levels drop between the initial primary 
kidney cultures and the fourth passage (figure 7.8). The changes in expression may 
reflect the increasing predominance of low expressing cell types as the culture is 
passaged. Alternatively it may reflect an alteration in the high expressing cells as it is 
passaged, although cell morphology looks very similar, even after several passages. 
Although the diversity of cell types present in our cultures are unknown previous studies 
by other groups have identified similar cultures to contain proximal and distal tubular 
cells and endothelial and fibroblasts cells (Yanai et al 1991a; Ebert et al., 1990).
7.6 Functional analysis of Evi-1 reporter constructs in primary kidney cultures
The primary kidney cultures described above were used for the functional 
analysis of Evi-1 tissue specific gene expression. Evi-1 reporter constructs were 
transfected into primary kidney cultures which have been shown to express relatively 
high levels of Evi-1 (Chapter 7.5).
A selection of reporter constructs used in the basal promoter expression studies 
were chosen to analyse tissue specific expression of the Evi-1 promoter. These included 
the largest two constructs, pGL2E8 and pGL2E5, which contain DHS I & DHS II, 
pGL2E2 which has lost DHS I, the pGL2-338 construct which represents the mdnimum 
optimal basal promoter, pGL2-284, which results in a 50% reduction in basal promoter 
activity, pGL2-15 which has no TATA box but has the major initiation sites and the 
pGL2basic vector (Chapter 5.5).
Evi-1 reporter constructs were transfected into primary adult kidney cells from 
'normal' mice using DOTAP (Materials and methods). The primary kidney cultures are 
difficult to transfect and the luciferase activities are considerably lower than those seen
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Figure 7.8: Northern blot showing Evi-1 expression in embryonic kidney cultures 
over time in culture.
Northern blot analysis using a 2kb SstI fragment Evi-1 cDNA ^^P-labelled probe.
All the kidney cultures were isolated from transgenic mice harbouring a temperature 
sensitive T antigen.
RNA was isolated from primary embryonic kidney cultures or kidney cultures after the 
1st, 2nd, 3rd or fourth passage. The appropriate RNA is indicated above each lane.
RNA loading was controlled by stripping the blots and re-probing with a 7S 32p. 
labelled probe.
T em p: 33
in the cell lines 293, HEC-1B and L929. The results of promoter activity are shown in 
figure 7.9. The histogram shows promoter activity relative to the largest 8 kb fragment 
which represents 100% activity. The results suggest that the pGL2E8 construct is 
approximately 50% more active than the other reporter constructs tested, which is in 
contrast to the pattern of expression observed in the basal promoter studies. 
Furthermore, the drop in activity between -338 to -284 observed in basal expression 
studies is not seen. These data suggest that there are functional cis-acting sequences, 
located within an approximately 3kb region from within exon I, into intron I and down 
to the end of exon II, which are responsible for the increased promoter activity 
observed. These preliminary experiments are also supported by similar results observed 
in primary tsT adult and embryonic kidney cultures (figure 7.10 & 7.11).
7.7 Activity of reporter constructs in passaged tsT kidney cultures
Results from Northern blots had suggested that the Evi-1 expression levels in tsT 
kidney cultures is significantly decreased over time in culture such that by the fourth 
passage Evi-1 expression is undetectable (Chapter 7.8). To see if loss of expression also 
correlated with a change in the activity of the Evi-1 promoter constructs the same 
reporter constructs were transfected into tsT adult kidney cultures which had been 
passaged for several weeks (Material & methods). The results are shown in figure 7.12. 
In contrast to primary kidney cultures, there was no significant change in the relative 
luciferase activity between the pGL2E8 and pGL2E5 constructs suggesting that the 3' 
3kb region was not contributing to the transcriptional activity in these cells. There was 
also no difference in activity down to pGL2-338 and then an approximately 50 % drop 
in promoter activity is seen between pGL2-338 and pGL2-284. This trend in promoter 
activity is the same as that in 293, HEC-1B and L929 cell lines, described previously 
(Chapter 5.5). A similar trend is also seen in passaged tsT embryonic kidney cultures
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Figure 7.9: A histogram showing relative luciferase activity from Evi-1 promoter
constructs in primary adult kidney cultures.
5 jig of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
Pgal, which contains a P-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20|ig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 7.10: A histogram showing relative luciferase activity from Evi-1 promoter
constructs in primary adult tsT kidney cultures.
5p,g of pGL2basic or equimolar amounts were transfected with 5jng of pHSV- 
(3gal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 7.11: A histogram showing relative luciferase activity from Evi-1 promoter
constructs in primary embryonic tsT kidney cultures.
5(ig of pGL2basic or equimolar amounts were transfected with 5pg of pHSV- 
Pgal, which contains a P-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20pg with pKSH+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Figure 7.12: A histogram showing relative luciferase activity from Evi-1 promoter
constructs in passage adult tsT kidney cultures.
5pg of pGL2basic or equimolar amounts were transfected with 5jig of pHSV- 
Pgal, which contains a P-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20|ig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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transfected with the same constructs (figure 7.13). Consequently, there is a correlation 
between expression of the endogenous Evi-1 and activity of 3kb region.
7.8 Conclusions of transfections into primary and passaged kidney cultures
DHS analysis using an SstI digest revealed a faint DHS site which may map 
over the border between exon I and intron I. Deletion of this region in previous basal 
transcription studies and now also in passaged tsT kidney cultures has no effect on 
transcriptional activity. In contrast, preliminary results in primary kidney cultures has 
shown that an 8 kb EcoRI/Smal fragment within the pGL2E8 reporter construct has 
significantly higher activity (50-80%) in primary kidney cultures than the pGL2E5 
construct which has a 3' 3kb deletion including the exon I/intron I boundary. This 
suggests that tissue specific ds-acting sequences are present within a 3kb region from an 
SstI site at +272 to the end of exon II and that previous DHS analysis might suggest 
that this activity is located over the border of exon I/intron I.
In support of these observations are the results in passaged tsT kidney cultures, 
which have lost endogenous Evi-1 expression over time in culture, and the pattern of 
exogenous gene expression reverts to basal transcriptional regulation. Consequently, 
there is a correlation between Evi-1 expressing cultures and enhanced activity of 
pGL2E8 suggesting tissue specific expression of this construct in a proportion of 
primary kidney cells.
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Figure 7.13: A histogram showing relative luciferase activity from Evi-1 promoter
constructs in passaged embryonic tsT kidney cultures.
5pg of pGL2basic or equimolar amounts were transfected with 5(ig of pHSV- 
Pgal, which contains a p-galactosidase gene under the HSV-2 IE5 gene promoter. The 
total amount of DNA transfected was then made upto 20|ig with pKSII+ bluescript 
vector.
Transfections were carried out using DOTAP as described by the manufacturer.
The histogram illustrates the results obtained from a typical experiment carried 
out at least three times. Shaded bars on the histogram represent the average value from 
at least four independent transfections. Error bars show the maximum error from the 
mean.
The particular luciferase reporter construct used in each reaction is shown
schematically below each bar.
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Part 4: Discussion
Chapter 8: Discussion
Previous studies have implicated Evi-1 as being an important transcription factor 
in the development of specific murine tissues (kidney, lung and developing oocytes) and 
in the progression of some murine and human leukaemias, following ectopic expression 
of the gene. The aim of this project was to assess the factors controlling transcriptional 
regulation of the Evi-1 gene. The primary observations from this work are summarised 
below;
We have defined a minimal promoter activity between nucleotides -341 and +163
relative to the major initiation site, which coincides with the presence of a DHS,
designated DHS II. Sequential 5' deletion of the optimal basal promoter delineates two
regions -341 to -284 and -284 to -254 which are critical for maximal promoter activity in
293, HEC-1B and L929 cells. A DNAse 1 footprint was identified in each of these
regions, and designated FpIII and FpIV respectively. EMSA analysis identified a
potentially novel factor (complex), designated EvBPl which is required for optimal
activity and coincides with FpIII. The EvBPl monomer/oligo is approximately 97kD,
is
recognises the sequence tttccctggggaaa and''ubiquitous. EMSA analysis of FpIV 
identified a CCAAT binding protein, which might be CPI, binding to this region. In 
addition we have identified a 3' region between +48 to +163 important to basal activity.
We have established Evi-1 expressing kidney cultures as a system to examine 
tissue specific expression. This allowed the identification of a 3kb region, located 
between exon I and II, necessary for higher activity in the cultures. This activity might 
correlate with a DHS site which is part of the DHS II complex. Furthermore, a second 
ubiquitous DHS I site was identified, although a function has not been defined for this 
region yet.
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8.1 Minimal basal promoter activity
Functional analysis of the Evi-1 promoter identified a minimal promoter -341 to 
+163 which correlates with the presence of DHS II. In addition two footprinted regions, 
FpIH and FpIV, have been identified whose combined loss correlated with a drop in 70% 
of the total activity of the promoter. The protein interactions which occur over FpTTT 
and FpIV are discussed below;
The FpIII region binds a potentially novel transcription factor
EMSA of the FpIH region identified a major binding complex, designated EvBPl 
in all cell types examined. Deletion of this site, from -338 to -284, results in 50% drop in 
activity suggesting that the EvBPl complex is also a positive regulator of basal promoter 
activity. The majority of transcription factors bind to palindromic sequences which 
influences the way proteins line up with respect to the major/minor grooves of DNA 
(Pabo & Sauer, 1992). Consistent with this the EvBPl complex binds an 14bp imperfect 
palindromic sequence (chapter 6.7), tttccctggggaaa, which is absolutely conserved in the 
human Evi-1 promoter sequence (Ihle, unpublished data) suggesting that this recognition 
site may play an important part in regulation the Evi-1 gene. There were no other 
proteins identified upstream of EvBPl and the minor complexes downstream were 
observed to alter in intensity between experiments and cell lines (chapter 6.3). 
Consequently, we therefore propose that EvBPl is the major complex binding over this 
region contributing to basal promoter activity. To confirm this we intend to specifically 
delete the EvBPl binding site and examine the affect on optimal promoter activity. 
Alternatively, multiple copies of EvBPl binding sequence may be cloned upstream of an 
minimal promoter to see if it activates a heterologous promoter.
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Attempts to identify the components of the EvBPl complex by competition with 
consensus binding site oligonucleotides for other transcription factors revealed a potential 
link with C/EBP. However, the EvBPl complex is composed of a 97kD monomer/oligo, 
which may form dimers, and is heat labile which contrast with the properties exhibited by 
members of the C/EBP family. Competition of the EvBPl complex with excess C/EBP 
consensus site oligonucleotides may be due to fortuitous similarities in the sequence and 
represents a non-specific interaction. It is also plausible that other factors are present in 
the complex but perhaps only EvBPl binds DNA and therefore is cross-linked. The 
identity of the competitor of the EvBPl complex is unknown. Therefore, EvBPl might 
be a novel transcription factor which is involved in the transcriptional regulation of the 
Evi-1 gene.
In addition to EvBPl this region contains a number of putative recognition 
sequences for other proteins, including AP3, C/EBP, ets sequence and an inverted AP2 
sequence. AP2 (a  and P), members of the ets and C/EBP family have distinct expression 
patterns and have been implicated in tissue specific regulation (Mitchell et al., 1991; 
Moser et al., 1995; Seth et al., 1992; Birkenmeier et al., 1989). It is conceivable that the 
proteins binding over this region may differ depending on the cellular environment, and 
thereby influence tissue specific, inducible or basal expression of the EVI-1 protein. In 
support of this hypothesis is an observation from the competition experiments which 
suggest that the complex was composed of members of the C/EBP family. EMSA 
analysis using a C/EBP ^P-labelled probe, showed that the 3' FpIII region was able to 
compete for a C/EBP specific complex, which contrasted with the results using the whole 
Fpin or 5'Fpm region (chapter 6.5). The 3'FpIII probe contains only half of the EvBPl 
palindrome region and is unable to bind C/EBP. It is possible that in the absence of 
EvBPl that this unmasks a C/EBP site. However, if so, the excess Fpin and 5'Fpm 
should bind all the EvBPl but still have oligonucleotides free to compete for C/EBP. An 
explanation for this might be that EvBPl is particularly abundant. In support of this, the
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majority of labelled FpIH is shifted (figure 6.6) into the EvBPl complex, suggesting the 
levels of EvBPl may be particularly high in 293 cells. Alternatively, the intact inverted 
repeat may form secondary structure which prevents interaction of a C/EBP-like factor. 
Nonetheless, the data suggest that there are circumstances when this region can bind 
C/EBP.
DNA/Protein interaction over the FpIV region
As mentioned previously there are a selection of common motifs often found 
within the promoter of class II genes. Consistent with this, there are putative CCAAT 
and GC box elements within the Evi-1 promoter. Deletion of FpIV (-284 to -254) results 
in substantial reductions in basal promoter activity. Significantly a CCAAT box located 
upstream of the major initiation sites of the Evi-1 gene, was located in the middle of the 
FpIV region. A computer-based search of the Site-data data base of the FpIV region 
identified the CCAAT box as a putative CPI factor binding site. The CPI complex is 
composed of two sub-units CP la and CP lb which are both required for appropriate 
DNA binding (Chodosh et al., 1988). In addition to CPI a number of other proteins 
may also recognise the CCAAT site, including members of the C/EBP family, CP2 and 
NF1/CTF. However, the CCAAT proteins show selectivity for different sequences with 
the region immediately surrounding the CCAAT box important in specificity (Chodosh et 
al., 1988). CPI or related factors have been shown to bind to other promoter regions 
including the mouse a  globin, the MHC class II E a  and human hsp70 promoter (Cohen 
et al., 1986; Wu et al., 1987) and activate transcription in a positive manner. Further 
experiments are required to confirm the binding of CPI to this region which would 
initially include heat stability experiments to eliminate C/EBP factors binding to the FpIV 
region.
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FpIV is an extensive footprint from -277 to -208 suggesting that other proteins 
are binding over this region and this has been confirmed by EMSA analysis. 
Consequently, we cannot yet attribute the reduction in optimal promoter activity with the 
loss of only the CCAAT site. Once again it will be necessary to specifically delete the 
CCAAT site to conclusively determine its role in optimal basal promoter activity.
Protein interaction with other regions o f the minimal promoter
Functional analysis also identified other regions important in optimal basal 
promoter activity. For example, a steady reduction in activity was observed in 5' deletions 
between -254 to -15. It should be noted that deletions from -154 also result in the loss of 
minor initiation sites which may contribute to the reduction in activity. Furthermore, a 
substantial drop in basal promoter activity was also observed in the 3' deletion between 
+163 to +48. Preliminary EMSA analysis has suggested that there are protein interactions 
within these regions of the Evi-1 promoter (data not shown). For example, the Spl 
transcription factor may appear to target a putative Spl site between -163 to -158. 
Although there is no consensus Spl site between +163 to +48 the region is quite GC-rich 
and preliminary evidence that Spl may also bind in this region. The next logical step 
would be to use a combination of footprinting, EMSA and antibody supershift analysis of 
these regions to identify where the protein interactions occur and the factors binding.
8.2 Tissue specific expression of the Evi-1 promoter
Since DHS sites are generally associated with active promoter and enhancer 
elements (Gross and Garrard, 1988) we looked for a correlation between expression of 
the gene in a basal-, tissue specific- , and ectopic- manner and the chromatin structure
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surrounding the 5' Evi-1 gene. DHS analysis was performed in a number of different cell 
lines or tissues, i.e. DA-3, L929, FDCP-1 cells and kidney and spleen tissue and 
identified two DHS sites I and II over an 18kb region in the 5' Evil locus.
Functional analysis of the 5' Evi-1 locus identified a minimal basal promoter which 
correlated with the DHS II region. As already mentioned a number of protein
interactions have been observed over this region in vitro which presumably contribute to 
basal transcriptional activity. However, the functional significance of the DHS II region in 
tissue specific expression of the Evi-1 gene is less clear. Classically, tissue specific or 
lineage expression of a gene often correlates with the presence of a specific DHS site 
Although DHS II is present exclusively in Evi-1 expressing cells, its presence did not 
correlate with high level tissue specific expression of the gene, since it was also identified 
in low expressing Evi-1 cells (L929) (figure 4.7). This might suggest that tissue specific 
expression of the Evi-1 promoter may be dependent purely on the interaction of tissue 
specific transcription factors with DHS I or II rather, than being reliant on the relief of 
repressive effects mediated by the chromatin framework, following induction of tissue 
specific DHS sites. In support of this, a region of DHS II may confer tissue specific 
expression in primary murine kidney cultures.
It is possible that tissue specific expression of the Evi-1 gene may be dependent 
on the appropriate interaction of more ubiquitous factors. This form of regulation is also 
observed in other promoters. For example, the Pim-1 gene is selectively transcribed in 
haemato-lymphoid cell lines despite G/C-rich housekeeping promoter (Meeker et al., 
1990). Ectopic expression of the Evi-1 promoter in DA-3 cells illustrates that high levels 
of Evi-1 promoter expression is presumably not absolutely dependant on tissue specific 
factors, but may be mimicked by the integrated LTR. Consistent with this hypothesis is 
the presence of a DHS site at the Fim-3 locus mapping within the integrated LTR, found 
in DA-3 cells but not kidney tissue (Chapter 4.5). Similarly, ectopic expression of EVI-1
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in the translocation, inv (3)(q21q26), is believed to bring the gene under the regulation of 
the highly expressed Ribophorin I gene (Suzukama et al., 1994). Since the Ribophorin I 
gene is a constitutively active gene presumably ubiquitous factors regulate the promoter 
and subsequently the Evi-1 promoter in this translocation.
Presumably, if the Evi-1 promoter was regulated by constitutive factors the gene 
would have to be repressed in non—expressing cells, possibly by chromatin structure or 
methylation. Since there is no evidence for tissue specific DHS sites this may suggest that 
methylation is important in Evi-1 repression. Intriguing, one allele of the Evi-1 gene is 
methylated in DA-3 cells, the high expressing murine myeloid cell line (Bartholomew & 
Ihle, 1991). This question remains unsolved although some preliminary data suggests that 
the Evi-1 gene is not upregulated in 293 and RAG kidney cells following treatment with 
5-azacytidine (data not shown).
Functional analysis o f tissue specific expression o f the Evi-1 gene
The Evi-1 gene is normally expressed in a tissue specific manner, and therefore, 
one of the objectives of this study was to identify cis- and trans-acting factors involved. 
However, the absence of appropriate cell lines which express the endogenous Evi-1 gene 
has hindered this analysis. Therefore, a kidney cell culture system has been established to 
address this issue. Although normal kidney cultures express high levels of Evi-1 they have 
limited growth. By contrast, the tsT kidney cultures have extensive growth although, 
unfortunately, high levels of Evi-1 expression are maintained only for a limited period of 
time (3/4 passages). Attempts to isolate cell lines from this kidney culture have proved 
unsuccessful, and in any case since Evi-1 expression is lost after 3/4 passages it is likely 
that any cell lines established will have relatively low levels of Evi-1 expression.
Since these cultures initially consist of multiple cell types continued culture may 
favour establishment of cells which don't express Evi-1. Furthermore ft is interesting that
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only low Evi-1 expression is observed in the kidney cell lines examined suggesting that 
these cell lines might be established from cells not expressing Evi-1 or which have lost 
Evi-1 expression. Although In situ hybridisation experiments have suggested that high 
levels of Evi-1 are restricted mainly to kidney tubules the kidney is a heterogeneous organ 
and the precise cell type which expresses are unknown. Consequently, it is not 
immediately clear whether high levels of expression of Evi-1 in kidney is due to a general 
upregulation in a number of cell types or alternatively a small number of cells with high 
levels of expression.
A number of genes are commonly downregulated over time in culture by a 
mechanism that is thought to be due to the inhibitory effects of methylation over the 
appropriate promoter region. Examples include the thymidine kinase (Wise & Harris) 
and metallothionein (Compere & Palmittier, 1981) genes. Consequently, it is possible 
that Evi-1 may be repressed in a similar manner. Since it is not clear precisely what 
biological role Evi-1 plays in both adult and embryonic kidney development it is difficult 
to assess whether this may conflict with the establishment of high expressing cell lines. 
Interestingly, a separate study observed that Evi-1 mRNA levels are consistently reduced 
in a selection of kidney tumours (Bartholomew & Oshimura, unpublished data) 
suggesting that this event may be important in kidney tumour progression. Presumably, 
this effect must be tissue type dependant since, by contrast, ectopic expression of Evi-1 is 
believed to be an important determinant in the progression of some leukaemias and high 
Evi-1 expression is observed in established myeloid cell lines. Any of these possibilities, 
either singularly or in combination, may contribute to the technical problems of 
establishing and maintaining high Evi-1 expressing cell lines.
Functional analysis of the Evi-1 promoter in the primary kidney cultures has 
implicated a 3kb region 3' to the major transcriptional initiation sites as being important in 
tissue specific expression of the gene. The location of tissue specific elements within this 
3kb region which includes exon I and intron I and exon II is unknown. However, our
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analysis suggests a DHS site maps to this region at the exon I/intron I boundary. To 
identify putative protein binding sites within the exon I/intron I boundary an 
approximately 200bp of DNA from the end of exon I to an EcoRI site within intron I has 
been sequenced. The sequence is particularly G/C-rich and contains a putative site for 
Spl. Interestingly, these factors have been implicated in tissue specific expression of 
other genes and Spl has been proposed to be able to stabilise DNA looping, and 
enhancer mediated activation (Su et al., 1991). It is therefore conceivable that this region 
may direct tissue specific expression independently or alternatively by interaction with 
enhancer elements, possibly located within DHS I or IL However, further constructs will 
need to be made to assess: 1) the contribution of DHS I to tissue specific expression; 2) 
the region within the 3' 3kb region responsible for tissue specific expression. These 
studies could be performed in the primary kidney cultures, particularly if the transfection 
conditions are improved.
8.3 cAMP regulation of the Evi-1 promoter
Previous studies have shown that the Evi-1 promoter has been shown to be 
responsive to the levels of cAMP within cells and may be induced upto 16-fold by the 
addition of forskolin in the epithelial renal carcinoma cell line, A704 (Bartholomew & 
Clarke., 1993). However, the s tan ces  reponsible for this regulation have not been 
discribed. Response to intracellular cAMP levels can be mediated by two cis-acting 
elements, cyclic AMP response elements (CREs) and TPA response elements (TREs) 
which bind CREB (reviewed by Sassone-Corsi, 1995) and the AP2 proteins respectively, 
although both sequences may also bind other factors (reviewed by Karin, 1988). This is 
particularly interesting with regard to Evi-1 since there are three putative AP2 sites within 
the Evi-1 promoter and also putative CRE sites further upstream within DHS I (chapter 
5.16). The putative AP2 sites are located, (1) over the EvBPl recognition site (2) further
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upstream partially overlapping a previously identified footprinted region, Fpl 
(Bartholomew, unpublished data) (3) further downstream within the region lost in the 
deletion +163 to +48. A related factor to AP2, designated AP2(3 has recently been 
cloned, suggesting that there may be a family of related proteins (Moser et al., 1995). 
Interestingly, expression of AP2(3 is particularly high in kidney cells.
It would be of interest to identify which cw-acting elements are responsible for 
cAMP induction of Evi-1 but further investigation have been hampered by the low 
transfection efficiency of the A704 cell line (data not shown). Preliminary studies in 293 
cells, using forskolin to induce cAMP levels, did not have an effect on a 5kb Evi-1 
pGL2E5 reporter construct (data not shown). However, since forskolin does not induce 
the endogenous gene in 293 cells it is possible that there are other tissue specific factors 
present in A704 cells which contribute to the induction response. Consistent with this, a 
number of tissue specific regulated promoters require cAMP inducible elements in 
addition to a tissue specific factors to achieve optimal expression. For example, the tissue 
specific enhancer of the human glycoprotein hormone a-subunit gene requires cAMP- 
inducible elements to confer tissue specificity (Delgeane et al., 1987).
It is not clear whether the cAMP responsive pathway is important in vivo for the 
tissue specific expression pattern of the Evi-1 gene. However, it may be significant that 
the stimulation of adenylate cyclase activity by putative stimulating agents appears to be 
different for specific cell types in the kidney (Wilson et al., 1987). It would be 
interesting to see whether the cAMP response observed in A704 cells (16-fold) and 
normal primary kidney (2-fold) (Bartholomew & Clarke, 1993), is observed in the tsT 
kidney cultures.
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8.4 The function of DHS I
The location of the DHS I approximately 2 kb upstream of exon I suggested that 
this region may act as an enhancer of the Evi-1 gene, however, we have found no activity, 
either positive or negative, for this region on the basal expression of the Evi-1 promoter 
or on the heterologous SV40 or minimal tk promoters in transient transfection assays. 
Transient transfection experiments were used to identify transcriptional control elements 
and allow relatively rapid and comparative analysis of a range of constructs. However, a 
disadvantage of this technique is that the transient constructs are not organised into 
appropriate nucleosomal units, which may be essential for the function of some cis- 
elements on transcriptional expression. It is therefore possible that the function of DHS I 
region is not observed in transient assays. Examples of this type of regulation include the 
SAR (Klehr et al., 1991) or the functionally related Drosophila Scs regions, whose 
presence may activate transcription if stably integrated into the genome, but have no 
effect in transient transfection assays (chapter 1.8). Furthermore, there is evidence 
suggesting that some enhancers in vivo may function by suppressing PEV (chapter 1.7), 
altering the chromatin framework surrounding a gene resulting in a more accessible 
promoter region (Walters et al., 1996).
Although, the function of DHS I is as yet unknown, it is conceivable that it may 
function in a manner similar to that mentioned above. As a consequence, future 
experiments should involve the stable transfection of Evi-1 reporter constructs into cells 
to assess if DHS I has an effect on basal transcription levels. There are also a number of 
disadvantages about the use of stabile transfections. It is time consuming, particularly 
with a range of constructs, constructs may show positional dependent expression 
depending on the integration site, and the integrated constructs may form concatamgrs, 
altering the copy number. However, this can be controlled for by analysing a pool of 
colonies.
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Alternatively, the DHS I region may be important in the cAMP inducible nature of 
the Evi-1 gene. This is particularly significant because as mentioned previously the DHS 
I region contains putative API, CRE and TRE elements. However, it is also possible that 
DHS I has no enhancer capacity and that DHS I may reflect the presence of an 
alternative promoter, possibly even a tissue specific promoter. However, loss of DHS I 
in transient transfection assays had no effect on the overall promoter activity, suggesting 
that this probably isn't the case in basal expressing cells. It should also be noted, that the 
primary function of DHS I may be independent of transcription altogether, since DHS 
sites are also associated with sites for origins of DNA replication and chromosome 
segregation (Wolffe & Pruss, 1996).
Do other tissue specific DHS sites exist ?
It is conceivable that there are unidentified tissue specific DHS sites within the 
18kb region, but due to the heterogeneous nature of the kidney the proportion of high 
expressing cells within the population may be too small to detect them. Alternatively, 
since distal enhancers/silencers may function at considerable distances up- and 
downstream of the promoter there may be other DHS sites outside the 18kb region 
examined in this study. It is therefore still possible that the Evi-1 promoter region may be 
a target for other tissue specific enhancers.
We can conclude that the transcriptional regulation of the Evi-1 gene is 
complicated. The temporal and spatial expression pattern of Evi-1 in embryonic 
development suggests that the regulation of Evi-1 in development is tightly controlled. 
De-regulation of expression has profound consequences, this is dramatically 
demonstrated when Evi-1 is aberrantly expressed. For example, ablation of the Evi-1
1to<k id i
gene in knock-out studies A embryonic • while ectopic expression of the gene is 
associated the progression of some leukaemias. As a consequence it is perhaps not
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